1	The	DT	O	the	det	2	SENT_1	[p1l459t88r503b110],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nsubj	18	SENT_1	[p1l512t88r741b117],
3	loumal	JJ	O	loumal	amod	18	SENT_1	[p1l750t88r834b115],
4	(	CD	NUMBER	(	num	5	SENT_1	[p1l844t88r920b116],
5	2007	CD	DATE	2007	dep	3	SENT_1	[p1l844t88r920b116],
6	)	NN	O	)	dep	5	SENT_1	[p1l844t88r920b116],
7	7	CD	NUMBER	7	num	6	SENT_1	[p1l931t89r950b114],
8	,	,	O	,	_	0	SENT_1	[p1l931t89r950b114],
9	404-407	CD	NUMBER	404-407	num	13	SENT_1	[p1l959t88r1054b110],
10	©	CD	NUMBER	©	num	13	SENT_1	[p1l349t120r365b139],
11	2007	CD	DATE	2007	num	13	SENT_1	[p1l373t120r420b139],
12	Nature	NNP	O	Nature	nn	13	SENT_1	[p1l429t120r491b139],
13	Publishing	NNP	O	Publishing	appos	5	SENT_1	[p1l501t119r594b145],
14	Group	NNP	O	Group	nn	16	SENT_1	[p1l603t120r661b145],
15	All	NNP	O	All	nn	16	SENT_1	[p1l669t119r691b139],
16	rights	NNS	O	rights	nsubj	17	SENT_1	[p1l700t119r751b145],
17	reserved	VBD	O	reserve	rcmod	13	SENT_1	[p1l760t119r835b139],
18	1470-269X	NN	O	1470-269x	_	0	SENT_1	[p1l845t119r980b141],
19	/	:	O	/	punct	23	SENT_1	[p1l845t119r980b141],
20	07	CD	NUMBER	07	dep	23	SENT_1	[p1l845t119r980b141],
21	$	$	MONEY	$	dep	20	SENT_1	[p1l989t119r1054b140],
22	30.00	CD	MONEY	30.00	num	21	SENT_1	[p1l989t119r1054b140],
23	www.nature.com/tp]	NN	O	www.nature.com/tp]	parataxis	18	SENT_1	[p1l858t165r1053b190],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l1665t229r1919b268],
2	ARTICLE	NN	O	article	_	0	SENT_2	[p1l1939t229r2149b268],

1	Reduced	VBN	O	reduce	_	0	SENT_3	[p1l16t362r381b437],
2	folate	JJ	O	folate	amod	4	SENT_3	[p1l421t362r662b437],
3	carrier	NN	O	carrier	nn	4	SENT_3	[p1l703t364r1041b437],
4	—	NN	O	—	dobj	1	SENT_3	[p1l703t364r1041b437],
5	1	CD	NUMBER	1	num	6	SENT_3	[p1l703t364r1041b437],
6	80G	NN	O	80g	npadvmod	7	SENT_3	[p1l1102t364r1278b437],
7	>	JJR	O	>	dep	10	SENT_3	[p1l1304t365r1446b437],
8	A	DT	O	a	det	9	SENT_3	[p1l1304t365r1446b437],
9	polymorphism	NN	O	polymorphism	nsubj	10	SENT_3	[p1l1486t362r2111b461],
10	affects	VBZ	O	affect	dep	1	SENT_3	[p1l12t487r284b562],
11	methotrexate	NN	O	methotrexate	nn	13	SENT_3	[p1l328t487r912b562],
12	treatment	NN	O	treatment	nn	13	SENT_3	[p1l951t496r1385b562],
13	outcome	NN	O	outcome	dobj	10	SENT_3	[p1l1422t496r1807b562],
14	in	IN	O	in	_	0	SENT_3	[p1l1851t489r1920b561],
15	rheumatoid	JJ	O	rheumatoid	amod	16	SENT_3	[p1l15t612r515b687],
16	arthritis	NN	O	arthritis	prep_in	13	SENT_3	[p1l559t612r883b687],

1	M	NN	O	m	_	0	SENT_4	[p1l12t775r49b809],
2	Drozdzik	NN	O	drozdzik	nn	3	SENT_4	[p1l65t769r270b817],
3	‘	NN	O	‘	dep	1	SENT_4	[p1l65t769r270b817],
4	,	,	O	,	_	0	SENT_4	[p1l65t769r270b817],
5	T	NN	O	t	nn	7	SENT_4	[p1l283t775r310b809],
6	Rudas	NNP	PERSON	Rudas	nn	7	SENT_4	[p1l323t769r469b817],
7	‘	NNP	O	‘	conj_and	3	SENT_4	[p1l323t769r469b817],
8	,	,	O	,	_	0	SENT_4	[p1l323t769r469b817],
9	A	NNP	O	A	nn	10	SENT_4	[p1l483t775r512b809],
10	Pawlikl	NNP	O	Pawlikl	conj_and	3	SENT_4	[p1l525t769r679b817],
11	,	,	O	,	_	0	SENT_4	[p1l525t769r679b817],
12	W	NNP	O	W	nn	14	SENT_4	[p1l8t833r53b867],
13	Gornik	NNP	O	Gornik	nn	14	SENT_4	[p1l70t827r234b875],
14	‘	NN	O	‘	conj_and	3	SENT_4	[p1l70t827r234b875],
15	,	,	O	,	_	0	SENT_4	[p1l70t827r234b875],
16	M	NN	O	m	nn	18	SENT_4	[p1l257t833r294b867],
17	Kurzawski	NN	O	kurzawskus	nn	18	SENT_4	[p1l317t827r527b867],
18	‘	NN	O	‘	conj_and	3	SENT_4	[p1l317t827r527b867],
19	and	CC	O	and	_	0	SENT_4	[p1l552t831r625b867],
20	M	NN	O	m	nn	21	SENT_4	[p1l12t891r49b925],
21	Herczynskaz	NN	O	herczynskaz	dep	1	SENT_4	[p1l72t885r315b937],

1	‘	NNP	O	‘	nn	2	SENT_5	[p1l10t980r192b1016],
2	Department	NNP	O	Department	_	0	SENT_5	[p1l10t980r192b1016],
3	of	IN	O	of	_	0	SENT_5	[p1l204t983r232b1008],
4	Pharmacology	NNP	O	Pharmacology	prep_of	2	SENT_5	[p1l242t983r445b1016],
5	,	,	O	,	_	0	SENT_5	[p1l242t983r445b1016],
6	Pomeranian	NNP	ORGANIZATION	Pomeranian	nn	8	SENT_5	[p1l461t984r627b1008],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_5	[p1l10t1020r119b1046],
8	University	NNP	ORGANIZATION	University	conj_and	4	SENT_5	[p1l132t1021r271b1053],
9	,	,	O	,	_	0	SENT_5	[p1l132t1021r271b1053],
10	Szczecin	NNP	LOCATION	Szczecin	conj_and	4	SENT_5	[p1l287t1021r410b1051],
11	,	,	O	,	_	0	SENT_5	[p1l287t1021r410b1051],
12	Poland	NNP	LOCATION	Poland	conj_and	4	SENT_5	[p1l425t1020r521b1046],
13	and	CC	O	and	_	0	SENT_5	[p1l532t1020r586b1046],
14	2Department	NN	O	2department	conj_and	4	SENT_5	[p1l9t1055r192b1091],
15	of	IN	O	of	_	0	SENT_5	[p1l203t1058r232b1083],
16	Rheumatology	NNP	O	Rheumatology	prep_of	2	SENT_5	[p1l241t1058r446b1091],
17	,	,	O	,	_	0	SENT_5	[p1l241t1058r446b1091],
18	County	NNP	LOCATION	County	nn	19	SENT_5	[p1l462t1059r562b1091],
19	Hospital	NNP	LOCATION	Hospital	appos	16	SENT_5	[p1l572t1058r691b1091],
20	,	,	O	,	_	0	SENT_5	[p1l572t1058r691b1091],
21	Szczecin	NNP	LOCATION	Szczecin	appos	16	SENT_5	[p1l11t1096r133b1126],
22	,	,	O	,	_	0	SENT_5	[p1l11t1096r133b1126],
23	Poland	NNP	LOCATION	Poland	appos	16	SENT_5	[p1l149t1095r244b1120],

1	Correspondence	NN	O	correspondence	_	0	SENT_6	[p1l10t1178r271b1211],
2	:	:	O	:	_	0	SENT_6	[p1l10t1178r271b1211],
3	Dr	NN	O	dr	dep	1	SENT_6	[p1l11t1216r45b1240],
4	A	DT	O	a	det	5	SENT_6	[p1l55t1216r76b1240],
5	Pawlik	NNP	O	Pawlik	dep	1	SENT_6	[p1l89t1215r186b1246],
6	,	,	O	,	_	0	SENT_6	[p1l89t1215r186b1246],
7	Department	NNP	ORGANIZATION	Department	appos	1	SENT_6	[p1l202t1216r377b1248],
8	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l389t1215r417b1240],
9	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_of	7	SENT_6	[p1l430t1215r644b1248],
10	,	,	O	,	_	0	SENT_6	[p1l430t1215r644b1248],
11	Pomeranian	NNP	ORGANIZATION	Pomeranian	nn	13	SENT_6	[p1l11t1253r181b1278],
12	Medical	NNP	ORGANIZATION	Medical	nn	13	SENT_6	[p1l196t1253r307b1278],
13	University	NNP	ORGANIZATION	University	appos	1	SENT_6	[p1l323t1253r471b1286],
14	,	,	O	,	_	0	SENT_6	[p1l323t1253r471b1286],
15	ul	NN	O	ul	appos	1	SENT_6	[p1l486t1253r518b1278],
16	.	.	O	.	_	0	SENT_6	[p1l486t1253r518b1278],

1	Powst	NNP	O	Powst	_	0	SENT_7	[p1l535t1254r626b1278],
2	.	.	O	.	_	0	SENT_7	[p1l535t1254r626b1278],

1	Wlkp	NNP	MISC	Wlkp	_	0	SENT_8	[p1l8t1290r90b1323],
2	.	.	O	.	_	0	SENT_8	[p1l8t1290r90b1323],

1	72	CD	NUMBER	72	_	0	SENT_9	[p1l106t1291r148b1320],
2	,	,	O	,	_	0	SENT_9	[p1l106t1291r148b1320],
3	70-111	CD	NUMBER	70-111	num	6	SENT_9	[p1l165t1291r261b1315],
4	Szczecin	NNP	LOCATION	Szczecin	nn	6	SENT_9	[p1l281t1291r409b1320],
5	,	,	O	,	_	0	SENT_9	[p1l281t1291r409b1320],
6	Poland	NNP	LOCATION	Poland	appos	1	SENT_9	[p1l425t1290r530b1315],
7	.	.	O	.	_	0	SENT_9	[p1l425t1290r530b1315],

1	E-mail	NN	O	e-mail	_	0	SENT_10	[p1l11t1327r105b1352],
2	:	:	O	:	_	0	SENT_10	[p1l11t1327r105b1352],
3	pawand@poczta.onet.pl	NN	O	pawand@poczta.onet.pl	dep	1	SENT_10	[p1l121t1327r471b1360],

1	Received	VBN	O	receive	_	0	SENT_11	[p1l11t2578r145b2603],
2	17	CD	DATE	17	dobj	1	SENT_11	[p1l161t2579r196b2603],
3	October	NNP	DATE	October	tmod	1	SENT_11	[p1l209t2578r336b2603],
4	2006	CD	DATE	2006	num	3	SENT_11	[p1l348t2579r430b2608],
5	;	:	O	;	_	0	SENT_11	[p1l348t2579r430b2608],
6	revised	VBN	O	revise	parataxis	1	SENT_11	[p1l446t2578r553b2603],
7	4	CD	NUMBER	4	num	9	SENT_11	[p1l567t2579r586b2603],
8	lanuary	JJ	O	lanuary	amod	9	SENT_11	[p1l598t2579r714b2611],
9	2007	CD	DATE	2007	dobj	6	SENT_11	[p1l9t2616r92b2646],
10	;	:	O	;	_	0	SENT_11	[p1l9t2616r92b2646],
11	accepted	VBN	O	accept	parataxis	1	SENT_11	[p1l116t2615r254b2649],
12	9	CD	DATE	9	dobj	11	SENT_11	[p1l278t2616r295b2641],
13	January	NNP	DATE	January	tmod	11	SENT_11	[p1l317t2617r433b2649],
14	2007	CD	DATE	2007	num	13	SENT_11	[p1l456t2616r538b2646],
15	;	:	O	;	_	0	SENT_11	[p1l456t2616r538b2646],
16	published	VBN	O	publish	parataxis	1	SENT_11	[p1l564t2615r712b2649],
17	online	NN	O	online	prep	16	SENT_11	[p1l9t2653r104b2678],
18	27	CD	DATE	27	dep	17	SENT_11	[p1l118t2654r154b2678],
19	February	NNP	DATE	February	tmod	16	SENT_11	[p1l168t2653r302b2686],
20	2007	CD	DATE	2007	num	19	SENT_11	[p1l315t2654r389b2678],

1	The	DT	O	the	det	7	SENT_12	[p1l747t764r814b795],
2	folate	JJ	O	folate	amod	7	SENT_12	[p1l833t764r934b795],
3	antagonist	NN	O	antagonist	nn	7	SENT_12	[p1l955t764r1147b805],
4	methotrexate	NN	O	methotrexate	nn	7	SENT_12	[p1l1167t764r1412b795],
5	(	CD	NUMBER	(	num	7	SENT_12	[p1l1433t764r1547b803],
6	MTX	NN	O	mtx	nn	7	SENT_12	[p1l1433t764r1547b803],
7	)	NN	O	)	nsubj	10	SENT_12	[p1l1433t764r1547b803],
8	is	VBZ	O	be	cop	10	SENT_12	[p1l1569t764r1592b795],
9	a	DT	O	a	det	10	SENT_12	[p1l1612t773r1629b795],
10	drug	NN	O	drug	_	0	SENT_12	[p1l1651t764r1734b805],
11	currently	RB	DATE	currently	advmod	12	SENT_12	[p1l1756t764r1917b805],
12	used	VBN	O	use	partmod	10	SENT_12	[p1l1938t764r2018b795],
13	in	IN	O	in	_	0	SENT_12	[p1l2041t764r2070b795],
14	the	DT	O	the	det	15	SENT_12	[p1l2092t764r2149b795],
15	treatment	NN	O	treatment	prep_in	12	SENT_12	[p1l748t814r929b842],
16	of	IN	O	of	_	0	SENT_12	[p1l950t811r985b842],
17	rheumatoid	JJ	O	rheumatoid	amod	19	SENT_12	[p1l1008t810r1216b842],
18	arthritis	NN	O	arthritis	nn	19	SENT_12	[p1l1240t810r1375b842],
19	(	NN	O	(	prep_of	15	SENT_12	[p1l1399t811r1483b850],
20	RA	NN	O	ra	prep	19	SENT_12	[p1l1399t811r1483b850],
21	)	CD	NUMBER	)	dep	20	SENT_12	[p1l1399t811r1483b850],
22	.	.	O	.	_	0	SENT_12	[p1l1399t811r1483b850],

1	MTX	NN	O	mtx	nsubj	2	SENT_13	[p1l1510t812r1594b842],
2	enters	VBZ	O	enter	_	0	SENT_13	[p1l1616t814r1724b842],
3	the	DT	O	the	det	4	SENT_13	[p1l1746t810r1804b842],
4	cells	NNS	O	cell	dobj	2	SENT_13	[p1l1826t810r1901b842],
5	through	IN	O	through	_	0	SENT_13	[p1l1922t810r2068b852],
6	the	DT	O	the	det	9	SENT_13	[p1l2092t810r2149b842],
7	reduced	VBN	O	reduce	amod	9	SENT_13	[p1l750t857r894b888],
8	folate	NN	O	folate	nn	9	SENT_13	[p1l914t857r1015b888],
9	carrier	NN	O	carrier	prep_through	2	SENT_13	[p1l1034t858r1148b888],
10	(	CD	NUMBER	(	num	12	SENT_13	[p1l1167t857r1301b896],
11	RFC-1	NN	O	rfc-1	nn	12	SENT_13	[p1l1167t857r1301b896],
12	)	NN	O	)	dep	9	SENT_13	[p1l1167t857r1301b896],
13	and	CC	O	and	_	0	SENT_13	[p1l1321t857r1387b888],
14	is	VBZ	O	be	auxpass	15	SENT_13	[p1l1409t858r1431b888],
15	activated	VBN	O	activate	conj_and	2	SENT_13	[p1l1451t857r1613b888],
16	to	TO	O	to	_	0	SENT_13	[p1l1633t861r1669b888],
17	polyglutamates	NNS	O	polyglutamate	prep_to	15	SENT_13	[p1l1690t857r1979b898],
18	.	.	O	.	_	0	SENT_13	[p1l1690t857r1979b898],

1	Previous	JJ	O	previous	amod	2	SENT_14	[p1l2002t858r2149b888],
2	studies	NNS	O	study	nsubj	4	SENT_14	[p1l748t904r872b935],
3	have	VBP	O	have	aux	4	SENT_14	[p1l898t904r980b935],
4	shown	VBN	O	show	_	0	SENT_14	[p1l1004t904r1121b935],
5	that	IN	O	that	complm	9	SENT_14	[p1l1146t904r1219b935],
6	RFC-1	NN	MISC	rfc-1	nn	7	SENT_14	[p1l1244t905r1340b935],
7	expression	NN	O	expression	nsubj	9	SENT_14	[p1l1373t905r1562b945],
8	may	MD	O	may	aux	9	SENT_14	[p1l1589t913r1665b945],
9	influence	VB	O	influence	ccomp	4	SENT_14	[p1l1689t904r1852b935],
10	the	DT	O	the	det	11	SENT_14	[p1l1876t904r1933b935],
11	efficacy	NN	O	efficacy	dobj	9	SENT_14	[p1l1958t904r2093b945],
12	of	IN	O	of	_	0	SENT_14	[p1l2116t904r2151b935],
13	therapy	NN	O	therapy	prep_of	11	SENT_14	[p1l748t950r887b992],
14	with	IN	O	with	_	0	SENT_14	[p1l900t950r978b982],
15	MTX	NN	O	mtx	prep_with	9	SENT_14	[p1l997t952r1091b982],
16	.	.	O	.	_	0	SENT_14	[p1l997t952r1091b982],

1	The	DT	O	the	det	2	SENT_15	[p1l1107t950r1174b982],
2	studies	NNS	O	study	nsubj	3	SENT_15	[p1l1189t950r1313b982],
3	suggest	VBP	O	suggest	_	0	SENT_15	[p1l1328t954r1467b992],
4	that	IN	O	that	complm	10	SENT_15	[p1l1481t950r1553b982],
5	G80A	NN	O	g80a	nn	6	SENT_15	[p1l1568t951r1670b982],
6	polymorphism	NN	O	polymorphism	nsubjpass	10	SENT_15	[p1l1685t950r1946b992],
7	in	IN	O	in	_	0	SENT_15	[p1l1964t951r1993b981],
8	RFC-7	NN	O	rfc-7	prep_in	6	SENT_15	[p1l2012t951r2107b982],
9	is	VBZ	O	be	auxpass	10	SENT_15	[p1l2127t951r2149b982],
10	associated	VBN	O	associate	ccomp	3	SENT_15	[p1l749t997r932b1028],
11	with	IN	O	with	_	0	SENT_15	[p1l960t997r1037b1028],
12	altered	JJ	O	altered	amod	14	SENT_15	[p1l1066t997r1188b1028],
13	folate/antifolate	JJ	O	folate/antifolate	amod	14	SENT_15	[p1l1215t997r1504b1032],
14	levels	NNS	O	level	prep_with	10	SENT_15	[p1l1533t997r1627b1028],
15	and	CC	O	and	_	0	SENT_15	[p1l1655t997r1720b1028],
16	the	DT	O	the	det	17	SENT_15	[p1l1748t997r1805b1028],
17	subjects	NNS	O	subject	nsubj	23	SENT_15	[p1l1832t997r1976b1038],
18	carrying	VBG	O	carry	partmod	17	SENT_15	[p1l2003t998r2148b1038],
19	homozygous	JJ	O	homozygous	amod	22	SENT_15	[p1l750t1044r983b1085],
20	mutant	JJ	O	mutant	amod	22	SENT_15	[p1l1000t1047r1132b1075],
21	8OAA	NN	O	8oaa	nn	22	SENT_15	[p1l1147t1045r1243b1075],
22	genotype	NN	O	genotype	dobj	18	SENT_15	[p1l1258t1047r1430b1085],
23	tend	VBP	O	tend	ccomp	3	SENT_15	[p1l1445t1044r1526b1075],
24	to	TO	O	to	aux	25	SENT_15	[p1l1542t1048r1578b1075],
25	have	VB	O	have	xcomp	23	SENT_15	[p1l1595t1044r1678b1075],
26	higher	JJR	O	higher	amod	28	SENT_15	[p1l1695t1044r1811b1085],
27	plasma	NN	O	plasma	nn	28	SENT_15	[p1l1826t1044r1951b1085],
28	folate	NN	O	folate	dobj	25	SENT_15	[p1l1966t1044r2066b1075],
29	and	CC	O	and	_	0	SENT_15	[p1l2082t1044r2148b1075],
30	MTX	NN	O	mtx	nn	31	SENT_15	[p1l751t1092r834b1122],
31	concentrations	NNS	O	concentration	dobj	25	SENT_15	[p1l851t1091r1119b1122],
32	and	CC	O	and	_	0	SENT_15	[p1l1135t1091r1201b1122],
33	higher	JJR	O	higher	amod	36	SENT_15	[p1l1220t1091r1336b1132],
34	erythrocyte	NN	O	erythrocyte	nn	36	SENT_15	[p1l1351t1091r1557b1132],
35	polyglutamate	NN	O	polyglutamate	nn	36	SENT_15	[p1l1575t1091r1837b1132],
36	levels	NNS	O	level	conj_and	28	SENT_15	[p1l1855t1091r1949b1122],
37	compared	VBN	O	compare	_	0	SENT_15	[p1l1965t1091r2148b1132],
38	with	IN	O	with	prepc_compared_with	36	SENT_15	[p1l748t1137r825b1168],
39	those	DT	O	those	pobj	36	SENT_15	[p1l844t1137r941b1168],
40	with	IN	O	with	_	0	SENT_15	[p1l958t1137r1036b1168],
41	the	DT	O	the	det	43	SENT_15	[p1l1055t1137r1112b1168],
42	wild	JJ	O	wild	amod	43	SENT_15	[p1l1129t1137r1203b1168],
43	type	NN	O	type	prep_with	39	SENT_15	[p1l1222t1141r1301b1178],
44	or	CC	O	or	_	0	SENT_15	[p1l1319t1146r1356b1168],
45	heterozygous	JJ	O	heterozygous	amod	46	SENT_15	[p1l1373t1137r1616b1178],
46	genotype	NN	O	genotype	prep_with	39	SENT_15	[p1l1634t1141r1816b1178],
47	.	.	O	.	_	0	SENT_15	[p1l1634t1141r1816b1178],

1	It	PRP	O	it	nsubj	3	SENT_16	[p1l1838t1138r1860b1168],
2	is	VBZ	O	be	cop	3	SENT_16	[p1l1877t1138r1899b1168],
3	possible	JJ	O	possible	_	0	SENT_16	[p1l1918t1137r2061b1178],
4	that	IN	O	that	complm	8	SENT_16	[p1l2078t1137r2151b1168],
5	this	DT	O	this	det	6	SENT_16	[p1l748t1184r811b1215],
6	polymorphism	NN	O	polymorphism	nsubj	8	SENT_16	[p1l826t1184r1087b1225],
7	might	MD	O	might	aux	8	SENT_16	[p1l1104t1184r1211b1225],
8	influence	VB	O	influence	ccomp	3	SENT_16	[p1l1225t1184r1388b1215],
9	MTX	NN	O	mtx	nn	11	SENT_16	[p1l1403t1185r1487b1215],
10	treatment	NN	O	treatment	nn	11	SENT_16	[p1l1501t1188r1682b1215],
11	outcome	NN	O	outcome	dobj	8	SENT_16	[p1l1694t1188r1855b1215],
12	in	IN	O	in	_	0	SENT_16	[p1l1870t1185r1899b1215],
13	patients	NNS	O	patient	prep_in	11	SENT_16	[p1l1916t1185r2057b1225],
14	with	IN	O	with	_	0	SENT_16	[p1l2070t1184r2148b1215],
15	RA	NN	O	ra	prep_with	8	SENT_16	[p1l751t1232r805b1262],
16	.	.	O	.	_	0	SENT_16	[p1l751t1232r805b1262],

1	In	IN	O	in	_	0	SENT_17	[p1l824t1232r853b1262],
2	the	DT	O	the	det	4	SENT_17	[p1l869t1231r927b1262],
3	present	JJ	DATE	present	amod	4	SENT_17	[p1l944t1234r1077b1272],
4	study	NN	O	study	prep_in	7	SENT_17	[p1l1090t1231r1197b1272],
5	,	,	O	,	_	0	SENT_17	[p1l1090t1231r1197b1272],
6	we	PRP	O	we	nsubj	7	SENT_17	[p1l1214t1240r1266b1262],
7	examined	VBD	O	examine	_	0	SENT_17	[p1l1281t1231r1458b1262],
8	the	DT	O	the	det	9	SENT_17	[p1l1475t1231r1532b1262],
9	association	NN	O	association	nsubj	15	SENT_17	[p1l1548t1231r1743b1262],
10	between	IN	O	between	_	0	SENT_17	[p1l1761t1231r1915b1262],
11	RFC	NNP	O	RFC	prep_between	9	SENT_17	[p1l1934t1232r2029b1262],
12	—	CD	NUMBER	—	number	13	SENT_17	[p1l1934t1232r2029b1262],
13	7	CD	NUMBER	7	num	15	SENT_17	[p1l1934t1232r2029b1262],
14	G80A	NN	O	g80a	nn	15	SENT_17	[p1l2048t1232r2150b1262],
15	polymorphism	NN	O	polymorphism	xcomp	7	SENT_17	[p1l750t1277r1011b1319],
16	and	CC	O	and	_	0	SENT_17	[p1l1037t1277r1103b1309],
17	treatment	NN	O	treatment	nn	18	SENT_17	[p1l1128t1281r1309b1309],
18	outcome	NN	O	outcome	xcomp	7	SENT_17	[p1l1332t1281r1493b1309],
19	in	IN	O	in	_	0	SENT_17	[p1l1519t1278r1548b1308],
20	patients	NNS	O	patient	prep_in	15	SENT_17	[p1l1575t1278r1717b1319],
21	with	IN	O	with	_	0	SENT_17	[p1l1739t1277r1817b1309],
22	RA	NN	O	ra	prep_with	20	SENT_17	[p1l1845t1279r1890b1309],
23	administered	VBN	O	administer	partmod	22	SENT_17	[p1l1913t1277r2148b1309],
24	MTX	NNP	O	MTX	dobj	23	SENT_17	[p1l751t1325r844b1355],
25	.	.	O	.	_	0	SENT_17	[p1l751t1325r844b1355],

1	The	DT	O	the	det	2	SENT_18	[p1l861t1324r928b1355],
2	study	NN	O	study	nsubjpass	4	SENT_18	[p1l944t1324r1043b1365],
3	was	VBD	O	be	auxpass	4	SENT_18	[p1l1057t1333r1125b1355],
4	carried	VBN	O	carry	dep	9	SENT_18	[p1l1141t1324r1262b1355],
5	out	RP	O	out	prt	4	SENT_18	[p1l1280t1328r1340b1355],
6	on	IN	O	on	_	0	SENT_18	[p1l1355t1333r1399b1355],
7	174	CD	NUMBER	174	num	8	SENT_18	[p1l1419t1325r1485b1355],
8	patients	NNS	O	patient	prep_on	4	SENT_18	[p1l1503t1325r1645b1365],
9	diagnosed	VBD	O	diagnose	_	0	SENT_18	[p1l1661t1324r1847b1365],
10	with	IN	O	with	_	0	SENT_18	[p1l1863t1324r1941b1355],
11	RA	NN	O	ra	prep_with	9	SENT_18	[p1l1961t1325r2006b1355],
12	treated	VBN	O	treat	partmod	11	SENT_18	[p1l2021t1324r2148b1355],
13	with	IN	O	with	_	0	SENT_18	[p1l748t1371r825b1403],
14	MTX	NN	O	mtx	prep_with	12	SENT_18	[p1l849t1372r933b1402],
15	(	CD	NUMBER	(	num	14	SENT_18	[p1l953t1371r1128b1411],
16	7.5	CD	NUMBER	7.5	num	17	SENT_18	[p1l953t1371r1128b1411],
17	—	NN	O	—	nsubj	9	SENT_18	[p1l953t1371r1128b1411],
18	15.0	CD	NUMBER	15.0	num	19	SENT_18	[p1l953t1371r1128b1411],
19	mg	NN	O	mg	dep	17	SENT_18	[p1l1140t1380r1196b1413],
20	weekly	JJ	SET	weekly	amod	21	SENT_18	[p1l1216t1371r1354b1413],
21	)	NN	O	)	dep	19	SENT_18	[p1l1216t1371r1354b1413],
22	plus	CC	O	plus	_	0	SENT_18	[p1l1376t1371r1447b1413],
23	low	JJ	O	low	amod	24	SENT_18	[p1l1468t1371r1531b1403],
24	doses	NNS	O	dose	dep	17	SENT_18	[p1l1550t1371r1649b1403],
25	of	IN	O	of	_	0	SENT_18	[p1l1669t1371r1704b1403],
26	methylprednisone	NN	O	methylprednisone	prep_of	24	SENT_18	[p1l1723t1371r2062b1413],
27	.	.	O	.	_	0	SENT_18	[p1l1723t1371r2062b1413],

1	The	DT	O	the	det	3	SENT_19	[p1l2082t1371r2149b1403],
2	RFC-1	NN	O	rfc-1	nn	3	SENT_19	[p1l750t1419r845b1450],
3	8OG	NN	O	8og	npadvmod	4	SENT_19	[p1l863t1419r1007b1450],
4	>	JJR	O	>	amod	7	SENT_19	[p1l863t1419r1007b1450],
5	A	DT	O	a	det	7	SENT_19	[p1l863t1419r1007b1450],
6	polymorphism	NN	O	polymorphism	nn	7	SENT_19	[p1l1020t1418r1281b1460],
7	(	NN	O	(	nsubjpass	20	SENT_19	[p1l1297t1418r1465b1460],
8	resulting	VBG	O	result	partmod	7	SENT_19	[p1l1297t1418r1465b1460],
9	in	IN	O	in	_	0	SENT_19	[p1l1481t1419r1510b1449],
10	a	DT	O	a	det	12	SENT_19	[p1l1525t1427r1542b1450],
11	histidine-to-arginine	JJ	O	histidine-to-arginine	amod	12	SENT_19	[p1l1558t1418r1924b1460],
12	substitution	NN	O	substitution	prep_in	8	SENT_19	[p1l1936t1418r2148b1450],
13	at	IN	O	at	_	0	SENT_19	[p1l749t1469r782b1497],
14	codon	NN	O	codon	prep_at	12	SENT_19	[p1l804t1465r916b1497],
15	27	CD	NUMBER	27	num	14	SENT_19	[p1l941t1466r985b1497],
16	of	IN	O	of	_	0	SENT_19	[p1l1009t1465r1044b1497],
17	RFC-1	NN	O	rfc-1	nn	18	SENT_19	[p1l1067t1465r1185b1505],
18	)	NN	O	)	prep_of	14	SENT_19	[p1l1067t1465r1185b1505],
19	was	VBD	O	be	auxpass	20	SENT_19	[p1l1208t1474r1275b1497],
20	detected	VBN	O	detect	_	0	SENT_19	[p1l1298t1465r1456b1497],
21	using	VBG	O	use	xcomp	20	SENT_19	[p1l1481t1466r1575b1507],
22	a	DT	O	a	det	26	SENT_19	[p1l1599t1474r1616b1497],
23	polymerase	NN	O	polymerase	nn	26	SENT_19	[p1l1641t1465r1847b1507],
24	chain	NN	O	chain	nn	26	SENT_19	[p1l1870t1465r1965b1497],
25	reactionrestriction	NN	O	reactionrestriction	nn	26	SENT_19	[p1l1991t1466r2149b1497, p1l750t1513r927b1544],
26	fragment	NN	O	fragment	dobj	21	SENT_19	[p1l959t1512r1128b1554],
27	length	NN	O	length	nn	29	SENT_19	[p1l1160t1512r1273b1554],
28	polymorphism	NN	O	polymorphism	nn	29	SENT_19	[p1l1309t1512r1570b1554],
29	method	NN	O	method	dep	26	SENT_19	[p1l1605t1512r1756b1544],
30	.	.	O	.	_	0	SENT_19	[p1l1605t1512r1756b1544],

1	The	DT	O	the	det	2	SENT_20	[p1l1789t1512r1856b1544],
2	probability	NN	O	probability	nsubj	10	SENT_20	[p1l1890t1512r2085b1554],
3	of	IN	O	of	_	0	SENT_20	[p1l2116t1512r2151b1544],
4	remission	NN	O	remission	prep_of	2	SENT_20	[p1l750t1560r917b1590],
5	of	IN	O	of	_	0	SENT_20	[p1l933t1559r968b1590],
6	RA	NN	O	ra	nn	7	SENT_20	[p1l982t1561r1027b1590],
7	symptoms	NNS	O	symptom	prep_of	4	SENT_20	[p1l1040t1563r1228b1600],
8	was	VBD	O	be	cop	10	SENT_20	[p1l1240t1568r1308b1590],
9	3.32-fold	RB	O	3.32-fold	advmod	10	SENT_20	[p1l1324t1559r1486b1590],
10	higher	JJR	O	higher	_	0	SENT_20	[p1l1503t1559r1619b1600],
11	in	IN	O	in	_	0	SENT_20	[p1l1633t1560r1662b1590],
12	carriers	NNS	O	carrier	prep_in	10	SENT_20	[p1l1677t1560r1806b1590],
13	of	IN	O	of	_	0	SENT_20	[p1l1820t1559r1855b1590],
14	8OAA	NN	O	8oaa	nn	15	SENT_20	[p1l1867t1560r1964b1590],
15	genotype	NN	O	genotype	prep_of	12	SENT_20	[p1l1977t1563r2149b1600],
16	as	IN	O	as	prep	10	SENT_20	[p1l749t1615r783b1637],
17	compared	VBN	O	compare	_	0	SENT_20	[p1l797t1606r980b1647],
18	with	IN	O	with	prepc_compared_with	10	SENT_20	[p1l994t1606r1072b1637],
19	patients	NNS	O	patient	pobj	10	SENT_20	[p1l1089t1606r1230b1647],
20	with	IN	O	with	_	0	SENT_20	[p1l1243t1606r1321b1637],
21	80GG	NN	O	80gg	nn	22	SENT_20	[p1l1337t1607r1441b1637],
22	genotype	NN	O	genotype	prep_with	19	SENT_20	[p1l1458t1609r1630b1647],
23	(	CD	NUMBER	(	num	24	SENT_20	[p1l1644t1606r1716b1645],
24	P	NN	O	p	dep	22	SENT_20	[p1l1644t1606r1716b1645],
25	:	:	O	:	_	0	SENT_20	[p1l1644t1606r1716b1645],
26	0.021	CD	NUMBER	0.021	dep	24	SENT_20	[p1l1726t1607r1841b1644],
27	,	,	O	,	_	0	SENT_20	[p1l1726t1607r1841b1644],
28	OR	NN	O	or	appos	26	SENT_20	[p1l1857t1607r1911b1637],
29	=	JJ	O	=	amod	28	SENT_20	[p1l1921t1621r1948b1631],
30	3.32	CD	NUMBER	3.32	tmod	29	SENT_20	[p1l1961t1607r2049b1644],
31	,	,	O	,	_	0	SENT_20	[p1l1961t1607r2049b1644],
32	95	CD	PERCENT	95	number	33	SENT_20	[p1l2066t1607r2149b1637],
33	%	NN	PERCENT	%	amod	34	SENT_20	[p1l2066t1607r2149b1637],
34	CI	NN	O	ci	appos	26	SENT_20	[p1l749t1654r795b1685],
35	:	:	O	:	_	0	SENT_20	[p1l749t1654r795b1685],
36	1.26-8	CD	NUMBER	1.26-8	num	38	SENT_20	[p1l816t1653r1024b1693],
37	.79	CD	NUMBER	.79	num	38	SENT_20	[p1l816t1653r1024b1693],
38	)	NN	O	)	dep	24	SENT_20	[p1l816t1653r1024b1693],
39	.	.	O	.	_	0	SENT_20	[p1l816t1653r1024b1693],

1	The	DT	O	the	det	2	SENT_21	[p1l1040t1653r1107b1685],
2	frequency	NN	O	frequency	nsubj	10	SENT_21	[p1l1122t1653r1304b1695],
3	of	IN	O	of	_	0	SENT_21	[p1l1319t1653r1354b1685],
4	A	DT	O	a	det	5	SENT_21	[p1l1367t1654r1393b1684],
5	allele	NN	O	allele	prep_of	2	SENT_21	[p1l1408t1653r1498b1685],
6	among	IN	O	among	_	0	SENT_21	[p1l1514t1662r1641b1695],
7	MTX	NNP	O	MTX	nn	8	SENT_21	[p1l1660t1654r1744b1684],
8	responders	NNS	O	responder	prep_among	5	SENT_21	[p1l1761t1653r1958b1695],
9	was	VBD	O	be	cop	10	SENT_21	[p1l1972t1662r2040b1685],
10	62.1	CD	NUMBER	62.1	dep	23	SENT_21	[p1l2057t1654r2147b1691],
11	,	,	O	,	_	0	SENT_21	[p1l2057t1654r2147b1691],
12	compared	VBN	O	compare	_	0	SENT_21	[p1l749t1700r931b1741],
13	to	TO	O	to	prepc_compared_to	10	SENT_21	[p1l962t1704r998b1732],
14	47.8	CD	PERCENT	47.8	num	15	SENT_21	[p1l1028t1701r1148b1732],
15	%	NN	PERCENT	%	pobj	10	SENT_21	[p1l1028t1701r1148b1732],
16	in	IN	O	in	_	0	SENT_21	[p1l1180t1701r1209b1731],
17	a	DT	O	a	det	18	SENT_21	[p1l1241t1709r1258b1732],
18	group	NN	O	group	prep_in	15	SENT_21	[p1l1289t1709r1397b1741],
19	of	IN	O	of	_	0	SENT_21	[p1l1428t1700r1463b1732],
20	poor	JJ	O	poor	amod	22	SENT_21	[p1l1493t1709r1577b1741],
21	MTX	NN	O	mtx	nn	22	SENT_21	[p1l1608t1701r1692b1731],
22	responders	NNS	O	responder	prep_of	18	SENT_21	[p1l1723t1700r1920b1741],
23	(	VBP	O	(	_	0	SENT_21	[p1l1951t1701r2147b1739],
24	P	NN	O	p	dobj	23	SENT_21	[p1l1951t1701r2147b1739],
25	=	JJ	O	=	amod	26	SENT_21	[p1l1951t1701r2147b1739],
26	0.013	CD	NUMBER	0.013	nsubj	23	SENT_21	[p1l1951t1701r2147b1739],
27	,	,	O	,	_	0	SENT_21	[p1l1951t1701r2147b1739],
28	OR	NN	O	or	appos	26	SENT_21	[p1l749t1748r840b1779],
29	:	:	O	:	_	0	SENT_21	[p1l749t1748r840b1779],
30	1.78	CD	NUMBER	1.78	dep	28	SENT_21	[p1l853t1748r941b1785],
31	,	,	O	,	_	0	SENT_21	[p1l853t1748r941b1785],
32	95	CD	PERCENT	95	number	33	SENT_21	[p1l960t1748r1043b1779],
33	%	NN	PERCENT	%	amod	34	SENT_21	[p1l960t1748r1043b1779],
34	CI	NN	O	ci	appos	30	SENT_21	[p1l1060t1748r1106b1779],
35	:	:	O	:	_	0	SENT_21	[p1l1060t1748r1106b1779],
36	1.13-2	CD	NUMBER	1.13-2	number	37	SENT_21	[p1l1127t1747r1335b1787],
37	.81	CD	NUMBER	.81	num	38	SENT_21	[p1l1127t1747r1335b1787],
38	)	NN	O	)	dep	34	SENT_21	[p1l1127t1747r1335b1787],
39	.	.	O	.	_	0	SENT_21	[p1l1127t1747r1335b1787],

1	Moreover	RB	O	moreover	advmod	9	SENT_22	[p1l1355t1748r1538b1785],
2	,	,	O	,	_	0	SENT_22	[p1l1355t1748r1538b1785],
3	the	DT	O	the	det	4	SENT_22	[p1l1556t1747r1613b1779],
4	increase	NN	O	increase	nsubjpass	9	SENT_22	[p1l1631t1748r1774b1779],
5	of	IN	O	of	_	0	SENT_22	[p1l1791t1747r1826b1779],
6	aminotransferase	NN	O	aminotransferase	nn	7	SENT_22	[p1l1841t1747r2149b1779],
7	activity	NN	O	activity	prep_of	4	SENT_22	[p1l749t1795r877b1836],
8	was	VBD	O	be	auxpass	9	SENT_22	[p1l889t1803r957b1826],
9	noted	VBN	O	note	_	0	SENT_22	[p1l972t1794r1074b1826],
10	more	RBR	O	more	advmod	11	SENT_22	[p1l1091t1803r1183b1826],
11	frequently	RB	O	frequently	advmod	9	SENT_22	[p1l1196t1794r1382b1836],
12	in	IN	O	in	_	0	SENT_22	[p1l1396t1795r1425b1825],
13	carriers	NNS	O	carrier	prep_in	9	SENT_22	[p1l1440t1795r1568b1826],
14	of	IN	O	of	_	0	SENT_22	[p1l1582t1794r1617b1826],
15	8OAA	NN	O	8oaa	nn	16	SENT_22	[p1l1629t1795r1726b1826],
16	genotype	NN	O	genotype	prep_of	13	SENT_22	[p1l1739t1798r1921b1836],
17	.	.	O	.	_	0	SENT_22	[p1l1739t1798r1921b1836],

1	The	DT	O	the	det	3	SENT_23	[p1l1935t1794r2002b1826],
2	present	JJ	DATE	present	amod	3	SENT_23	[p1l2017t1798r2151b1836],
3	data	NNS	O	datum	nsubj	4	SENT_23	[p1l749t1841r826b1873],
4	suggest	VBP	O	suggest	_	0	SENT_23	[p1l841t1845r980b1883],
5	that	IN	O	that	complm	18	SENT_23	[p1l993t1841r1066b1873],
6	evaluation	NN	O	evaluation	nsubj	18	SENT_23	[p1l1079t1841r1264b1873],
7	of	IN	O	of	_	0	SENT_23	[p1l1280t1841r1316b1873],
8	RFC-1	NN	O	rfc-1	nn	10	SENT_23	[p1l1330t1842r1425b1873],
9	gene	NN	O	gene	nn	10	SENT_23	[p1l1443t1851r1532b1883],
10	8OG	NN	O	8og	prep_of	6	SENT_23	[p1l1547t1842r1691b1873],
11	>	JJR	O	>	amod	13	SENT_23	[p1l1547t1842r1691b1873],
12	A	DT	O	a	det	13	SENT_23	[p1l1547t1842r1691b1873],
13	polymorphism	NN	O	polymorphism	dep	10	SENT_23	[p1l1706t1841r1967b1883],
14	may	MD	O	may	aux	18	SENT_23	[p1l1984t1851r2060b1883],
15	be	VB	O	be	cop	18	SENT_23	[p1l2075t1841r2117b1873],
16	a	DT	O	a	det	18	SENT_23	[p1l2131t1851r2149b1873],
17	useful	JJ	O	useful	amod	18	SENT_23	[p1l750t1888r851b1919],
18	tool	NN	O	tool	ccomp	4	SENT_23	[p1l869t1888r937b1919],
19	to	TO	O	to	aux	20	SENT_23	[p1l955t1892r990b1919],
20	optimize	VB	O	optimize	infmod	18	SENT_23	[p1l1007t1889r1164b1929],
21	MTX	NN	O	mtx	nn	22	SENT_23	[p1l1183t1889r1267b1919],
22	therapy	NN	O	therapy	dobj	20	SENT_23	[p1l1283t1888r1422b1929],
23	in	IN	O	in	_	0	SENT_23	[p1l1439t1889r1467b1919],
24	patients	NNS	O	patient	prep_in	20	SENT_23	[p1l1487t1889r1628b1929],
25	with	IN	O	with	_	0	SENT_23	[p1l1644t1888r1722b1919],
26	RA	NN	O	ra	prep_with	24	SENT_23	[p1l1742t1889r1796b1919],
27	.	.	O	.	_	0	SENT_23	[p1l1742t1889r1796b1919],

1	The	DT	O	the	det	3	SENT_24	[p1l753t1935r812b1966],
2	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nn	3	SENT_24	[p1l823t1935r1150b1976],
3	journal	NN	O	journal	_	0	SENT_24	[p1l1158t1935r1281b1973],
4	(	CD	NUMBER	(	num	5	SENT_24	[p1l1290t1935r1407b1974],
5	2007	CD	DATE	2007	dep	3	SENT_24	[p1l1290t1935r1407b1974],
6	)	NN	O	)	dep	5	SENT_24	[p1l1290t1935r1407b1974],
7	7	CD	NUMBER	7	num	6	SENT_24	[p1l1422t1936r1451b1972],
8	,	,	O	,	_	0	SENT_24	[p1l1422t1936r1451b1972],
9	404-407	CD	NUMBER	404-407	appos	6	SENT_24	[p1l1465t1936r1638b1973],
10	;	:	O	;	_	0	SENT_24	[p1l1465t1936r1638b1973],
11	doi	FW	O	doi	dep	5	SENT_24	[p1l1653t1935r2147b1976],
12	:10.1038	CD	NUMBER	:10.1038	dep	11	SENT_24	[p1l1653t1935r2147b1976],
13	/	:	O	/	punct	3	SENT_24	[p1l1653t1935r2147b1976],
14	sj	NN	O	sj	dep	3	SENT_24	[p1l1653t1935r2147b1976],
15	.	.	O	.	_	0	SENT_24	[p1l1653t1935r2147b1976],

1	tpj	NN	O	tpj	_	0	SENT_25	[p1l1653t1935r2147b1976],
2	.6500438	CD	NUMBER	.6500438	num	1	SENT_25	[p1l1653t1935r2147b1976],
3	;	:	O	;	_	0	SENT_25	[p1l1653t1935r2147b1976],
4	published	VBN	O	publish	dep	1	SENT_25	[p1l750t1981r924b2023],
5	online	NN	O	online	prep	4	SENT_25	[p1l942t1981r1052b2013],
6	27	CD	DATE	27	dep	5	SENT_25	[p1l1070t1982r1114b2012],
7	February	NNP	DATE	February	tmod	4	SENT_25	[p1l1133t1981r1289b2023],
8	2007	CD	DATE	2007	num	7	SENT_25	[p1l1305t1982r1397b2013],

1	Keywords	NNS	O	keyword	_	0	SENT_26	[p1l749t2078r920b2111],
2	:	:	O	:	_	0	SENT_26	[p1l749t2078r920b2111],
3	rheumatoid	JJ	O	rheumatoid	amod	4	SENT_26	[p1l951t2078r1118b2103],
4	arthritis	NN	O	arthritis	dep	1	SENT_26	[p1l1132t2078r1248b2109],
5	;	:	O	;	_	0	SENT_26	[p1l1132t2078r1248b2109],
6	RFC-1	NN	O	rfc-1	dep	4	SENT_26	[p1l1264t2079r1356b2109],
7	;	:	O	;	_	0	SENT_26	[p1l1264t2079r1356b2109],
8	methotrexate	NN	O	methotrexate	dep	4	SENT_26	[p1l1372t2078r1575b2109],
9	;	:	O	;	_	0	SENT_26	[p1l1372t2078r1575b2109],
10	polymorphism	NN	O	polymorphism	dep	8	SENT_26	[p1l1590t2078r1799b2111],

1	Introduction	NN	O	introduction	_	0	SENT_27	[p1l749t2262r987b2291],

1	Methotrexate	NNP	O	Methotrexate	nsubj	33	SENT_28	[p1l748t2355r981b2383],
2	(	CD	NUMBER	(	num	1	SENT_28	[p1l1008t2355r1116b2390],
3	MTX	NNP	O	MTX	nsubj	8	SENT_28	[p1l1008t2355r1116b2390],
4	)	CD	NUMBER	)	num	3	SENT_28	[p1l1008t2355r1116b2390],
5	is	VBZ	O	be	cop	8	SENT_28	[p1l1142t2357r1166b2383],
6	a	DT	O	a	det	8	SENT_28	[p1l1191t2363r1208b2383],
7	folate	JJ	O	folate	amod	8	SENT_28	[p1l1232t2355r1328b2383],
8	antagonist	NN	O	antagonist	rcmod	1	SENT_28	[p1l1353t2357r1536b2392],
9	first	JJ	ORDINAL	first	advmod	10	SENT_28	[p1l1559t2355r1626b2383],
10	developed	VBN	O	develop	dep	8	SENT_28	[p1l1650t2355r1826b2392],
11	for	IN	O	for	_	0	SENT_28	[p1l1850t2355r1898b2383],
12	treatment	NN	O	treatment	prep_for	10	SENT_28	[p1l1922t2359r2093b2383],
13	of	IN	O	of	_	0	SENT_28	[p1l2117t2355r2152b2383],
14	malignancies	NNS	O	malignancy	prep_of	12	SENT_28	[p1l748t2402r976b2439],
15	and	CC	O	and	_	0	SENT_28	[p1l1010t2402r1074b2430],
16	subsequently	RB	O	subsequently	advmod	17	SENT_28	[p1l1108t2402r1335b2439],
17	used	VBN	O	use	conj_and	10	SENT_28	[p1l1366t2402r1445b2430],
18	in	IN	O	in	_	0	SENT_28	[p1l1477t2403r1512b2430],
19	non	JJ	O	non	amod	20	SENT_28	[p1l1545t2402r1805b2439],
20	—	NN	O	—	prep_in	17	SENT_28	[p1l1545t2402r1805b2439],
21	neoplastic	JJ	O	neoplastic	amod	22	SENT_28	[p1l1545t2402r1805b2439],
22	diseases	NNS	O	disease	dobj	10	SENT_28	[p1l1838t2402r1972b2430],
23	such	JJ	O	such	_	0	SENT_28	[p1l2006t2402r2084b2430],
24	as	IN	O	as	_	0	SENT_28	[p1l2118t2410r2149b2430],
25	rheumatoid	JJ	O	rheumatoid	amod	28	SENT_28	[p1l748t2455r952b2483],
26	arthritis	NN	O	arthritis	nn	28	SENT_28	[p1l975t2455r1112b2483],
27	(	NN	O	(	nn	28	SENT_28	[p1l1137t2451r1234b2490],
28	RA	NN	O	ra	prep_such_as	22	SENT_28	[p1l1137t2451r1234b2490],
29	)	CD	NUMBER	)	number	30	SENT_28	[p1l1137t2451r1234b2490],
30	.1	CD	NUMBER	.1	dep	28	SENT_28	[p1l1137t2451r1234b2490],
31	The	DT	O	the	det	32	SENT_28	[p1l1258t2455r1323b2483],
32	drug	NN	O	drug	dep	30	SENT_28	[p1l1347t2455r1425b2492],
33	inhibits	VBZ	O	inhibit	_	0	SENT_28	[p1l1448t2455r1581b2483],
34	cell	NN	O	cell	nn	35	SENT_28	[p1l1604t2455r1662b2483],
35	proliferation	NN	O	proliferation	dobj	33	SENT_28	[p1l1685t2455r1903b2492],
36	primarily	RB	O	primarily	advmod	33	SENT_28	[p1l1926t2455r2087b2492],
37	by	IN	O	by	_	0	SENT_28	[p1l2108t2455r2151b2492],
38	inhibiting	VBG	O	inhibit	prepc_by	33	SENT_28	[p1l748t2508r923b2546],
39	de	FW	O	de	nn	41	SENT_28	[p1l935t2508r970b2537],
40	novo	FW	O	novo	nn	41	SENT_28	[p1l981t2516r1056b2537],
41	synthesis	NN	O	synthesis	dobj	38	SENT_28	[p1l1068t2508r1225b2546],
42	of	IN	O	of	_	0	SENT_28	[p1l1237t2508r1272b2537],
43	purines	NNS	O	purine	prep_of	41	SENT_28	[p1l1281t2510r1409b2546],
44	and	CC	O	and	_	0	SENT_28	[p1l1422t2508r1486b2537],
45	pyrimidines	NNS	O	pyrimidine	prep_of	41	SENT_28	[p1l1497t2508r1714b2546],
46	.	.	O	.	_	0	SENT_28	[p1l1497t2508r1714b2546],

1	MTX	NNP	O	MTX	nsubjpass	3	SENT_29	[p1l1727t2509r1813b2536],
2	is	VBZ	O	be	auxpass	3	SENT_29	[p1l1824t2510r1849b2537],
3	taken	VBN	O	take	_	0	SENT_29	[p1l1861t2508r1957b2537],
4	up	RP	O	up	prt	3	SENT_29	[p1l1967t2516r2012b2546],
5	by	IN	O	by	_	0	SENT_29	[p1l2023t2508r2066b2546],
6	cells	NNS	O	cell	agent	3	SENT_29	[p1l2077t2508r2149b2537],
7	via	IN	O	via	_	0	SENT_29	[p1l747t2557r798b2583],
8	the	DT	O	the	det	14	SENT_29	[p1l820t2555r875b2583],
9	reduced	VBN	O	reduce	amod	14	SENT_29	[p1l897t2555r1034b2583],
10	folate	NN	O	folate	nn	14	SENT_29	[p1l1056t2555r1152b2583],
11	carrier	NN	O	carrier	nn	14	SENT_29	[p1l1175t2557r1284b2583],
12	(	CD	NUMBER	(	num	14	SENT_29	[p1l1307t2555r1399b2590],
13	RFC	NNP	O	RFC	nn	14	SENT_29	[p1l1307t2555r1399b2590],
14	)	NN	O	)	prep_via	6	SENT_29	[p1l1307t2555r1399b2590],
15	and	CC	O	and	_	0	SENT_29	[p1l1424t2555r1488b2583],
16	then	RB	O	then	prep_via	6	SENT_29	[p1l1509t2555r1590b2583],
17	converted	VBD	O	convert	rcmod	16	SENT_29	[p1l1612t2555r1784b2583],
18	within	IN	O	within	_	0	SENT_29	[p1l1805t2555r1920b2583],
19	the	DT	O	the	det	20	SENT_29	[p1l1942t2555r1997b2583],
20	cells	NNS	O	cell	prep_within	17	SENT_29	[p1l2020t2555r2093b2583],
21	to	TO	O	to	_	0	SENT_29	[p1l2115t2559r2149b2583],
22	polyglutamates	NNS	O	polyglutamate	prep_to	17	SENT_29	[p1l748t2598r1041b2639],
23	?	.	O	?	_	0	SENT_29	[p1l748t2598r1041b2639],

1	MTX	NN	O	mtx	nn	2	SENT_30	[p1l1067t2603r1153b2630],
2	polyglutamates	NNS	O	polyglutamate	nsubj	5	SENT_30	[p1l1179t2602r1445b2639],
3	are	VBP	O	be	cop	5	SENT_30	[p1l1472t2610r1522b2630],
4	long-living	JJ	O	long-living	amod	5	SENT_30	[p1l1549t2602r1739b2639],
5	metabolites	NNS	O	metabolite	_	0	SENT_30	[p1l1765t2602r1966b2630],
6	retaining	VBG	O	retain	partmod	5	SENT_30	[p1l1993t2603r2150b2639],
7	some	DT	O	some	det	9	SENT_30	[p1l749t2657r837b2677],
8	antifolate	JJ	O	antifolate	amod	9	SENT_30	[p1l858t2649r1023b2677],
9	activities	NNS	O	activity	dobj	6	SENT_30	[p1l1043t2650r1195b2677],
10	of	IN	O	of	_	0	SENT_30	[p1l1216t2649r1250b2677],
11	the	DT	O	the	det	13	SENT_30	[p1l1268t2649r1323b2677],
12	parent	NN	O	parent	nn	13	SENT_30	[p1l1342t2653r1454b2686],
13	compound	NN	O	compound	prep_of	9	SENT_30	[p1l1474t2649r1671b2686],
14	.	.	O	.	_	0	SENT_30	[p1l1474t2649r1671b2686],

1	The	DT	O	the	det	3	SENT_31	[p1l1692t2649r1757b2677],
2	cellular	JJ	O	cellular	amod	3	SENT_31	[p1l1777t2649r1904b2677],
3	formation	NN	O	formation	_	0	SENT_31	[p1l1923t2649r2097b2677],
4	of	IN	O	of	prep	3	SENT_31	[p1l2117t2649r2152b2677],

1	MTX	NN	O	mtx	nn	2	SENT_32	[p1l8t2843r183b2898],
2	polyglutamate	NN	O	polyglutamate	nsubj	3	SENT_32	[p1l224t2840r737b2916],
3	plays	VBZ	O	play	_	0	SENT_32	[p1l779t2840r958b2916],
4	a	DT	O	a	det	6	SENT_32	[p1l1001t2857r1036b2898],
5	major	JJ	O	major	amod	6	SENT_32	[p1l1078t2843r1286b2916],
6	role	NN	O	role	dobj	3	SENT_32	[p1l1327t2840r1459b2898],
7	in	IN	O	in	_	0	SENT_32	[p1l1502t2843r1573b2897],
8	cytotoxicity	NN	O	cytotoxicity	prep_in	6	SENT_32	[p1l1615t2843r2041b2916],
9	of	IN	O	of	_	0	SENT_32	[p1l2081t2840r2153b2898],
10	MTX	NNP	O	MTX	prep_of	8	SENT_32	[p1l8t2937r201b2992],
11	.	.	O	.	_	0	SENT_32	[p1l8t2937r201b2992],

1	Those	DT	O	those	det	3	SENT_33	[p1l260t2935r469b2993],
2	poluglutamated	JJ	O	poluglutamated	amod	3	SENT_33	[p1l525t2935r1090b3011],
3	derivates	NNS	O	derivate	nsubj	17	SENT_33	[p1l1147t2935r1459b2993],
4	not	RB	O	not	neg	5	SENT_33	[p1l1516t2942r1637b2993],
5	only	RB	O	only	preconj	6	SENT_33	[p1l1693t2935r1853b3011],
6	inhibit	VBP	O	inhibit	_	0	SENT_33	[p1l1907t2935r2149b2993],
7	dihydrofolate	JJ	O	dihydrofolate	amod	8	SENT_33	[p1l9t3029r489b3105],
8	reductase	NN	O	reductase	dobj	6	SENT_33	[p1l538t3029r887b3100],
9	,	,	O	,	_	0	SENT_33	[p1l538t3029r887b3100],
10	the	DT	O	the	det	13	SENT_33	[p1l939t3029r1052b3087],
11	major	JJ	O	major	amod	13	SENT_33	[p1l1100t3032r1308b3105],
12	MTX	NN	O	mtx	nn	13	SENT_33	[p1l1353t3032r1529b3087],
13	target	NN	O	target	appos	8	SENT_33	[p1l1577t3037r1797b3105],
14	,	,	O	,	_	0	SENT_33	[p1l1577t3037r1797b3105],
15	but	CC	O	but	_	0	SENT_33	[p1l1847t3029r1966b3087],
16	also	RB	O	also	_	0	SENT_33	[p1l2014t3030r2148b3087],
17	have	VBP	O	have	conj_and	6	SENT_33	[p1l9t3124r173b3182],
18	markedly	RB	O	markedly	advmod	20	SENT_33	[p1l198t3124r530b3200],
19	increased	VBN	O	increase	amod	20	SENT_33	[p1l551t3124r881b3182],
20	affinity	NN	O	affinity	dobj	17	SENT_33	[p1l905t3124r1163b3200],
21	for	IN	O	for	_	0	SENT_33	[p1l1184t3124r1282b3182],
22	certain	JJ	O	certain	amod	23	SENT_33	[p1l1304t3127r1546b3182],
23	enzymes	NNS	O	enzyme	prep_for	17	SENT_33	[p1l1570t3141r1873b3200],
24	such	JJ	O	such	_	0	SENT_33	[p1l1899t3124r2059b3182],
25	as	IN	O	as	_	0	SENT_33	[p1l2083t3141r2148b3182],
26	thymidylate	NN	O	thymidylate	nn	28	SENT_33	[p1l8t3218r440b3294],
27	synthase	NN	O	synthase	nn	28	SENT_33	[p1l472t3211r831b3294],
28	.3	NN	NUMBER	.3	prep_such_as	23	SENT_33	[p1l472t3211r831b3294],

1	The	DT	O	the	det	2	SENT_34	[p1l83t3314r216b3371],
2	RFC	NNP	O	RFC	nsubj	13	SENT_34	[p1l244t3315r402b3384],
3	,	,	O	,	_	0	SENT_34	[p1l244t3315r402b3384],
4	an	DT	O	a	det	6	SENT_34	[p1l434t3330r518b3371],
5	anion	NN	O	anion	nn	6	SENT_34	[p1l545t3317r749b3371],
6	exchanger	NN	O	exchanger	appos	2	SENT_34	[p1l777t3314r1155b3389],
7	,	,	O	,	_	0	SENT_34	[p1l777t3314r1155b3389],
8	is	VBZ	O	be	cop	13	SENT_34	[p1l1186t3317r1236b3371],
9	a	DT	O	a	det	13	SENT_34	[p1l1264t3330r1299b3371],
10	65	CD	NUMBER	65	num	13	SENT_34	[p1l1327t3315r1404b3371],
11	kDa	NN	O	kda	nn	13	SENT_34	[p1l1425t3314r1563b3371],
12	transmembrane	NN	O	transmembrane	nn	13	SENT_34	[p1l1589t3314r2148b3371],
13	protein	NN	O	protein	_	0	SENT_34	[p1l8t3412r267b3485],
14	comprising	VBG	O	comprise	partmod	13	SENT_34	[p1l290t3412r689b3485],
15	591	CD	NUMBER	591	num	17	SENT_34	[p1l712t3411r832b3467],
16	amino-acid	JJ	O	amino-acid	amod	17	SENT_34	[p1l861t3409r1260b3467],
17	residues	NNS	O	residue	dobj	14	SENT_34	[p1l1282t3409r1580b3479],
18	,	,	O	,	_	0	SENT_34	[p1l1282t3409r1580b3479],
19	which	WDT	O	which	nsubj	20	SENT_34	[p1l1606t3409r1826b3467],
20	transfers	VBZ	O	transfer	rcmod	17	SENT_34	[p1l1849t3409r2148b3467],
21	hydrophilic	JJ	O	hydrophilic	amod	22	SENT_34	[p1l9t3504r424b3580],
22	folates	NNS	O	folate	dobj	20	SENT_34	[p1l466t3504r694b3562],
23	across	IN	O	across	_	0	SENT_34	[p1l737t3521r945b3562],
24	the	DT	O	the	det	26	SENT_34	[p1l988t3504r1100b3562],
25	cell	NN	O	cell	nn	26	SENT_34	[p1l1143t3504r1262b3562],
26	membrane	NN	O	membrane	prep_across	20	SENT_34	[p1l1304t3504r1684b3562],
27	using	VBG	O	use	partmod	26	SENT_34	[p1l1725t3507r1918b3580],
28	negatively	RB	O	negatively	advmod	27	SENT_34	[p1l1958t3521r2148b3580, p1l8t3599r207b3674],
29	charged	VBN	O	charge	partmod	26	SENT_34	[p1l250t3599r528b3674],
30	glutamate	JJ	O	glutamate	amod	31	SENT_34	[p1l573t3599r927b3674],
31	residue	NN	O	residue	dobj	29	SENT_34	[p1l974t3599r1224b3656],
32	of	IN	O	of	_	0	SENT_34	[p1l1271t3598r1342b3656],
33	folate	NN	O	folate	prep_of	31	SENT_34	[p1l1383t3598r1599b3656],
34	.	.	O	.	_	0	SENT_34	[p1l1383t3598r1599b3656],

1	In	IN	O	in	_	0	SENT_35	[p1l1650t3601r1723b3656],
2	humans	NNS	O	human	prep_in	4	SENT_35	[p1l1768t3599r2054b3656],
3	it	PRP	O	it	nsubj	4	SENT_35	[p1l2100t3602r2149b3656],
4	exists	VBZ	O	exist	_	0	SENT_35	[p1l9t3697r201b3752],
5	in	IN	O	in	prep	4	SENT_35	[p1l265t3697r336b3751],
6	a	DT	O	a	det	7	SENT_35	[p1l400t3711r435b3752],
7	highly	RB	O	highly	pobj	5	SENT_35	[p1l499t3694r729b3770],
8	glycosylated	VBN	O	glycosylate	partmod	7	SENT_35	[p1l791t3694r1227b3770],
9	form	NN	O	form	dobj	8	SENT_35	[p1l1291t3694r1460b3752],
10	with	IN	O	with	_	0	SENT_35	[p1l1523t3694r1684b3752],
11	a	DT	O	a	det	12	SENT_35	[p1l1748t3711r1783b3752],
12	mass	NN	O	mass	prep_with	8	SENT_35	[p1l1847t3711r2016b3752],
13	of	IN	O	of	_	0	SENT_35	[p1l2081t3694r2153b3752],
14	approximately	RB	O	approximately	quantmod	15	SENT_35	[p2l9t16r526b92],
15	92	CD	NUMBER	92	num	16	SENT_35	[p2l577t18r659b74],
16	kDa	NN	O	kda	prep_of	12	SENT_35	[p2l676t16r831b74],
17	.	.	O	.	_	0	SENT_35	[p2l676t16r831b74],

1	The	DT	O	the	det	2	SENT_36	[p2l885t16r1018b74],
2	gene	NN	O	gene	nsubj	10	SENT_36	[p2l1070t33r1234b92],
3	coding	VBG	O	code	partmod	2	SENT_36	[p2l1287t16r1529b92],
4	for	IN	O	for	_	0	SENT_36	[p2l1579t16r1678b74],
5	the	DT	O	the	det	8	SENT_36	[p2l1728t16r1841b74],
6	human	JJ	O	human	amod	8	SENT_36	[p2l1893t16r2149b74],
7	RFC	NN	O	rfc	nn	8	SENT_36	[p2l9t112r150b169],
8	protein	NN	O	protein	prep_for	3	SENT_36	[p2l179t114r438b187],
9	is	VBZ	O	be	cop	10	SENT_36	[p2l468t114r518b169],
10	located	JJ	O	located	_	0	SENT_36	[p2l548t111r803b169],
11	on	IN	O	on	_	0	SENT_36	[p2l834t128r925b169],
12	the	DT	O	the	det	14	SENT_36	[p2l955t111r1067b169],
13	long	JJ	O	long	amod	14	SENT_36	[p2l1097t111r1256b187],
14	arm	NN	O	arm	prep_on	10	SENT_36	[p2l1285t128r1421b169],
15	of	IN	O	of	_	0	SENT_36	[p2l1452t111r1523b169],
16	chromosome	NN	O	chromosome	prep_of	14	SENT_36	[p2l1549t111r2012b169],
17	21	CD	NUMBER	21	num	16	SENT_36	[p2l2044t112r2144b181],
18	,	,	O	,	_	0	SENT_36	[p2l2044t112r2144b181],
19	specifically	RB	O	specifically	advmod	10	SENT_36	[p2l10t203r401b279],
20	the	DT	O	the	det	25	SENT_36	[p2l424t204r537b261],
21	21q22	NN	O	21q22	nn	25	SENT_36	[p2l564t205r1082b279],
22	.2	NN	NUMBER	.2	nn	25	SENT_36	[p2l564t205r1082b279],
23	—	CD	NUMBER	—	num	25	SENT_36	[p2l564t205r1082b279],
24	q22	NN	O	q22	nn	25	SENT_36	[p2l564t205r1082b279],
25	.3	NN	NUMBER	.3	nsubj	39	SENT_36	[p2l564t205r1082b279],
26	region	NN	O	region	nn	28	SENT_36	[p2l1112t197r1392b279],
27	.4	CD	NUMBER	.4	num	28	SENT_36	[p2l1112t197r1392b279],
28	Tolner	NNP	O	Tolner	dep	25	SENT_36	[p2l1416t204r1645b261],
29	et	FW	O	et	nn	30	SENT_36	[p2l1670t209r1731b261],
30	al.	FW	O	al.	dep	25	SENT_36	[p2l1750t197r1863b261],
31	5	CD	NUMBER	5	dep	30	SENT_36	[p2l1750t197r1863b261],
32	studied	VBN	O	study	ccomp	10	SENT_36	[p2l1893t204r2149b261],
33	cDNA	NN	O	cdna	dobj	32	SENT_36	[p2l9t301r216b357],
34	from	IN	O	from	_	0	SENT_36	[p2l265t299r435b357],
35	16	CD	NUMBER	16	num	37	SENT_36	[p2l491t301r568b357],
36	genomic	JJ	O	genomic	amod	37	SENT_36	[p2l619t302r924b375],
37	clones	NNS	O	clone	prep_from	32	SENT_36	[p2l974t299r1196b357],
38	and	CC	O	and	_	0	SENT_36	[p2l1247t299r1379b357],
39	obtained	VBN	O	obtain	conj_and	32	SENT_36	[p2l1429t299r1741b357],
40	two	CD	NUMBER	two	num	42	SENT_36	[p2l1791t307r1921b357],
41	overlapping	VBG	O	overlap	amod	42	SENT_36	[p2l1972t316r2148b357, p2l9t396r277b472],
42	sequences	NNS	O	sequence	dobj	39	SENT_36	[p2l340t413r692b472],
43	covering	VBG	O	cover	partmod	42	SENT_36	[p2l756t399r1061b472],
44	the	DT	O	the	det	46	SENT_36	[p2l1123t396r1235b454],
45	RFC-1	NN	MISC	rfc-1	nn	46	SENT_36	[p2l1295t398r1499b454],
46	gene	NN	O	gene	dobj	43	SENT_36	[p2l1569t413r1751b472],
47	.	.	O	.	_	0	SENT_36	[p2l1569t413r1751b472],

1	The	DT	O	the	det	3	SENT_37	[p2l1817t396r1949b454],
2	first	JJ	ORDINAL	first	amod	3	SENT_37	[p2l2013t396r2149b454],
3	standard	NN	O	standard	_	0	SENT_37	[p2l10t491r332b561],
4	,	,	O	,	_	0	SENT_37	[p2l10t491r332b561],
5	labeled	VBN	O	label	partmod	3	SENT_37	[p2l366t491r617b548],
6	)	NN	O	)	dobj	5	SENT_37	[p2l646t491r1044b561],
7	.	.	O	.	_	0	SENT_37	[p2l646t491r1044b561],

1	hRFC-1-1	NN	O	hrfc-1-1	dep	7	SENT_38	[p2l646t491r1044b561],
2	,	,	O	,	_	0	SENT_38	[p2l646t491r1044b561],
3	is	VBZ	O	be	cop	7	SENT_38	[p2l1079t494r1129b548],
4	a	DT	O	a	det	7	SENT_38	[p2l1160t507r1195b548],
5	19	CD	NUMBER	19	num	7	SENT_38	[p2l1229t492r1305b548],
6	kb	NN	O	kb	nn	7	SENT_38	[p2l1324t491r1406b548],
7	segment	NN	O	segment	_	0	SENT_38	[p2l1438t498r1733b566],
8	containing	VBG	O	contain	partmod	7	SENT_38	[p2l1762t494r2150b566],
9	exons	NNS	O	exon	dobj	8	SENT_38	[p2l9t602r213b643],
10	1	CD	NUMBER	1	nsubj	7	SENT_38	[p2l261t587r312b655],
11	,	,	O	,	_	0	SENT_38	[p2l261t587r312b655],
12	2	CD	NUMBER	2	appos	10	SENT_38	[p2l360t587r416b655],
13	,	,	O	,	_	0	SENT_38	[p2l360t587r416b655],
14	3	CD	NUMBER	3	appos	12	SENT_38	[p2l465t587r500b643],
15	and	CC	O	and	_	0	SENT_38	[p2l545t585r677b643],
16	4	CD	NUMBER	4	appos	12	SENT_38	[p2l718t587r776b643],
17	.	.	O	.	_	0	SENT_38	[p2l718t587r776b643],

1	The	DT	O	the	det	3	SENT_39	[p2l820t585r953b643],
2	second	JJ	ORDINAL	second	amod	3	SENT_39	[p2l997t585r1240b643],
3	standard	NN	O	standard	nsubj	10	SENT_39	[p2l1284t585r1606b655],
4	,	,	O	,	_	0	SENT_39	[p2l1284t585r1606b655],
5	/	:	O	/	punct	6	SENT_39	[p2l1652t585r2051b655],
6	lhRFC-1-2	NN	O	lhrfc-1-2	dep	3	SENT_39	[p2l1652t585r2051b655],
7	,	,	O	,	_	0	SENT_39	[p2l1652t585r2051b655],
8	is	VBZ	O	be	cop	10	SENT_39	[p2l2097t588r2148b643],
9	slightly	RB	O	slightly	advmod	10	SENT_39	[p2l10t680r273b756],
10	shorter	JJR	O	shorter	_	0	SENT_39	[p2l301t680r549b738],
11	at	IN	O	at	_	0	SENT_39	[p2l578t687r641b738],
12	17kb	CD	NUMBER	17kb	prep_at	10	SENT_39	[p2l676t680r853b738],
13	and	CC	O	and	_	0	SENT_39	[p2l883t680r1015b738],
14	contains	VBZ	O	contain	conj_and	10	SENT_39	[p2l1043t683r1344b738],
15	exons	NNS	O	exon	dobj	14	SENT_39	[p2l1375t697r1579b738],
16	5	CD	NUMBER	5	dobj	10	SENT_39	[p2l1610t683r1644b738],
17	and	CC	O	and	_	0	SENT_39	[p2l1678t680r1810b738],
18	6	CD	NUMBER	6	dobj	10	SENT_39	[p2l1840t682r1896b738],
19	.	.	O	.	_	0	SENT_39	[p2l1840t682r1896b738],

1	The	DT	O	the	det	4	SENT_40	[p2l1927t680r2060b738],
2	5	CD	NUMBER	5	num	4	SENT_40	[p2l2092t679r2146b738],
3	’	NN	O	’	nn	4	SENT_40	[p2l2092t679r2146b738],
4	end	NN	O	end	_	0	SENT_40	[p2l9t774r140b832],
5	of	IN	O	of	prep	4	SENT_40	[p2l162t774r233b832],
6	/	:	O	/	punct	4	SENT_40	[p2l251t774r632b832],
7	lhRFC-1-2	NN	O	lhrfc-1-2	nsubj	8	SENT_40	[p2l251t774r632b832],
8	overlaps	VBZ	O	overlap	dep	4	SENT_40	[p2l655t774r946b850],
9	1.5	CD	NUMBER	1.5	num	10	SENT_40	[p2l975t776r1071b832],
10	kb	NN	O	kb	dobj	8	SENT_40	[p2l1091t774r1174b832],
11	of	IN	O	of	_	0	SENT_40	[p2l1197t774r1269b832],
12	the	DT	O	the	det	15	SENT_40	[p2l1286t774r1399b832],
13	3	CD	NUMBER	3	num	15	SENT_40	[p2l1423t772r1478b832],
14	’	NN	O	’	nn	15	SENT_40	[p2l1423t772r1478b832],
15	end	NN	O	end	prep_of	10	SENT_40	[p2l1503t774r1634b832],
16	of	IN	O	of	_	0	SENT_40	[p2l1656t774r1728b832],
17	2hRFC-1-1	NN	O	2hrfc-1-1	prep_of	15	SENT_40	[p2l1745t774r2143b844],
18	,	,	O	,	_	0	SENT_40	[p2l1745t774r2143b844],
19	and	CC	O	and	_	0	SENT_40	[p2l9t869r141b927],
20	thus	RB	O	thus	advmod	23	SENT_40	[p2l168t869r321b927],
21	together	RB	O	together	advmod	23	SENT_40	[p2l350t869r648b945],
22	they	PRP	O	they	nsubj	23	SENT_40	[p2l675t869r833b945],
23	cover	VBP	O	cover	dep	4	SENT_40	[p2l861t886r1050b927],
24	34.5	CD	NUMBER	34.5	num	25	SENT_40	[p2l1079t871r1223b927],
25	kb	NN	O	kb	dobj	23	SENT_40	[p2l1244t869r1345b927],
26	.	.	O	.	_	0	SENT_40	[p2l1244t869r1345b927],

1	The	DT	O	the	det	3	SENT_41	[p2l1376t869r1509b927],
2	full-length	JJ	O	full-length	amod	3	SENT_41	[p2l1538t869r1913b945],
3	cDNA	NN	O	cdna	nsubjpass	5	SENT_41	[p2l1943t871r2149b927],
4	was	VBD	O	be	auxpass	5	SENT_41	[p2l7t980r135b1021],
5	confirmed	VBN	O	confirm	_	0	SENT_41	[p2l163t963r529b1021],
6	as	IN	O	as	_	0	SENT_41	[p2l556t980r621b1021],
7	the	DT	O	the	det	9	SENT_41	[p2l648t963r761b1021],
8	RFC-1	NN	MISC	rfc-1	nn	9	SENT_41	[p2l785t965r990b1021],
9	gene	NN	O	gene	prep_as	5	SENT_41	[p2l1024t980r1187b1039],
10	by	IN	O	by	_	0	SENT_41	[p2l1213t964r1301b1039],
11	transfection	NN	O	transfection	prep_by	9	SENT_41	[p2l1325t963r1750b1021],
12	into	IN	O	into	_	0	SENT_41	[p2l1777t966r1921b1021],
13	MTXresistant	JJ	O	mtxresistant	amod	14	SENT_41	[p2l1947t966r2147b1021, p2l9t1061r306b1116],
14	cells	NNS	O	cell	prep_into	5	SENT_41	[p2l346t1058r513b1128],
15	,	,	O	,	_	0	SENT_41	[p2l346t1058r513b1128],
16	which	WDT	O	which	nsubj	19	SENT_41	[p2l556t1058r776b1116],
17	have	VBP	O	have	aux	19	SENT_41	[p2l816t1058r981b1116],
18	become	VBN	O	become	cop	19	SENT_41	[p2l1020t1058r1294b1116],
19	resistant	JJ	O	resistant	rcmod	14	SENT_41	[p2l1334t1061r1631b1116],
20	to	TO	O	to	_	0	SENT_41	[p2l1671t1065r1740b1116],
21	this	DT	O	this	det	23	SENT_41	[p2l1781t1058r1910b1116],
22	folate	NN	O	folate	nn	23	SENT_41	[p2l1951t1058r2147b1116],
23	analog	NN	O	analog	prep_to	19	SENT_41	[p2l9t1153r245b1229],
24	by	IN	O	by	_	0	SENT_41	[p2l289t1153r376b1229],
25	producing	VBG	O	produce	prepc_by	19	SENT_41	[p2l421t1153r787b1229],
26	a	DT	O	a	det	27	SENT_41	[p2l833t1170r868b1211],
27	mutation	NN	O	mutation	dobj	25	SENT_41	[p2l915t1156r1247b1211],
28	in	IN	O	in	_	0	SENT_41	[p2l1294t1156r1364b1210],
29	the	DT	O	the	det	30	SENT_41	[p2l1412t1153r1524b1211],
30	protein	NN	O	protein	prep_in	25	SENT_41	[p2l1571t1156r1830b1229],
31	and	CC	O	and	_	0	SENT_41	[p2l1879t1153r2010b1211],
32	no	RB	O	no	advmod	33	SENT_41	[p2l2057t1170r2148b1211],
33	longer	RBR	O	longer	advmod	19	SENT_41	[p2l9t1248r235b1324],
34	take	VB	O	take	rcmod	14	SENT_41	[p2l263t1248r406b1306],
35	up	RP	O	up	prt	34	SENT_41	[p2l435t1265r526b1324],
36	MTX	NNP	O	MTX	dobj	34	SENT_41	[p2l555t1251r748b1306],
37	.	.	O	.	_	0	SENT_41	[p2l555t1251r748b1306],

1	Recent	JJ	O	recent	amod	2	SENT_42	[p2l86t1346r323b1402],
2	studies	NNS	O	study	nsubj	4	SENT_42	[p2l360t1344r600b1402],
3	have	VBP	O	have	aux	4	SENT_42	[p2l636t1344r801b1402],
4	suggested	VBN	O	suggest	_	0	SENT_42	[p2l839t1344r1178b1420],
5	that	IN	O	that	complm	11	SENT_42	[p2l1212t1344r1355b1402],
6	G80A	NN	O	g80a	nn	7	SENT_42	[p2l1392t1346r1588b1402],
7	polymorphism	NN	O	polymorphism	nsubj	18	SENT_42	[p2l1622t1344r2148b1420],
8	in	IN	O	in	_	0	SENT_42	[p2l9t1441r79b1495],
9	RFC-1	NN	O	rfc-1	prep_in	7	SENT_42	[p2l117t1439r321b1496],
10	is	VBZ	O	be	auxpass	11	SENT_42	[p2l370t1441r420b1496],
11	associated	VBN	O	associate	ccomp	4	SENT_42	[p2l463t1438r819b1496],
12	with	IN	O	with	_	0	SENT_42	[p2l858t1438r1020b1496],
13	altered	JJ	O	altered	amod	15	SENT_42	[p2l1061t1438r1301b1496],
14	folate/antifolate	JJ	O	folate/antifolate	amod	15	SENT_42	[p2l1342t1437r1912b1503],
15	levels	NNS	O	level	prep_with	11	SENT_42	[p2l1955t1438r2148b1496],
16	and	CC	O	and	_	0	SENT_42	[p2l9t1532r141b1589],
17	may	MD	O	may	aux	18	SENT_42	[p2l170t1549r322b1607],
18	inﬂuence	VB	O	inﬂuence	conj_and	11	SENT_42	[p2l349t1531r680b1589],
19	the	DT	O	the	det	20	SENT_42	[p2l710t1532r823b1589],
20	efficacy	NN	O	efficacy	dobj	18	SENT_42	[p2l854t1531r1122b1607],
21	of	IN	O	of	_	0	SENT_42	[p2l1151t1531r1222b1589],
22	therapy	NN	O	therapy	prep_of	20	SENT_42	[p2l1247t1532r1520b1607],
23	with	IN	O	with	_	0	SENT_42	[p2l1545t1532r1706b1589],
24	MTX	NN	O	mtx	nn	26	SENT_42	[p2l1735t1525r2026b1589],
25	.6	CD	NUMBER	.6	num	26	SENT_42	[p2l1735t1525r2026b1589],
26	‘	NN	O	‘	prep_with	18	SENT_42	[p2l1735t1525r2026b1589],
27	8	CD	NUMBER	8	num	26	SENT_42	[p2l1735t1525r2026b1589],

1	In	IN	O	in	_	0	SENT_43	[p2l86t1631r159b1685],
2	the	DT	O	the	det	4	SENT_43	[p2l224t1628r337b1686],
3	present	JJ	DATE	present	amod	4	SENT_43	[p2l403t1635r663b1704],
4	study	NN	O	study	prep_in	7	SENT_43	[p2l730t1628r931b1704],
5	,	,	O	,	_	0	SENT_43	[p2l730t1628r931b1704],
6	we	PRP	O	we	nsubj	7	SENT_43	[p2l1000t1645r1096b1686],
7	examined	VBD	O	examine	_	0	SENT_43	[p2l1164t1628r1512b1686],
8	the	DT	O	the	det	9	SENT_43	[p2l1578t1628r1690b1686],
9	association	NN	O	association	dobj	7	SENT_43	[p2l1758t1631r2149b1686],
10	between	IN	O	between	_	0	SENT_43	[p2l7t1723r304b1781],
11	RFC-1	NN	O	rfc-1	nn	13	SENT_43	[p2l352t1724r557b1781],
12	G80A	NN	O	g80a	nn	13	SENT_43	[p2l611t1724r808b1781],
13	polymorphism	NN	O	polymorphism	prep_between	9	SENT_43	[p2l854t1723r1380b1799],
14	and	CC	O	and	_	0	SENT_43	[p2l1429t1723r1560b1781],
15	treatment	NN	O	treatment	nn	16	SENT_43	[p2l1608t1730r1958b1781],
16	outcome	NN	O	outcome	prep_between	9	SENT_43	[p2l2006t1730r2148b1781, p2l9t1835r197b1876],
17	in	IN	O	in	_	0	SENT_43	[p2l228t1821r298b1875],
18	patients	NNS	O	patient	prep_in	13	SENT_43	[p2l327t1821r609b1894],
19	with	IN	O	with	_	0	SENT_43	[p2l637t1818r799b1876],
20	RA	NN	O	ra	prep_with	7	SENT_43	[p2l829t1820r927b1875],
21	administered	VBN	O	administer	partmod	20	SENT_43	[p2l956t1818r1420b1876],
22	MTX	NNP	O	MTX	dobj	21	SENT_43	[p2l1448t1821r1641b1876],
23	.	.	O	.	_	0	SENT_43	[p2l1448t1821r1641b1876],

1	Results	NNS	O	result	_	0	SENT_44	[p2l11t2023r279b2080],

1	The	DT	O	the	det	2	SENT_45	[p2l7t2212r139b2270],
2	efficacy	NN	O	efficacy	nsubjpass	11	SENT_45	[p2l164t2212r433b2288],
3	of	IN	O	of	_	0	SENT_45	[p2l455t2212r527b2270],
4	RA	NN	O	ra	nn	5	SENT_45	[p2l546t2213r644b2269],
5	therapy	NN	O	therapy	prep_of	2	SENT_45	[p2l667t2212r940b2288],
6	with	IN	O	with	_	0	SENT_45	[p2l959t2212r1120b2270],
7	MTX	NN	O	mtx	prep_with	5	SENT_45	[p2l1142t2214r1318b2269],
8	and	CC	O	and	_	0	SENT_45	[p2l1343t2212r1474b2270],
9	methylprednisone	NN	O	methylprednisone	prep_with	5	SENT_45	[p2l1497t2212r2147b2288],
10	is	VBZ	O	be	auxpass	11	SENT_45	[p2l9t2310r59b2365],
11	presented	VBN	O	present	_	0	SENT_45	[p2l90t2307r435b2383],
12	in	IN	O	in	_	0	SENT_45	[p2l465t2310r535b2364],
13	Table	NNP	O	Table	prep_in	11	SENT_45	[p2l565t2307r750b2365],
14	1	CD	NUMBER	1	num	13	SENT_45	[p2l789t2309r841b2365],
15	.	.	O	.	_	0	SENT_45	[p2l789t2309r841b2365],

1	Under	IN	O	under	_	0	SENT_46	[p2l876t2307r1098b2365],
2	MTX	NN	O	mtx	prep_under	15	SENT_46	[p2l1127t2310r1303b2365],
3	and	CC	O	and	_	0	SENT_46	[p2l1335t2307r1466b2365],
4	methylprednisone	NN	O	methylprednisone	prep_under	15	SENT_46	[p2l1497t2307r2147b2383],
5	(	CD	NUMBER	(	num	8	SENT_46	[p2l12t2403r172b2475],
6	MP	NN	O	mp	nn	8	SENT_46	[p2l12t2403r172b2475],
7	)	NN	O	)	nn	8	SENT_46	[p2l12t2403r172b2475],
8	therapy	NN	O	therapy	nsubjpass	15	SENT_46	[p2l214t2402r496b2478],
9	,	,	O	,	_	0	SENT_46	[p2l214t2402r496b2478],
10	remission	NN	O	remission	nsubjpass	15	SENT_46	[p2l539t2405r881b2460],
11	of	IN	O	of	_	0	SENT_46	[p2l919t2402r991b2460],
12	RA	NN	O	ra	nn	13	SENT_46	[p2l1026t2404r1123b2459],
13	symptoms	NNS	O	symptom	prep_of	10	SENT_46	[p2l1162t2410r1525b2478],
14	was	VBD	O	be	auxpass	15	SENT_46	[p2l1562t2419r1690b2460],
15	achieved	VBN	O	achieve	_	0	SENT_46	[p2l1729t2402r2040b2460],
16	in	IN	O	in	prep	15	SENT_46	[p2l2078t2405r2149b2459],

1	Table	NNP	O	Table	nn	3	SENT_47	[p2l7t2632r196b2688],
2	1	CD	NUMBER	1	num	3	SENT_47	[p2l236t2634r259b2688],
3	Relation	NN	O	relation	_	0	SENT_47	[p2l352t2634r621b2688],
4	of	IN	O	of	_	0	SENT_47	[p2l658t2634r726b2688],
5	patients	NNS	O	patient	prep_of	3	SENT_47	[p2l759t2634r1046b2705],
6	’	CD	NUMBER	’	num	7	SENT_47	[p2l759t2634r1046b2705],
7	response	NN	O	response	dep	3	SENT_47	[p2l1085t2650r1380b2705],
8	to	TO	O	to	_	0	SENT_47	[p2l1415t2640r1483b2688],
9	MTX	NN	O	mtx	nn	10	SENT_47	[p2l1520t2635r1674b2688],
10	treatment	NN	O	treatment	prep_to	7	SENT_47	[p2l1708t2640r2049b2688],
11	to	TO	O	to	_	0	SENT_47	[p2l2080t2640r2148b2688],
12	RFC-1	NN	O	rfc-1	nn	13	SENT_47	[p2l12t2720r189b2773],
13	genotypes	NNS	O	genotype	prep_to	10	SENT_47	[p2l228t2725r578b2790],

1	Responders	NNS	O	responder	nn	5	SENT_48	[p2l392t2892r742b2964],
2	,	,	O	,	_	0	SENT_48	[p2l392t2892r742b2964],
3	Poor	NNP	O	Poor	dep	5	SENT_48	[p2l981t2895r1119b2947],
4	P-value	NNP	O	P-value	nn	5	SENT_48	[p2l1346t2892r1567b2947],
5	OR	NN	O	or	_	0	SENT_48	[p2l1702t2894r1788b2947],
6	(	CD	PERCENT	(	number	7	SENT_48	[p2l1818t2893r1981b2960],
7	95	CD	PERCENT	95	num	8	SENT_48	[p2l1818t2893r1981b2960],
8	%	NN	PERCENT	%	dep	5	SENT_48	[p2l1818t2893r1981b2960],
9	CI	NN	O	ci	nn	10	SENT_48	[p2l2012t2892r2094b2961],
10	)	NN	O	)	dep	8	SENT_48	[p2l2012t2892r2094b2961],

1	n	NN	O	n	_	0	SENT_49	[p2l471t2992r503b3030],
2	=	JJ	O	=	amod	1	SENT_49	[p2l523t3003r572b3020],
3	58	CD	NUMBER	58	num	4	SENT_49	[p2l591t2978r669b3031],
4	responders	NNS	O	responder	tmod	2	SENT_49	[p2l876t2976r1211b3048],
5	,	,	O	,	_	0	SENT_49	[p2l876t2976r1211b3048],
6	n	NN	O	n	appos	4	SENT_49	[p2l926t3077r959b3115],
7	=	JJ	O	=	dep	1	SENT_49	[p2l979t3088r1028b3105],
8	1	CD	NUMBER	1	number	9	SENT_49	[p2l1057t3063r1075b3115],
9	76	CD	NUMBER	76	dep	7	SENT_49	[p2l1099t3063r1168b3115],

1	n	NN	PERCENT	n	nn	4	SENT_50	[p2l433t3287r465b3324],
2	%	NN	PERCENT	%	nn	4	SENT_50	[p2l663t3273r717b3325],
3	n	NN	PERCENT	n	nn	4	SENT_50	[p2l909t3287r942b3324],
4	%	NN	PERCENT	%	_	0	SENT_50	[p2l1139t3273r1193b3325],

1	RFC	NN	O	rfc	nn	4	SENT_51	[p2l12t3455r125b3508],
2	7	CD	NUMBER	7	num	4	SENT_51	[p2l135t3455r153b3508],
3	genotype	NN	O	genotype	nn	4	SENT_51	[p2l189t3460r488b3525],
4	AA	NN	O	aa	dep	12	SENT_51	[p2l7t3542r95b3594],
5	22	CD	NUMBER	22	dep	4	SENT_51	[p2l411t3541r486b3594],
6	37.93	CD	NUMBER	37.93	number	7	SENT_51	[p2l600t3541r776b3594],
7	24	CD	NUMBER	24	num	9	SENT_51	[p2l908t3541r984b3594],
8	20.69	CD	NUMBER	20.69	number	9	SENT_51	[p2l1073t3541r1253b3594],
9	0.021	CD	NUMBER	0.021	dep	5	SENT_51	[p2l1362t3541r1530b3594],
10	3.32	CD	NUMBER	3.32	num	11	SENT_51	[p2l1610t3541r1744b3594],
11	(	NN	O	(	dep	12	SENT_51	[p2l1776t3540r2147b3608],
12	1.26	CD	NUMBER	1.26	dep	23	SENT_51	[p2l1776t3540r2147b3608],
13	—	CD	NUMBER	—	number	14	SENT_51	[p2l1776t3540r2147b3608],
14	8.79	CD	NUMBER	8.79	num	16	SENT_51	[p2l1776t3540r2147b3608],
15	)	NN	O	)	nn	16	SENT_51	[p2l1776t3540r2147b3608],
16	GA	NN	O	ga	dep	12	SENT_51	[p2l10t3628r105b3681],
17	28	CD	NUMBER	28	number	18	SENT_51	[p2l411t3628r487b3681],
18	48.28	CD	NUMBER	48.28	num	20	SENT_51	[p2l595t3628r777b3681],
19	63	CD	NUMBER	63	number	20	SENT_51	[p2l909t3628r983b3681],
20	54.31	CD	NUMBER	54.31	dep	16	SENT_51	[p2l1073t3628r1241b3681],
21	0.387	CD	NUMBER	0.387	num	23	SENT_51	[p2l1362t3628r1543b3681],
22	1.61	CD	NUMBER	1.61	num	23	SENT_51	[p2l1610t3628r1732b3681],
23	(	NN	O	(	dep	28	SENT_51	[p2l1776t3627r2147b3695],
24	0.65	CD	NUMBER	0.65	number	25	SENT_51	[p2l1776t3627r2147b3695],
25	—	CD	NUMBER	—	dep	23	SENT_51	[p2l1776t3627r2147b3695],
26	3.96	CD	NUMBER	3.96	num	27	SENT_51	[p2l1776t3627r2147b3695],
27	)	NN	O	)	dep	25	SENT_51	[p2l1776t3627r2147b3695],
28	CG	NN	O	cg	dep	31	SENT_51	[p2l10t3715r109b3768],
29	8	CD	NUMBER	8	num	28	SENT_51	[p2l452t3715r487b3768],
30	13.79	CD	NUMBER	13.79	num	31	SENT_51	[p2l600t3715r777b3768],
31	29	CD	NUMBER	29	_	0	SENT_51	[p2l908t3715r984b3768],
32	25.00	CD	NUMBER	25.00	num	34	SENT_51	[p2l1073t3715r1254b3768],
33	—	NN	O	—	nn	34	SENT_51	[p2l1416t3747r1489b3752],
34	—	NN	O	—	dep	31	SENT_51	[p2l1859t3747r1932b3752],

1	RFC	NNP	O	RFC	nn	3	SENT_52	[p3l12t95r125b147],
2	1	CD	NUMBER	1	num	3	SENT_52	[p3l135t95r154b146],
3	alleles	NNS	O	allele	_	0	SENT_52	[p3l9t179r194b233],
4	A	DT	O	a	det	8	SENT_52	[p3l6t269r51b320],
5	72	CD	NUMBER	72	number	6	SENT_52	[p3l414t268r486b321],
6	62.1	CD	NUMBER	62.1	num	8	SENT_52	[p3l598t268r723b321],
7	111	CD	NUMBER	111	number	8	SENT_52	[p3l869t268r971b320],
8	47.8	CD	NUMBER	47.8	dep	3	SENT_52	[p3l1072t268r1212b321],
9	0.013	CD	NUMBER	0.013	number	10	SENT_52	[p3l1362t268r1541b321],
10	1.78	CD	NUMBER	1.78	num	11	SENT_52	[p3l1610t268r1745b321],
11	(	NN	O	(	dep	3	SENT_52	[p3l1776t266r2147b335],
12	1.13	CD	NUMBER	1.13	number	13	SENT_52	[p3l1776t266r2147b335],
13	—	CD	NUMBER	—	dep	16	SENT_52	[p3l1776t266r2147b335],
14	2.81	CD	NUMBER	2.81	number	15	SENT_52	[p3l1776t266r2147b335],
15	)	CD	NUMBER	)	dep	16	SENT_52	[p3l1776t266r2147b335],
16	G	NN	O	g	amod	11	SENT_52	[p3l10t375r55b427],
17	44	CD	NUMBER	44	number	18	SENT_52	[p3l409t376r487b427],
18	37.9	CD	NUMBER	37.9	num	20	SENT_52	[p3l600t375r736b427],
19	121	CD	NUMBER	121	number	20	SENT_52	[p3l869t375r971b427],
20	52.2	CD	NUMBER	52.2	dep	11	SENT_52	[p3l1073t375r1211b427],

1	Abbreviations	NNS	O	abbreviation	nsubj	19	SENT_53	[p3l6t519r378b564],
2	:	:	O	:	_	0	SENT_53	[p3l6t519r378b564],
3	CI	NN	O	ci	dep	1	SENT_53	[p3l404t520r470b573],
4	,	,	O	,	_	0	SENT_53	[p3l404t520r470b573],
5	confidence	NN	O	confidence	nn	6	SENT_53	[p3l496t519r780b564],
6	interval	NN	O	interval	appos	3	SENT_53	[p3l806t519r1008b573],
7	;	:	O	;	_	0	SENT_53	[p3l806t519r1008b573],
8	MTX	NNP	O	MTX	dep	3	SENT_53	[p3l1037t521r1171b573],
9	,	,	O	,	_	0	SENT_53	[p3l1037t521r1171b573],
10	methotrexate	NN	O	methotrexate	appos	8	SENT_53	[p3l1200t519r1564b573],
11	;	:	O	;	_	0	SENT_53	[p3l1200t519r1564b573],
12	OR	NN	O	or	dep	3	SENT_53	[p3l1591t520r1681b573],
13	,	,	O	,	_	0	SENT_53	[p3l1591t520r1681b573],
14	odds	NNS	O	odds	nn	15	SENT_53	[p3l1707t519r1831b564],
15	ratios	NNS	O	ratio	appos	12	SENT_53	[p3l1856t520r2007b573],
16	;	:	O	;	_	0	SENT_53	[p3l1856t520r2007b573],
17	RFC	NNP	O	RFC	dep	1	SENT_53	[p3l2035t520r2145b573],
18	,	,	O	,	_	0	SENT_53	[p3l2035t520r2145b573],
19	reduced	VBD	O	reduce	_	0	SENT_53	[p3l11t595r217b639],
20	folate	JJ	O	folate	amod	21	SENT_53	[p3l241t595r386b639],
21	carrier	NN	O	carrier	dobj	19	SENT_53	[p3l410t596r585b639],
22	.	.	O	.	_	0	SENT_53	[p3l410t596r585b639],

1	Fisher	NNP	PERSON	Fisher	poss	4	SENT_54	[p3l11t669r196b714],
2	's	POS	O	's	_	0	SENT_54	[p3l11t669r196b714],
3	exact	JJ	O	exact	amod	4	SENT_54	[p3l220t674r358b714],
4	test	NN	O	test	_	0	SENT_54	[p3l379t674r485b723],
5	;	:	O	;	_	0	SENT_54	[p3l379t674r485b723],
6	compared	VBN	O	compare	partmod	4	SENT_54	[p3l512t669r773b728],
7	to	TO	O	to	aux	8	SENT_54	[p3l798t674r850b714],
8	GO	VB	O	go	xcomp	6	SENT_54	[p3l874t671r956b714],
9	as	IN	O	as	_	0	SENT_54	[p3l982t682r1031b714],
10	reference	NN	O	reference	nn	11	SENT_54	[p3l1056t669r1294b714],
11	genotype	NN	O	genotype	prep_as	8	SENT_54	[p3l1318t674r1579b728],
12	.	.	O	.	_	0	SENT_54	[p3l1318t674r1579b728],

1	Reduced	VBN	O	reduce	_	0	SENT_55	[p3l9t893r209b938],
2	folate	JJ	O	folate	amod	4	SENT_55	[p3l227t893r370b938],
3	carrier-1	NN	O	carrier-1	nn	4	SENT_55	[p3l388t893r587b938],
4	m	NN	O	m	dobj	1	SENT_55	[p3l2025t881r2151b1005],
5	@	IN	O	@	_	0	SENT_55	[p3l2025t881r2151b1005],
6	M	NN	O	m	nn	7	SENT_55	[p3l10t966r46b1005],
7	Drozdzik	NNP	O	Drozdzik	prep_@	1	SENT_55	[p3l69t964r247b1006],
8	et	FW	O	et	nn	9	SENT_55	[p3l265t969r301b1006],
9	al	FW	O	al	dep	7	SENT_55	[p3l318t964r355b1006],

1	21.6	CD	PERCENT	21.6	num	2	SENT_56	[p3l9t1254r227b1310],
2	%	NN	PERCENT	%	nsubj	10	SENT_56	[p3l9t1254r227b1310],
3	of	IN	O	of	_	0	SENT_56	[p3l260t1252r331b1310],
4	patients	NNS	O	patient	prep_of	2	SENT_56	[p3l357t1255r640b1328],
5	with	IN	O	with	_	0	SENT_56	[p3l670t1252r831b1310],
6	RFC-1	NN	O	rfc-1	nn	9	SENT_56	[p3l859t1254r1064b1310],
7	80GG	NN	O	80gg	nn	9	SENT_56	[p3l1103t1254r1307b1310],
8	genotype	NN	O	genotype	nn	9	SENT_56	[p3l1338t1259r1664b1328],
9	carriers	NNS	O	carrier	prep_with	4	SENT_56	[p3l1697t1255r1950b1310],
10	(	VBP	O	(	_	0	SENT_56	[p3l1986t1252r2048b1324],
11	8	CD	NUMBER	8	dobj	10	SENT_56	[p3l1986t1252r2048b1324],
12	of	IN	O	of	_	0	SENT_56	[p3l2081t1252r2152b1310],
13	37	CD	NUMBER	37	number	14	SENT_56	[p3l10t1347r136b1419],
14	)	CD	NUMBER	)	prep_of	11	SENT_56	[p3l10t1347r136b1419],
15	,	,	O	,	_	0	SENT_56	[p3l10t1347r136b1419],
16	in	IN	O	in	_	0	SENT_56	[p3l176t1350r246b1404],
17	30.8	CD	PERCENT	30.8	num	18	SENT_56	[p3l282t1348r429b1405],
18	%	NN	PERCENT	%	prep_in	25	SENT_56	[p3l466t1348r531b1404],
19	of	IN	O	of	_	0	SENT_56	[p3l566t1347r637b1405],
20	subjects	NNS	O	subject	prep_of	18	SENT_56	[p3l669t1347r945b1423],
21	with	IN	O	with	_	0	SENT_56	[p3l979t1347r1140b1405],
22	80GA	NN	O	80ga	nn	23	SENT_56	[p3l1176t1348r1372b1405],
23	genotype	NN	O	genotype	prep_with	20	SENT_56	[p3l1406t1354r1732b1423],
24	(	CD	NUMBER	(	number	25	SENT_56	[p3l1771t1347r1877b1419],
25	28	CD	NUMBER	28	appos	14	SENT_56	[p3l1771t1347r1877b1419],
26	of	IN	O	of	_	0	SENT_56	[p3l1914t1347r1985b1405],
27	91	CD	NUMBER	91	num	28	SENT_56	[p3l2016t1347r2143b1419],
28	)	CD	NUMBER	)	prep_of	25	SENT_56	[p3l2016t1347r2143b1419],
29	,	,	O	,	_	0	SENT_56	[p3l2016t1347r2143b1419],
30	and	CC	O	and	_	0	SENT_56	[p3l9t1441r140b1499],
31	in	IN	O	in	conj_and	11	SENT_56	[p3l163t1444r233b1498],
32	47.8	CD	PERCENT	47.8	num	33	SENT_56	[p3l257t1443r475b1499],
33	%	NN	PERCENT	%	pobj	31	SENT_56	[p3l257t1443r475b1499],
34	of	IN	O	of	_	0	SENT_56	[p3l498t1441r570b1499],
35	patients	NNS	O	patient	prep_of	33	SENT_56	[p3l587t1444r869b1517],
36	with	IN	O	with	_	0	SENT_56	[p3l891t1441r1052b1499],
37	80AA	NN	O	80aa	nn	38	SENT_56	[p3l1077t1443r1265b1499],
38	genotype	NN	O	genotype	prep_with	35	SENT_56	[p3l1287t1449r1613b1517],
39	(	CD	NUMBER	(	number	40	SENT_56	[p3l1640t1442r1748b1514],
40	22	CD	NUMBER	22	dep	11	SENT_56	[p3l1640t1442r1748b1514],
41	of	IN	O	of	_	0	SENT_56	[p3l1771t1441r1843b1499],
42	46	CD	NUMBER	46	num	43	SENT_56	[p3l1861t1441r1989b1514],
43	)	NN	O	)	prep_of	40	SENT_56	[p3l1861t1441r1989b1514],
44	.	.	O	.	_	0	SENT_56	[p3l1861t1441r1989b1514],

1	The	DT	O	the	det	2	SENT_57	[p3l2015t1441r2147b1499],
2	probability	NN	O	probability	nsubj	10	SENT_57	[p3l8t1536r399b1612],
3	of	IN	O	of	_	0	SENT_57	[p3l450t1536r521b1594],
4	remission	NN	O	remission	prep_of	2	SENT_57	[p3l569t1539r911b1594],
5	of	IN	O	of	_	0	SENT_57	[p3l964t1536r1036b1594],
6	RA	NN	O	ra	nn	7	SENT_57	[p3l1084t1538r1182b1593],
7	symptoms	NNS	O	symptom	prep_of	4	SENT_57	[p3l1235t1544r1599b1612],
8	was	VBD	O	be	cop	10	SENT_57	[p3l1650t1553r1778b1594],
9	3.32-fold	RB	O	3.32-fold	advmod	10	SENT_57	[p3l1832t1536r2149b1594],
10	higher	JJR	O	higher	_	0	SENT_57	[p3l8t1632r239b1708],
11	in	IN	O	in	_	0	SENT_57	[p3l291t1635r362b1689],
12	carriers	NNS	O	carrier	prep_in	10	SENT_57	[p3l415t1635r668b1690],
13	of	IN	O	of	_	0	SENT_57	[p3l722t1632r794b1690],
14	80AA	NN	O	80aa	nn	15	SENT_57	[p3l844t1634r1033b1690],
15	genotype	NN	O	genotype	prep_of	12	SENT_57	[p3l1085t1639r1411b1708],
16	as	IN	O	as	prep	10	SENT_57	[p3l1466t1649r1531b1690],
17	compared	VBN	O	compare	_	0	SENT_57	[p3l1585t1632r1936b1708],
18	with	IN	O	with	prepc_compared_with	10	SENT_57	[p3l1987t1632r2149b1690],
19	patients	NNS	O	patient	pobj	10	SENT_57	[p3l8t1730r290b1802],
20	with	IN	O	with	_	0	SENT_57	[p3l313t1727r475b1784],
21	80GG	NN	O	80gg	nn	22	SENT_57	[p3l501t1728r704b1784],
22	genotype	NN	O	genotype	prep_with	19	SENT_57	[p3l729t1734r1055b1802],
23	(	CD	NUMBER	(	num	24	SENT_57	[p3l1084t1727r1218b1799],
24	P	NN	O	p	dep	22	SENT_57	[p3l1084t1727r1218b1799],
25	:	:	O	:	_	0	SENT_57	[p3l1084t1727r1218b1799],
26	0.021	CD	NUMBER	0.021	dep	24	SENT_57	[p3l1236t1728r1447b1797],
27	,	,	O	,	_	0	SENT_57	[p3l1236t1728r1447b1797],
28	OR	NN	O	or	appos	26	SENT_57	[p3l1478t1728r1585b1784],
29	=	JJ	O	=	amod	28	SENT_57	[p3l1602t1755r1654b1773],
30	3.32	CD	NUMBER	3.32	tmod	29	SENT_57	[p3l1673t1728r1839b1797],
31	,	,	O	,	_	0	SENT_57	[p3l1673t1728r1839b1797],
32	95	CD	PERCENT	95	number	33	SENT_57	[p3l1869t1728r2022b1784],
33	%	NN	PERCENT	%	amod	34	SENT_57	[p3l1869t1728r2022b1784],
34	CI	NN	O	ci	appos	26	SENT_57	[p3l2047t1728r2144b1784],
35	:	:	O	:	_	0	SENT_57	[p3l2047t1728r2144b1784],
36	1.26-8	CD	NUMBER	1.26-8	num	38	SENT_57	[p3l14t1822r395b1894],
37	.79	CD	NUMBER	.79	num	38	SENT_57	[p3l14t1822r395b1894],
38	)	NN	O	)	dep	24	SENT_57	[p3l14t1822r395b1894],
39	.	.	O	.	_	0	SENT_57	[p3l14t1822r395b1894],

1	The	DT	O	the	det	2	SENT_58	[p3l433t1822r566b1880],
2	frequency	NN	O	frequency	nsubj	11	SENT_58	[p3l602t1822r956b1898],
3	of	IN	O	of	_	0	SENT_58	[p3l990t1822r1061b1880],
4	A	DT	O	a	det	5	SENT_58	[p3l1091t1824r1143b1879],
5	allele	NN	O	allele	prep_of	2	SENT_58	[p3l1177t1822r1359b1880],
6	among	IN	O	among	_	0	SENT_58	[p3l1396t1839r1642b1898],
7	MTX	NNP	O	MTX	nn	8	SENT_58	[p3l1675t1824r1850b1879],
8	responders	NNS	O	responder	prep_among	5	SENT_58	[p3l1886t1839r2147b1898, p3l9t1917r149b1975],
9	was	VBD	O	be	cop	11	SENT_58	[p3l173t1934r300b1975],
10	62.1	CD	PERCENT	62.1	num	11	SENT_58	[p3l328t1919r563b1987],
11	%	NN	PERCENT	%	dep	24	SENT_58	[p3l328t1919r563b1987],
12	,	,	O	,	_	0	SENT_58	[p3l328t1919r563b1987],
13	compared	VBN	O	compare	_	0	SENT_58	[p3l593t1917r944b1993],
14	to	TO	O	to	prepc_compared_to	11	SENT_58	[p3l968t1924r1038b1975],
15	47.8	CD	PERCENT	47.8	num	16	SENT_58	[p3l1064t1919r1282b1975],
16	%	NN	PERCENT	%	pobj	11	SENT_58	[p3l1064t1919r1282b1975],
17	in	IN	O	in	_	0	SENT_58	[p3l1308t1920r1378b1974],
18	a	DT	O	a	det	19	SENT_58	[p3l1404t1934r1438b1975],
19	group	NN	O	group	prep_in	16	SENT_58	[p3l1463t1934r1668b1993],
20	of	IN	O	of	_	0	SENT_58	[p3l1694t1917r1765b1975],
21	poor	JJ	O	poor	amod	23	SENT_58	[p3l1785t1934r1950b1993],
22	MTX	NN	O	mtx	nn	23	SENT_58	[p3l1972t1920r2148b1974],
23	responders	NNS	O	responder	prep_of	19	SENT_58	[p3l8t2012r390b2087],
24	(	VBP	O	(	_	0	SENT_58	[p3l423t2012r786b2084],
25	P	NN	O	p	dobj	24	SENT_58	[p3l423t2012r786b2084],
26	=	JJ	O	=	amod	27	SENT_58	[p3l423t2012r786b2084],
27	0.013	CD	NUMBER	0.013	nsubj	24	SENT_58	[p3l423t2012r786b2084],
28	,	,	O	,	_	0	SENT_58	[p3l423t2012r786b2084],
29	OR	NN	O	or	appos	27	SENT_58	[p3l822t2013r998b2069],
30	:	:	O	:	_	0	SENT_58	[p3l822t2013r998b2069],
31	1.78	CD	NUMBER	1.78	dep	29	SENT_58	[p3l1022t2013r1184b2082],
32	,	,	O	,	_	0	SENT_58	[p3l1022t2013r1184b2082],
33	95	CD	PERCENT	95	number	34	SENT_58	[p3l1219t2013r1371b2069],
34	%	NN	PERCENT	%	amod	35	SENT_58	[p3l1219t2013r1371b2069],
35	CI	NN	O	ci	appos	31	SENT_58	[p3l1402t2013r1498b2069],
36	:	:	O	:	_	0	SENT_58	[p3l1402t2013r1498b2069],
37	1.13-2	CD	NUMBER	1.13-2	number	38	SENT_58	[p3l1538t2012r1919b2084],
38	.81	CD	NUMBER	.81	num	39	SENT_58	[p3l1538t2012r1919b2084],
39	)	NN	O	)	dep	35	SENT_58	[p3l1538t2012r1919b2084],
40	.	.	O	.	_	0	SENT_58	[p3l1538t2012r1919b2084],

1	In	IN	O	in	_	0	SENT_59	[p3l86t2110r158b2164],
2	a	DT	O	a	det	3	SENT_59	[p3l186t2124r221b2165],
3	group	NN	O	group	prep_in	33	SENT_59	[p3l249t2124r454b2183],
4	of	IN	O	of	_	0	SENT_59	[p3l482t2107r554b2165],
5	10	CD	NUMBER	10	num	6	SENT_59	[p3l583t2109r661b2165],
6	patients	NNS	O	patient	prep_of	3	SENT_59	[p3l687t2110r988b2183],
7	,	,	O	,	_	0	SENT_59	[p3l687t2110r988b2183],
8	an	DT	O	a	det	9	SENT_59	[p3l1021t2124r1106b2165],
9	increase	NN	O	increase	nsubjpass	33	SENT_59	[p3l1133t2110r1416b2165],
10	of	IN	O	of	_	0	SENT_59	[p3l1446t2107r1517b2165],
11	aminotransferase	NN	O	aminotransferase	nn	12	SENT_59	[p3l1540t2107r2147b2165],
12	activity	NN	O	activity	prep_of	9	SENT_59	[p3l9t2205r273b2278],
13	(	CD	NUMBER	(	num	15	SENT_59	[p3l314t2202r597b2274],
14	alanine	NN	O	alanine	nn	15	SENT_59	[p3l314t2202r597b2274],
15	transaminase	NN	O	transaminase	dep	25	SENT_59	[p3l637t2205r1106b2260],
16	(	CD	NUMBER	(	num	17	SENT_59	[p3l1150t2202r1355b2274],
17	ALT	NNP	O	ALT	dep	15	SENT_59	[p3l1150t2202r1355b2274],
18	)	CD	NUMBER	)	num	17	SENT_59	[p3l1150t2202r1355b2274],
19	,	,	O	,	_	0	SENT_59	[p3l1150t2202r1355b2274],
20	asparagine	NN	O	asparagine	appos	17	SENT_59	[p3l1400t2205r1772b2278],
21	transaminase	NN	O	transaminase	dep	25	SENT_59	[p3l1813t2205r2147b2260, p3l8t2314r162b2355],
22	(	CD	NUMBER	(	num	21	SENT_59	[p3l202t2297r410b2369],
23	AST	NNP	O	AST	nn	25	SENT_59	[p3l202t2297r410b2369],
24	)	CD	NUMBER	)	num	25	SENT_59	[p3l202t2297r410b2369],
25	)	NN	O	)	dep	9	SENT_59	[p3l202t2297r410b2369],
26	above	IN	O	above	_	0	SENT_59	[p3l450t2297r654b2355],
27	100	CD	NUMBER	100	num	28	SENT_59	[p3l697t2298r819b2355],
28	UI	NN	O	uus	prep_above	25	SENT_59	[p3l854t2299r936b2355],
29	during	IN	O	during	_	0	SENT_59	[p3l973t2297r1208b2373],
30	MTX	NN	O	mtx	nn	31	SENT_59	[p3l1242t2299r1417b2354],
31	therapy	NN	O	therapy	prep_during	9	SENT_59	[p3l1452t2297r1726b2373],
32	was	VBD	O	be	auxpass	33	SENT_59	[p3l1757t2314r1885b2355],
33	noted	VBN	O	note	_	0	SENT_59	[p3l1921t2297r2144b2367],
34	,	,	O	,	_	0	SENT_59	[p3l1921t2297r2144b2367],
35	which	WDT	O	which	nsubj	36	SENT_59	[p3l7t2390r227b2447],
36	resulted	VBD	O	result	ccomp	33	SENT_59	[p3l286t2390r566b2447],
37	in	IN	O	in	_	0	SENT_59	[p3l625t2393r695b2447],
38	discontinuation	NN	O	discontinuation	prep_in	36	SENT_59	[p3l755t2390r1322b2447],
39	of	IN	O	of	_	0	SENT_59	[p3l1382t2390r1453b2447],
40	treatment	NN	O	treatment	prep_of	38	SENT_59	[p3l1508t2398r1876b2447],
41	.	.	O	.	_	0	SENT_59	[p3l1508t2398r1876b2447],

1	Those	DT	O	those	det	3	SENT_60	[p3l1938t2390r2147b2447],
2	adverse	JJ	O	adverse	amod	3	SENT_60	[p3l9t2485r268b2543],
3	events	NNS	O	event	nsubjpass	5	SENT_60	[p3l320t2493r543b2543],
4	were	VBD	O	be	auxpass	5	SENT_60	[p3l592t2502r756b2543],
5	revealed	VBN	O	reveal	_	0	SENT_60	[p3l807t2485r1099b2543],
6	in	IN	O	in	_	0	SENT_60	[p3l1149t2488r1219b2542],
7	10.8	CD	PERCENT	10.8	num	8	SENT_60	[p3l1275t2487r1488b2543],
8	%	NN	PERCENT	%	prep_in	5	SENT_60	[p3l1275t2487r1488b2543],
9	of	IN	O	of	_	0	SENT_60	[p3l1540t2485r1611b2543],
10	patients	NNS	O	patient	prep_of	8	SENT_60	[p3l1656t2488r1938b2561],
11	with	IN	O	with	_	0	SENT_60	[p3l1987t2485r2148b2543],
12	80AA	NN	O	80aa	nn	13	SENT_60	[p3l10t2583r198b2639],
13	genotype	NN	O	genotype	prep_with	5	SENT_60	[p3l228t2588r573b2657],
14	,	,	O	,	_	0	SENT_60	[p3l228t2588r573b2657],
15	in	IN	O	in	_	0	SENT_60	[p3l609t2584r680b2638],
16	5.3	CD	PERCENT	5.3	num	17	SENT_60	[p3l713t2583r887b2639],
17	%	NN	PERCENT	%	prep_in	5	SENT_60	[p3l713t2583r887b2639],
18	with	IN	O	with	_	0	SENT_60	[p3l916t2581r1078b2639],
19	80AG	NN	O	80ag	prep_with	17	SENT_60	[p3l1111t2583r1324b2651],
20	,	,	O	,	_	0	SENT_60	[p3l1111t2583r1324b2651],
21	and	CC	O	and	_	0	SENT_60	[p3l1361t2581r1492b2639],
22	2.3	CD	PERCENT	2.3	num	23	SENT_60	[p3l1524t2583r1698b2639],
23	%	NN	PERCENT	%	prep_in	5	SENT_60	[p3l1524t2583r1698b2639],
24	with	IN	O	with	_	0	SENT_60	[p3l1728t2581r1890b2639],
25	80GG	NN	O	80gg	prep_with	23	SENT_60	[p3l1923t2583r2144b2639],
26	.	.	O	.	_	0	SENT_60	[p3l1923t2583r2144b2639],

1	The	DT	O	the	det	2	SENT_61	[p3l6t2676r139b2733],
2	probability	NN	O	probability	nsubj	8	SENT_61	[p3l173t2676r564b2751],
3	of	IN	O	of	_	0	SENT_61	[p3l596t2675r668b2733],
4	those	DT	O	those	det	5	SENT_61	[p3l697t2676r886b2733],
5	complications	NNS	O	complication	prep_of	2	SENT_61	[p3l921t2676r1421b2751],
6	was	VBD	O	be	cop	8	SENT_61	[p3l1454t2692r1582b2733],
7	fivefold	RB	O	fivefold	advmod	8	SENT_61	[p3l1616t2675r1885b2733],
8	higher	JJR	O	higher	_	0	SENT_61	[p3l1919t2676r2150b2751],
9	in	IN	O	in	_	0	SENT_61	[p3l8t2774r79b2828],
10	carriers	NNS	O	carrier	prep_in	8	SENT_61	[p3l103t2774r356b2829],
11	of	IN	O	of	_	0	SENT_61	[p3l381t2771r452b2829],
12	80AA	NN	O	80aa	nn	13	SENT_61	[p3l473t2773r661b2829],
13	genotype	NN	O	genotype	prep_of	10	SENT_61	[p3l684t2778r1010b2847],
14	compared	VBN	O	compare	_	0	SENT_61	[p3l1036t2771r1387b2847],
15	with	IN	O	with	prepc_compared_with	8	SENT_61	[p3l1408t2771r1569b2829],
16	80GG	NN	O	80gg	pobj	8	SENT_61	[p3l1594t2773r1798b2829],
17	genotype	NN	O	genotype	nn	18	SENT_61	[p3l1822t2778r2147b2847],
18	patients	NNS	O	patient	dep	16	SENT_61	[p3l8t2869r290b2942],
19	(	IN	O	(	_	0	SENT_61	[p3l349t2866r549b2938],
20	OR	NN	O	or	prep_(	18	SENT_61	[p3l349t2866r549b2938],
21	:	:	O	:	_	0	SENT_61	[p3l349t2866r549b2938],
22	5.09	CD	NUMBER	5.09	dep	18	SENT_61	[p3l570t2868r735b2936],
23	,	,	O	,	_	0	SENT_61	[p3l570t2868r735b2936],
24	95	CD	PERCENT	95	number	25	SENT_61	[p3l796t2868r948b2924],
25	%	NN	PERCENT	%	amod	26	SENT_61	[p3l796t2868r948b2924],
26	CI	NN	O	ci	appos	22	SENT_61	[p3l1004t2868r1101b2924],
27	:	:	O	:	_	0	SENT_61	[p3l1004t2868r1101b2924],
28	0.54	CD	NUMBER	0.54	dep	18	SENT_61	[p3l1159t2866r1590b2938],
29	—	CD	NUMBER	—	number	30	SENT_61	[p3l1159t2866r1590b2938],
30	47.74	CD	NUMBER	47.74	num	31	SENT_61	[p3l1159t2866r1590b2938],
31	)	NN	O	)	dep	28	SENT_61	[p3l1159t2866r1590b2938],
32	.	.	O	.	_	0	SENT_61	[p3l1159t2866r1590b2938],

1	However	RB	O	however	advmod	7	SENT_62	[p3l1650t2869r1976b2936],
2	,	,	O	,	_	0	SENT_62	[p3l1650t2869r1976b2936],
3	the	DT	O	the	det	4	SENT_62	[p3l2035t2866r2147b2924],
4	difference	NN	O	difference	nsubj	7	SENT_62	[p3l9t2960r358b3018],
5	did	VBD	O	do	aux	7	SENT_62	[p3l387t2961r499b3018],
6	not	RB	O	not	neg	7	SENT_62	[p3l525t2968r646b3018],
7	reach	VB	O	reach	_	0	SENT_62	[p3l672t2961r863b3018],
8	statistical	JJ	O	statistical	amod	9	SENT_62	[p3l891t2961r1221b3018],
9	significance	NN	O	significance	dobj	7	SENT_62	[p3l1249t2960r1666b3036],
10	owing	VBG	O	owe	partmod	9	SENT_62	[p3l1694t2964r1913b3036],
11	to	TO	O	to	_	0	SENT_62	[p3l1938t2968r2008b3018],
12	the	DT	O	the	det	14	SENT_62	[p3l2035t2961r2147b3018],
13	small	JJ	O	small	amod	14	SENT_62	[p3l10t3055r195b3113],
14	number	NN	O	number	prep_to	10	SENT_62	[p3l224t3055r504b3113],
15	of	IN	O	of	_	0	SENT_62	[p3l533t3055r604b3113],
16	cases	NNS	O	case	prep_of	14	SENT_62	[p3l630t3072r802b3113],
17	(	CD	NUMBER	(	num	18	SENT_62	[p3l835t3056r969b3127],
18	P	NN	O	p	dep	16	SENT_62	[p3l835t3056r969b3127],
19	:	:	O	:	_	0	SENT_62	[p3l835t3056r969b3127],
20	0.18	CD	NUMBER	0.18	dep	16	SENT_62	[p3l988t3056r1161b3127],
21	)	CD	NUMBER	)	number	22	SENT_62	[p3l988t3056r1161b3127],
22	(	CD	NUMBER	(	num	23	SENT_62	[p3l1198t3055r1405b3127],
23	Table	NNP	O	Table	dep	20	SENT_62	[p3l1198t3055r1405b3127],
24	2	CD	NUMBER	2	number	25	SENT_62	[p3l1436t3055r1520b3127],
25	)	CD	NUMBER	)	num	23	SENT_62	[p3l1436t3055r1520b3127],
26	.	.	O	.	_	0	SENT_62	[p3l1436t3055r1520b3127],

1	Discussion	NN	O	discussion	_	0	SENT_63	[p3l11t3282r404b3339],

1	MTX	NNP	O	MTX	nsubj	2	SENT_64	[p3l7t3473r183b3528],
2	used	VBD	O	use	_	0	SENT_64	[p3l220t3471r380b3529],
3	in	IN	O	in	mark	8	SENT_64	[p3l418t3474r488b3528],
4	high	JJ	O	high	amod	7	SENT_64	[p3l525t3471r873b3547],
5	—	NN	O	—	nn	7	SENT_64	[p3l525t3471r873b3547],
6	dose	NN	O	dose	nn	7	SENT_64	[p3l525t3471r873b3547],
7	therapy	NN	O	therapy	nsubj	8	SENT_64	[p3l912t3471r1185b3547],
8	reaches	VBZ	O	reach	advcl	2	SENT_64	[p3l1220t3471r1480b3529],
9	extracellular	JJ	O	extracellular	amod	10	SENT_64	[p3l1519t3471r1957b3529],
10	concentrations	NNS	O	concentration	nsubj	11	SENT_64	[p3l1995t3488r2148b3529, p3l9t3569r406b3624],
11	(	VBP	O	(	ccomp	8	SENT_64	[p3l433t3566r518b3638],
12	>	JJR	O	>	dobj	11	SENT_64	[p3l433t3566r518b3638],
13	20	CD	NUMBER	20	num	14	SENT_64	[p3l534t3568r617b3624],
14	umol/1	NN	O	umol/1	dobj	17	SENT_64	[p3l633t3566r891b3639],
15	)	CD	NUMBER	)	npadvmod	16	SENT_64	[p3l633t3566r891b3639],
16	high	JJ	O	high	amod	14	SENT_64	[p3l917t3566r1079b3642],
17	enough	JJ	O	enough	dep	12	SENT_64	[p3l1102t3566r1370b3642],
18	to	TO	O	to	aux	19	SENT_64	[p3l1393t3573r1462b3624],
19	facilitate	VB	O	facilitate	xcomp	17	SENT_64	[p3l1486t3566r1790b3624],
20	its	PRP$	O	its	poss	22	SENT_64	[p3l1814t3569r1893b3624],
21	simple	JJ	O	simple	amod	22	SENT_64	[p3l1918t3566r2147b3642],
22	diffusion	NN	O	diffusion	dobj	19	SENT_64	[p3l9t3659r325b3716],
23	across	IN	O	across	_	0	SENT_64	[p3l370t3676r578b3716],
24	the	DT	O	the	det	26	SENT_64	[p3l623t3659r735b3716],
25	cell	NN	O	cell	nn	26	SENT_64	[p3l781t3659r900b3716],
26	membrane	NN	O	membrane	prep_across	19	SENT_64	[p3l944t3660r1343b3716],
27	.	.	O	.	_	0	SENT_64	[p3l944t3660r1343b3716],

1	When	WRB	O	when	advmod	5	SENT_65	[p3l1391t3659r1608b3716],
2	lower	JJR	O	lower	amod	4	SENT_65	[p3l1651t3659r1846b3716],
3	routine	JJ	O	routine	amod	4	SENT_65	[p3l1889t3662r2147b3716],
4	doses	NNS	O	dose	nsubj	5	SENT_65	[p4l9t26r196b84],
5	(	VBP	O	(	advcl	18	SENT_65	[p4l231t26r393b102],
6	e.g.	FW	O	e.g.	dobj	5	SENT_65	[p4l231t26r393b102],
7	,	,	O	,	_	0	SENT_65	[p4l231t26r393b102],
8	as	IN	O	as	mark	14	SENT_65	[p4l431t43r496b84],
9	used	VBN	O	use	csubjpass	14	SENT_65	[p4l526t26r687b84],
10	in	IN	O	in	_	0	SENT_65	[p4l718t29r789b83],
11	RA	NN	O	ra	nn	12	SENT_65	[p4l821t26r941b98],
12	)	NN	O	)	prep_in	9	SENT_65	[p4l821t26r941b98],
13	are	VBP	O	be	auxpass	14	SENT_65	[p4l977t43r1078b84],
14	applied	VBN	O	apply	advcl	5	SENT_65	[p4l1112t26r1389b102],
15	,	,	O	,	_	0	SENT_65	[p4l1112t26r1389b102],
16	the	DT	O	the	det	17	SENT_65	[p4l1425t26r1538b84],
17	drug	NN	O	drug	nsubjpass	68	SENT_65	[p4l1571t26r1732b102],
18	uses	VBZ	O	use	_	0	SENT_65	[p4l1761t43r1905b84],
19	RFC-1	NN	O	rfc-1	dobj	18	SENT_65	[p4l1939t27r2143b84],
20	for	IN	O	for	_	0	SENT_65	[p4l8t120r107b178],
21	transport	NN	O	transport	prep_for	18	SENT_65	[p4l140t128r465b196],
22	into	IN	O	into	_	0	SENT_65	[p4l500t123r643b178],
23	the	DT	O	the	det	24	SENT_65	[p4l679t121r791b178],
24	cell	NN	O	cell	prep_into	18	SENT_65	[p4l828t120r946b178],
25	to	TO	O	to	aux	26	SENT_65	[p4l981t128r1051b178],
26	achieve	VB	O	achieve	infmod	24	SENT_65	[p4l1087t120r1351b178],
27	effective	JJ	O	effective	amod	30	SENT_65	[p4l1388t120r1682b178],
28	intracellular	JJ	O	intracellular	amod	30	SENT_65	[p4l1718t120r2149b178],
29	concentrations	NNS	O	concentration	nn	30	SENT_65	[p4l9t208r678b273],
30	.9	NN	NUMBER	.9	dobj	26	SENT_65	[p4l9t208r678b273],
31	'	''	O	'	_	0	SENT_65	[p4l9t208r678b273],
32	1	CD	NUMBER	1	number	33	SENT_65	[p4l9t208r678b273],
33	°	CD	NUMBER	°	num	35	SENT_65	[p4l9t208r678b273],
34	Previous	JJ	O	previous	amod	35	SENT_65	[p4l756t217r1052b273],
35	studies	NNS	O	study	nsubj	37	SENT_65	[p4l1132t215r1372b273],
36	have	VBP	O	have	aux	37	SENT_65	[p4l1451t215r1615b273],
37	shown	VBN	O	show	rcmod	30	SENT_65	[p4l1696t215r1928b273],
38	that	IN	O	that	complm	61	SENT_65	[p4l2005t215r2149b273],
39	downregulation	NN	O	downregulation	nsubj	61	SENT_65	[p4l9t311r574b387],
40	of	IN	O	of	_	0	SENT_65	[p4l630t311r702b369],
41	RFC-1	NN	MISC	rfc-1	nn	43	SENT_65	[p4l753t313r957b369],
42	gene	NN	O	gene	nn	43	SENT_65	[p4l1018t328r1182b387],
43	expression	NN	O	expression	prep_of	39	SENT_65	[p4l1238t314r1629b387],
44	,	,	O	,	_	0	SENT_65	[p4l1238t314r1629b387],
45	modification	NN	O	modification	nn	56	SENT_65	[p4l1689t311r2148b369],
46	of	IN	O	of	dep	56	SENT_65	[p4l9t405r81b463],
47	protein	NN	O	protein	nn	48	SENT_65	[p4l121t409r380b481],
48	structure	NN	O	structure	pobj	46	SENT_65	[p4l427t413r756b476],
49	,	,	O	,	_	0	SENT_65	[p4l427t413r756b476],
50	and	CC	O	and	_	0	SENT_65	[p4l807t406r938b463],
51	decreased	VBD	O	decrease	conj_and	46	SENT_65	[p4l984t406r1324b463],
52	MTX	NN	O	mtx	nn	53	SENT_65	[p4l1368t408r1544b463],
53	affinity	NN	O	affinity	dobj	51	SENT_65	[p4l1590t405r1849b481],
54	to	TO	O	to	_	0	SENT_65	[p4l1891t413r1961b463],
55	RFC	NNP	ORGANIZATION	RFC	prep_to	51	SENT_65	[p4l2008t407r2148b463],
56	protein	NN	O	protein	appos	43	SENT_65	[p4l8t504r267b577],
57	were	VBD	O	be	cop	61	SENT_65	[p4l288t518r451b559],
58	the	DT	O	the	det	61	SENT_65	[p4l475t501r588b559],
59	most	RBS	O	most	advmod	61	SENT_65	[p4l612t508r786b559],
60	frequent	JJ	O	frequent	amod	61	SENT_65	[p4l808t501r1110b577],
61	mechanisms	NNS	O	mechanism	ccomp	37	SENT_65	[p4l1132t501r1574b559],
62	leading	VBG	O	lead	partmod	61	SENT_65	[p4l1598t501r1859b577],
63	to	TO	O	to	_	0	SENT_65	[p4l1880t508r1950b559],
64	MTX	NNP	O	MTX	nn	65	SENT_65	[p4l1972t504r2148b558],
65	resistance	NN	O	resistance	prep_to	62	SENT_65	[p4l8t598r351b652],
66	and	CC	O	and	_	0	SENT_65	[p4l400t595r531b652],
67	are	VBP	O	be	auxpass	68	SENT_65	[p4l579t612r680b652],
68	associated	VBN	O	associate	conj_and	18	SENT_65	[p4l729t595r1085b652],
69	with	IN	O	with	_	0	SENT_65	[p4l1130t595r1291b652],
70	decreased	VBN	O	decrease	amod	73	SENT_65	[p4l1339t595r1680b652],
71	MTX	NN	O	mtx	nn	73	SENT_65	[p4l1725t598r1901b652],
72	transmembrane	NN	O	transmembrane	nn	73	SENT_65	[p4l1948t602r2148b652, p4l8t690r388b748],
73	transport	NN	O	transport	prep_with	68	SENT_65	[p4l425t697r750b766],
74	into	IN	O	into	_	0	SENT_65	[p4l786t693r929b748],
75	cells	NNS	O	cell	prep_into	73	SENT_65	[p4l966t690r1134b748],
76	.	.	O	.	_	0	SENT_65	[p4l966t690r1134b748],

1	The	DT	O	the	det	2	SENT_66	[p4l1172t690r1304b748],
2	presence	NN	O	presence	nsubj	16	SENT_66	[p4l1341t707r1646b766],
3	of	IN	O	of	_	0	SENT_66	[p4l1683t690r1754b748],
4	mutations	NNS	O	mutation	prep_of	2	SENT_66	[p4l1786t693r2148b748],
5	that	WDT	O	that	nsubj	12	SENT_66	[p4l8t784r152b842],
6	downregulate	VBP	O	downregulate	rcmod	4	SENT_66	[p4l191t784r674b860],
7	expression	NN	O	expression	dobj	6	SENT_66	[p4l717t787r1090b860],
8	of	IN	O	of	_	0	SENT_66	[p4l1131t784r1202b842],
9	RFC-1	NN	MISC	rfc-1	nn	10	SENT_66	[p4l1235t786r1439b842],
10	gene	NN	O	gene	prep_of	7	SENT_66	[p4l1486t801r1649b860],
11	and	CC	O	and	_	0	SENT_66	[p4l1691t784r1822b842],
12	produce	VBP	O	produce	rcmod	4	SENT_66	[p4l1862t784r2147b860],
13	transcriptional	JJ	O	transcriptional	amod	15	SENT_66	[p4l8t880r531b955],
14	silencing	NN	O	silencing	nn	15	SENT_66	[p4l558t879r874b955],
15	underlay	NN	O	underlay	dobj	12	SENT_66	[p4l897t879r1213b955],
16	decreased	VBD	O	decrease	_	0	SENT_66	[p4l1236t879r1576b937],
17	activity	NN	O	activity	dobj	16	SENT_66	[p4l1602t882r1866b955],
18	of	IN	O	of	_	0	SENT_66	[p4l1889t879r1961b937],
19	RFC1	NN	O	rfc1	nn	20	SENT_66	[p4l1983t881r2147b937, p4l14t975r43b1030],
20	gene	NN	O	gene	prep_of	17	SENT_66	[p4l89t966r424b1049],
21	.	.	O	.	_	0	SENT_66	[p4l89t966r424b1049],

1	“	NN	O	“	nn	3	SENT_67	[p4l89t966r424b1049],
2	'12	CD	NUMBER	'12	num	3	SENT_67	[p4l89t966r424b1049],
3	Modification	NN	O	modification	nsubjpass	10	SENT_67	[p4l463t973r924b1031],
4	of	IN	O	of	_	0	SENT_67	[p4l965t973r1036b1031],
5	the	DT	O	the	det	7	SENT_67	[p4l1073t973r1185b1031],
6	protein	NN	O	protein	nn	7	SENT_67	[p4l1226t976r1485b1049],
7	structure	NN	O	structure	prep_of	3	SENT_67	[p4l1527t980r1838b1031],
8	may	MD	O	may	aux	10	SENT_67	[p4l1879t990r2031b1049],
9	be	VB	O	be	auxpass	10	SENT_67	[p4l2067t973r2147b1031],
10	brought	VBN	O	bring	_	0	SENT_67	[p4l6t1069r292b1144],
11	about	RB	O	about	advmod	10	SENT_67	[p4l337t1069r537b1126],
12	by	IN	O	by	_	0	SENT_67	[p4l579t1069r667b1144],
13	truncating	JJ	O	truncating	amod	14	SENT_67	[p4l709t1072r1082b1144],
14	mutations	NNS	O	mutation	agent	10	SENT_67	[p4l1126t1072r1488b1126],
15	in	IN	O	in	_	0	SENT_67	[p4l1533t1072r1603b1126],
16	MTX-resistant	JJ	O	mtx-resistant	amod	17	SENT_67	[p4l1647t1071r2149b1126],
17	sublines	NNS	O	subline	prep_in	14	SENT_67	[p4l10t1164r313b1221],
18	.	.	O	.	_	0	SENT_67	[p4l10t1164r313b1221],

1	The	DT	O	the	nsubj	6	SENT_68	[p4l343t1164r476b1221],
2	truncated	VBN	O	truncate	partmod	1	SENT_68	[p4l504t1164r846b1221],
3	protein	NN	O	protein	dobj	2	SENT_68	[p4l872t1167r1131b1239],
4	alone	RB	O	alone	advmod	6	SENT_68	[p4l1160t1164r1351b1221],
5	is	VBZ	O	be	cop	6	SENT_68	[p4l1380t1167r1430b1221],
6	unable	JJ	O	unable	_	0	SENT_68	[p4l1458t1164r1697b1221],
7	to	TO	O	to	aux	8	SENT_68	[p4l1725t1171r1795b1221],
8	transport	VB	O	transport	xcomp	6	SENT_68	[p4l1824t1171r2149b1239],
9	MTX	NNP	O	MTX	dobj	8	SENT_68	[p4l7t1260r183b1315],
10	and	CC	O	and	_	0	SENT_68	[p4l239t1257r370b1315],
11	is	VBZ	O	be	auxpass	13	SENT_68	[p4l425t1260r476b1315],
12	correctly	RB	O	correctly	advmod	13	SENT_68	[p4l532t1257r843b1333],
13	considered	VBN	O	consider	conj_and	6	SENT_68	[p4l896t1257r1278b1315],
14	non-functional	JJ	O	non-functional	dobj	13	SENT_68	[p4l1333t1250r1959b1315],
15	.	.	O	.	_	0	SENT_68	[p4l1333t1250r1959b1315],

1	”	NN	O	”	_	0	SENT_69	[p4l1333t1250r1959b1315],
2	The	DT	O	the	det	4	SENT_69	[p4l2015t1257r2147b1315],
3	decreased	VBN	O	decrease	amod	4	SENT_69	[p4l9t1353r349b1410],
4	affinity	NN	O	affinity	nsubjpass	12	SENT_69	[p4l385t1352r643b1428],
5	of	IN	O	of	_	0	SENT_69	[p4l677t1352r749b1410],
6	RFC	NN	ORGANIZATION	rfc	nn	7	SENT_69	[p4l780t1354r920b1410],
7	protein	NN	O	protein	prep_of	4	SENT_69	[p4l956t1356r1215b1428],
8	to	TO	O	to	_	0	SENT_69	[p4l1249t1360r1319b1410],
9	MTX	NNP	O	MTX	prep_to	7	SENT_69	[p4l1355t1355r1530b1410],
10	may	MD	O	may	aux	12	SENT_69	[p4l1565t1369r1718b1428],
11	be	VB	O	be	auxpass	12	SENT_69	[p4l1749t1353r1829b1410],
12	brought	VBN	O	bring	rcmod	1	SENT_69	[p4l1863t1353r2148b1428],

1	Table	NNP	O	Table	_	0	SENT_70	[p4l7t1582r196b1638],
2	2	CD	NUMBER	2	num	5	SENT_70	[p4l226t1583r264b1637],
3	MTX	NNP	O	MTX	nn	5	SENT_70	[p4l346t1585r499b1638],
4	adverse	JJ	O	adverse	amod	5	SENT_70	[p4l530t1583r785b1638],
5	events	NNS	O	event	dep	1	SENT_70	[p4l814t1589r1030b1638],
6	in	IN	O	in	_	0	SENT_70	[p4l1060t1584r1117b1637],
7	relation	NN	O	relation	prep_in	5	SENT_70	[p4l1150t1583r1403b1638],
8	to	TO	O	to	_	0	SENT_70	[p4l1433t1589r1501b1638],
9	RFC-1	NN	O	rfc-1	nn	10	SENT_70	[p4l1534t1585r1711b1638],
10	genotype	NN	O	genotype	prep_to	7	SENT_70	[p4l1750t1589r2068b1655],

1	Adverse	JJ	O	adverse	amod	2	SENT_71	[p4l740t1757r973b1811],
2	effects	NNS	O	effect	_	0	SENT_71	[p4l999t1757r1186b1811],
3	on	IN	O	on	_	0	SENT_71	[p4l1213t1773r1286b1811],
4	course	NN	O	course	prep_on	2	SENT_71	[p4l1315t1773r1506b1811],
5	of	IN	O	of	_	0	SENT_71	[p4l1532t1757r1595b1811],
6	treatment	NN	O	treatment	nn	10	SENT_71	[p4l1617t1763r1914b1811],
7	n	NN	PERCENT	n	nn	10	SENT_71	[p4l532t1955r564b1993],
8	%	NN	PERCENT	%	nn	10	SENT_71	[p4l831t1941r885b1994],
9	P	NN	O	p	nn	10	SENT_71	[p4l1217t1942r1248b1993],
10	OR	NN	O	or	nn	15	SENT_71	[p4l1635t1941r1721b1994],
11	(	CD	PERCENT	(	number	13	SENT_71	[p4l1751t1940r1914b2008],
12	95	CD	PERCENT	95	number	13	SENT_71	[p4l1751t1940r1914b2008],
13	%	NN	PERCENT	%	amod	15	SENT_71	[p4l1751t1940r1914b2008],
14	CI	NN	O	ci	nn	15	SENT_71	[p4l1945t1940r2027b2008],
15	)	NN	O	)	prep_of	2	SENT_71	[p4l1945t1940r2027b2008],

1	RFC-7	NN	MISC	rfc-7	nn	4	SENT_72	[p4l12t2124r177b2177],
2	genotype	NN	O	genotype	nn	4	SENT_72	[p4l211t2128r492b2194],
3	AA	NN	O	aa	nn	4	SENT_72	[p4l6t2211r95b2263],
4	n	NN	O	n	_	0	SENT_72	[p4l124t2225r224b2263],
5	:	:	O	:	_	0	SENT_72	[p4l124t2225r224b2263],
6	37	CD	NUMBER	37	dep	4	SENT_72	[p4l245t2211r319b2264],
7	4	CD	NUMBER	4	number	8	SENT_72	[p4l528t2211r565b2263],
8	10.8	CD	NUMBER	10.8	dep	6	SENT_72	[p4l789t2211r925b2264],
9	0.183	CD	NUMBER	0.183	num	10	SENT_72	[p4l1146t2211r1312b2264],
10	‘	NN	O	‘	dep	17	SENT_72	[p4l1146t2211r1312b2264],
11	5.09	CD	NUMBER	5.09	number	12	SENT_72	[p4l1509t2211r1648b2264],
12	(	CD	NUMBER	(	dep	10	SENT_72	[p4l1679t2209r2092b2278],
13	O.	NNP	O	O.	dep	12	SENT_72	[p4l1679t2209r2092b2278],
14	54	CD	NUMBER	54	num	13	SENT_72	[p4l1679t2209r2092b2278],
15	—	CD	NUMBER	—	dep	17	SENT_72	[p4l1679t2209r2092b2278],
16	47.74	CD	NUMBER	47.74	num	17	SENT_72	[p4l1679t2209r2092b2278],
17	)	NN	O	)	dep	22	SENT_72	[p4l1679t2209r2092b2278],
18	0.22	CD	NUMBER	0.22	number	19	SENT_72	[p4l1146t2311r1318b2373],
19	”	CD	NUMBER	”	dep	17	SENT_72	[p4l1146t2311r1318b2373],
20	2.65	CD	NUMBER	2.65	num	21	SENT_72	[p4l1509t2320r1647b2373],
21	(	CD	NUMBER	(	dep	19	SENT_72	[p4l1679t2318r2051b2387],
22	O.	NNP	O	O.	dep	30	SENT_72	[p4l1679t2318r2051b2387],
23	7l	CD	NUMBER	7l	num	22	SENT_72	[p4l1679t2318r2051b2387],
24	—	CD	NUMBER	—	number	25	SENT_72	[p4l1679t2318r2051b2387],
25	9.92	CD	NUMBER	9.92	dep	22	SENT_72	[p4l1679t2318r2051b2387],
26	)	CD	NUMBER	)	num	28	SENT_72	[p4l1679t2318r2051b2387],
27	AG	NNP	ORGANIZATION	AG	nn	28	SENT_72	[p4l6t2430r99b2483],
28	n	NN	O	n	dep	25	SENT_72	[p4l133t2430r327b2483],
29	=	JJ	O	=	amod	30	SENT_72	[p4l133t2430r327b2483],
30	94	CD	NUMBER	94	dep	37	SENT_72	[p4l133t2430r327b2483],
31	5	CD	NUMBER	5	number	32	SENT_72	[p4l530t2431r564b2483],
32	5.3	CD	NUMBER	5.3	dep	30	SENT_72	[p4l827t2430r923b2483],
33	0.66	CD	NUMBER	0.66	num	34	SENT_72	[p4l1146t2430r1312b2483],
34	*	NN	O	*	dep	32	SENT_72	[p4l1146t2430r1312b2483],
35	’	CD	NUMBER	’	num	37	SENT_72	[p4l1146t2430r1312b2483],
36	2.36	CD	NUMBER	2.36	num	37	SENT_72	[p4l1509t2430r1649b2483],
37	(	NN	O	(	dep	43	SENT_72	[p4l1679t2429r2092b2497],
38	0.27	CD	NUMBER	0.27	num	39	SENT_72	[p4l1679t2429r2092b2497],
39	—	CD	NUMBER	—	dep	37	SENT_72	[p4l1679t2429r2092b2497],
40	20.84	CD	NUMBER	20.84	num	43	SENT_72	[p4l1679t2429r2092b2497],
41	)	NN	O	)	nn	43	SENT_72	[p4l1679t2429r2092b2497],
42	CG	NN	O	cg	nn	43	SENT_72	[p4l10t2539r108b2592],
43	n	NN	O	n	dep	4	SENT_72	[p4l142t2539r335b2592],
44	=	JJ	O	=	amod	45	SENT_72	[p4l142t2539r335b2592],
45	43	CD	NUMBER	43	dep	43	SENT_72	[p4l142t2539r335b2592],
46	1	CD	NUMBER	1	number	47	SENT_72	[p4l533t2539r552b2591],
47	2.3	CD	NUMBER	2.3	dep	45	SENT_72	[p4l828t2539r923b2592],

1	Abbreviations	NNS	O	abbreviation	nsubj	19	SENT_73	[p4l6t2683r377b2728],
2	:	:	O	:	_	0	SENT_73	[p4l6t2683r377b2728],
3	CI	NN	O	ci	dep	1	SENT_73	[p4l404t2685r470b2737],
4	,	,	O	,	_	0	SENT_73	[p4l404t2685r470b2737],
5	confidence	NN	O	confidence	nn	6	SENT_73	[p4l496t2683r781b2728],
6	interval	NN	O	interval	appos	3	SENT_73	[p4l805t2683r1008b2737],
7	;	:	O	;	_	0	SENT_73	[p4l805t2683r1008b2737],
8	MTX	NNP	O	MTX	dep	3	SENT_73	[p4l1037t2685r1171b2737],
9	,	,	O	,	_	0	SENT_73	[p4l1037t2685r1171b2737],
10	methotrexate	NN	O	methotrexate	appos	8	SENT_73	[p4l1200t2683r1564b2737],
11	;	:	O	;	_	0	SENT_73	[p4l1200t2683r1564b2737],
12	OR	NN	O	or	dep	3	SENT_73	[p4l1590t2685r1680b2737],
13	,	,	O	,	_	0	SENT_73	[p4l1590t2685r1680b2737],
14	odds	NNS	O	odds	nn	15	SENT_73	[p4l1707t2683r1831b2728],
15	ratios	NNS	O	ratio	appos	12	SENT_73	[p4l1856t2684r2006b2737],
16	;	:	O	;	_	0	SENT_73	[p4l1856t2684r2006b2737],
17	RFC	NNP	O	RFC	dep	1	SENT_73	[p4l2035t2685r2145b2737],
18	,	,	O	,	_	0	SENT_73	[p4l2035t2685r2145b2737],
19	reduced	VBD	O	reduce	_	0	SENT_73	[p4l10t2759r217b2804],
20	folate	JJ	O	folate	amod	21	SENT_73	[p4l241t2759r385b2804],
21	carrier	NN	O	carrier	dobj	19	SENT_73	[p4l410t2760r584b2804],
22	.	.	O	.	_	0	SENT_73	[p4l410t2760r584b2804],
23	"	''	O	"	punct	19	SENT_73	[p4l8t2834r305b2892],

1	“	RB	O	“	advmod	2	SENT_74	[p4l8t2834r305b2892],
2	Compared	VBN	O	compare	_	0	SENT_74	[p4l8t2834r305b2892],
3	with	IN	O	with	_	0	SENT_74	[p4l329t2834r441b2878],
4	GG	NNS	O	gg	nn	5	SENT_74	[p4l467t2835r549b2878],
5	genotype	NN	O	genotype	prep_with	2	SENT_74	[p4l575t2839r836b2892],
6	.	.	O	.	_	0	SENT_74	[p4l575t2839r836b2892],

1	bCompared	VBN	O	bcompare	_	0	SENT_75	[p4l9t2902r309b2968],
2	with	IN	O	with	_	0	SENT_75	[p4l333t2908r445b2954],
3	AG+GG	NN	O	ag+gg	nn	4	SENT_75	[p4l469t2910r667b2954],
4	genotypes	NNS	O	genotype	prep_with	1	SENT_75	[p4l694t2914r979b2968],
5	.	.	O	.	_	0	SENT_75	[p4l694t2914r979b2968],

1	mg	NN	O	mg	nsubj	2	SENT_76	[p4l8t3373r135b3497],
2	Reduced	VBN	O	reduce	_	0	SENT_76	[p4l1565t3385r1765b3430],
3	folate	NN	O	folate	nn	6	SENT_76	[p4l1783t3385r1925b3430],
4	carrier-1	NN	O	carrier-1	nn	6	SENT_76	[p4l1944t3385r2143b3430],
5	M	NN	O	m	nn	6	SENT_76	[p4l1809t3458r1846b3497],
6	Drozdzik	NNP	O	Drozdzik	dobj	2	SENT_76	[p4l1868t3456r2046b3498],
7	et	FW	O	et	nn	8	SENT_76	[p4l2065t3461r2101b3498],
8	al	FW	O	al	npadvmod	9	SENT_76	[p4l2117t3456r2153b3498],
9	about	IN	O	about	prep	2	SENT_76	[p5l9t84r210b142],
10	by	IN	O	by	pcomp	9	SENT_76	[p5l250t84r338b160],
11	substituting	VBG	O	substitute	pcomp	10	SENT_76	[p5l380t84r802b160],
12	amino-acid	JJ	O	amino-acid	amod	13	SENT_76	[p5l844t84r1243b142],
13	residues	NNS	O	residue	nsubj	14	SENT_76	[p5l1285t84r1566b142],
14	responsible	JJ	O	responsible	xcomp	11	SENT_76	[p5l1610t84r2007b160],
15	for	IN	O	for	_	0	SENT_76	[p5l2051t84r2150b142],
16	binding	VBG	O	bind	amod	17	SENT_76	[p5l7t177r287b253],
17	recognition	NN	O	recognition	prep_for	14	SENT_76	[p5l342t180r753b253],
18	or	CC	O	or	_	0	SENT_76	[p5l811t194r883b235],
19	affinity	NN	O	affinity	prep_for	14	SENT_76	[p5l939t170r1278b253],
20	.	.	O	.	_	0	SENT_76	[p5l939t170r1278b253],

1	”	NN	O	”	ccomp	9	SENT_77	[p5l939t170r1278b253],
2	Thus	RB	O	thus	advmod	1	SENT_77	[p5l1333t177r1524b247],
3	,	,	O	,	_	0	SENT_77	[p5l1333t177r1524b247],
4	the	DT	O	the	det	6	SENT_77	[p5l1585t177r1698b235],
5	transporter	NN	O	transporter	nn	6	SENT_77	[p5l1756t184r2150b253],
6	activity	NN	O	activity	nsubjpass	9	SENT_77	[p5l9t275r274b348],
7	may	MD	O	may	aux	9	SENT_77	[p5l303t289r456b348],
8	be	VB	O	be	auxpass	9	SENT_77	[p5l484t272r565b330],
9	involved	VBN	O	involve	_	0	SENT_77	[p5l598t272r907b330],
10	in	IN	O	in	_	0	SENT_77	[p5l939t275r1009b329],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_77	[p5l1042t272r1446b348],
12	effects	NNS	O	effect	prep_in	9	SENT_77	[p5l1479t272r1700b330],
13	under	IN	O	under	_	0	SENT_77	[p5l1733t272r1942b330],
14	MTX	NN	O	mtx	nn	15	SENT_77	[p5l1973t275r2148b330],
15	treatment	NN	O	treatment	prep_under	12	SENT_77	[p5l8t375r359b425],
16	and	CC	O	and	_	0	SENT_77	[p5l406t367r537b425],
17	account	NN	O	account	prep_under	12	SENT_77	[p5l583t375r864b425],
18	for	IN	O	for	_	0	SENT_77	[p5l910t367r1008b425],
19	part	NN	O	part	prep_for	9	SENT_77	[p5l1053t375r1193b443],
20	of	IN	O	of	_	0	SENT_77	[p5l1240t367r1311b425],
21	the	DT	O	the	det	24	SENT_77	[p5l1353t367r1465b425],
22	large	JJ	O	large	amod	24	SENT_77	[p5l1512t367r1680b443],
23	interpatient	JJ	O	interpatient	amod	24	SENT_77	[p5l1726t370r2149b443],
24	variability	NN	O	variability	prep_of	19	SENT_77	[p5l7t463r368b539],
25	in	IN	O	in	_	0	SENT_77	[p5l392t466r463b520],
26	response	NN	O	response	prep_in	24	SENT_77	[p5l490t480r795b539],
27	to	TO	O	to	_	0	SENT_77	[p5l823t470r893b521],
28	MTX	NN	O	mtx	nn	29	SENT_77	[p5l919t465r1095b520],
29	medication	NN	O	medication	prep_to	9	SENT_77	[p5l1122t463r1541b521],
30	.	.	O	.	_	0	SENT_77	[p5l1122t463r1541b521],

1	Recent	JJ	O	recent	amod	2	SENT_78	[p5l1574t465r1811b521],
2	evidence	NN	O	evidence	nsubj	3	SENT_78	[p5l1838t463r2147b521],
3	suggests	VBZ	O	suggest	_	0	SENT_78	[p5l10t565r294b633],
4	that	IN	O	that	complm	10	SENT_78	[p5l338t558r481b615],
5	G80A	NN	O	g80a	nn	6	SENT_78	[p5l525t559r722b615],
6	polymorphism	NN	O	polymorphism	nsubjpass	18	SENT_78	[p5l764t558r1289b633],
7	in	IN	O	in	_	0	SENT_78	[p5l1333t561r1403b615],
8	RFC-1	NN	O	rfc-1	prep_in	6	SENT_78	[p5l1443t559r1648b615],
9	is	VBZ	O	be	auxpass	10	SENT_78	[p5l1698t561r1748b615],
10	associated	VBN	O	associate	ccomp	3	SENT_78	[p5l1793t558r2149b615],
11	with	IN	O	with	_	0	SENT_78	[p5l7t653r168b711],
12	altered	JJ	O	altered	amod	14	SENT_78	[p5l212t653r451b711],
13	folate/antifolate	JJ	O	folate/antifolate	amod	14	SENT_78	[p5l494t653r1064b718],
14	levels	NNS	O	level	prep_with	10	SENT_78	[p5l1107t653r1301b711],
15	and	CC	O	and	_	0	SENT_78	[p5l1345t653r1476b711],
16	is	VBZ	O	be	auxpass	18	SENT_78	[p5l1519t656r1569b711],
17	modestly	RB	O	modestly	advmod	18	SENT_78	[p5l1613t653r1940b729],
18	associated	VBN	O	associate	conj_and	10	SENT_78	[p5l1981t670r2147b711, p5l9t747r219b805],
19	with	IN	O	with	_	0	SENT_78	[p5l270t747r432b805],
20	the	DT	O	the	det	21	SENT_78	[p5l485t747r598b805],
21	risk	NN	O	risk	prep_with	18	SENT_78	[p5l653t747r778b805],
22	for	IN	O	for	_	0	SENT_78	[p5l830t747r928b805],
23	neural	JJ	O	neural	amod	27	SENT_78	[p5l981t747r1205b805],
24	tube	NN	O	tube	nn	27	SENT_78	[p5l1259t747r1413b805],
25	defect	NN	O	defect	nn	27	SENT_78	[p5l1468t740r1932b805],
26	.1	CD	NUMBER	.1	num	27	SENT_78	[p5l1468t740r1932b805],
27	°	NN	O	°	prep_for	21	SENT_78	[p5l1468t740r1932b805],
28	'	''	DATE	'	_	0	SENT_78	[p5l1468t740r1932b805],
29	15	CD	DATE	15	number	30	SENT_78	[p5l1468t740r1932b805],
30	'16	CD	DATE	'16	num	31	SENT_78	[p5l1468t740r1932b805],
31	Data	NNS	O	datum	nsubj	32	SENT_78	[p5l1987t750r2149b805],
32	suggest	VBP	O	suggest	rcmod	27	SENT_78	[p5l10t850r264b918],
33	that	IN	O	that	complm	41	SENT_78	[p5l286t843r429b900],
34	subjects	NNS	O	subject	nsubj	41	SENT_78	[p5l453t843r729b918],
35	carrying	VBG	O	carry	partmod	34	SENT_78	[p5l752t846r1043b918],
36	the	DT	O	the	det	40	SENT_78	[p5l1064t843r1177b900],
37	homozygous	JJ	O	homozygous	amod	40	SENT_78	[p5l1200t843r1652b918],
38	mutant	JJ	O	mutant	amod	40	SENT_78	[p5l1675t850r1938b900],
39	8OAA	NN	O	8oaa	nn	40	SENT_78	[p5l1961t844r2149b900],
40	genotype	NN	O	genotype	dobj	35	SENT_78	[p5l9t945r335b1014],
41	tend	VBP	O	tend	ccomp	32	SENT_78	[p5l362t938r523b996],
42	to	TO	O	to	aux	43	SENT_78	[p5l549t945r619b996],
43	have	VB	O	have	xcomp	41	SENT_78	[p5l646t938r811b996],
44	higher	JJR	O	higher	amod	46	SENT_78	[p5l838t938r1069b1014],
45	plasma	NN	O	plasma	nn	46	SENT_78	[p5l1094t938r1343b1014],
46	folate	NN	O	folate	dobj	43	SENT_78	[p5l1370t938r1567b996],
47	and	CC	O	and	_	0	SENT_78	[p5l1595t938r1727b996],
48	MTX	NN	O	mtx	nn	49	SENT_78	[p5l1752t941r1928b995],
49	levels	NNS	O	level	conj_and	46	SENT_78	[p5l1955t938r2148b996],
50	and	CC	O	and	_	0	SENT_78	[p5l9t1032r141b1090],
51	higher	JJR	O	higher	amod	54	SENT_78	[p5l166t1032r397b1108],
52	erythrocyte	NN	O	erythrocyte	nn	54	SENT_78	[p5l422t1032r828b1108],
53	polyglutamate	NN	O	polyglutamate	nn	54	SENT_78	[p5l854t1032r1366b1108],
54	levels	NNS	O	level	conj_and	46	SENT_78	[p5l1393t1032r1586b1090],
55	compared	VBN	O	compare	_	0	SENT_78	[p5l1613t1032r1964b1108],
56	with	IN	O	with	prepc_compared_with	54	SENT_78	[p5l1987t1032r2148b1090],
57	those	DT	O	those	pobj	54	SENT_78	[p5l8t1126r198b1184],
58	with	IN	O	with	_	0	SENT_78	[p5l226t1126r388b1184],
59	the	DT	O	the	det	61	SENT_78	[p5l417t1126r529b1184],
60	wild	JJ	O	wild	amod	61	SENT_78	[p5l558t1126r711b1184],
61	type	NN	O	type	prep_with	57	SENT_78	[p5l740t1133r890b1202],
62	or	CC	O	or	_	0	SENT_78	[p5l922t1143r993b1184],
63	heterozygous	JJ	O	heterozygous	amod	64	SENT_78	[p5l1021t1126r1490b1202],
64	genotype	NN	O	genotype	conj_or	57	SENT_78	[p5l1521t1119r2017b1202],
65	.15	CD	NUMBER	.15	number	66	SENT_78	[p5l1521t1119r2017b1202],
66	'17	CD	NUMBER	'17	dep	64	SENT_78	[p5l1521t1119r2017b1202],

1	In	IN	O	in	_	0	SENT_79	[p5l86t1224r159b1278],
2	the	DT	O	the	det	4	SENT_79	[p5l188t1222r301b1279],
3	present	JJ	DATE	present	amod	4	SENT_79	[p5l332t1229r591b1297],
4	study	NN	O	study	prep_in	26	SENT_79	[p5l623t1221r825b1297],
5	,	,	O	,	_	0	SENT_79	[p5l623t1221r825b1297],
6	the	DT	O	the	det	7	SENT_79	[p5l860t1221r972b1279],
7	inﬂuence	NN	O	inﬂuence	nsubjpass	26	SENT_79	[p5l1004t1221r1334b1279],
8	of	IN	O	of	_	0	SENT_79	[p5l1366t1221r1438b1279],
9	RFC-1	NN	MISC	rfc-1	nn	10	SENT_79	[p5l1460t1223r1665b1279],
10	gene	NN	O	gene	prep_of	7	SENT_79	[p5l1703t1238r1866b1297],
11	(	CD	NUMBER	(	num	12	SENT_79	[p5l1901t1222r2145b1294],
12	G8OA	NN	O	g8oa	dep	10	SENT_79	[p5l1901t1222r2145b1294],
13	)	CD	NUMBER	)	num	14	SENT_79	[p5l1901t1222r2145b1294],
14	polymorphism	NN	O	polymorphism	dep	12	SENT_79	[p5l8t1316r534b1392],
15	on	IN	O	on	_	0	SENT_79	[p5l560t1333r652b1374],
16	treatment	NN	O	treatment	nn	17	SENT_79	[p5l676t1324r1027b1374],
17	outcome	NN	O	outcome	prep_on	14	SENT_79	[p5l1053t1324r1362b1374],
18	with	IN	O	with	_	0	SENT_79	[p5l1386t1316r1547b1374],
19	MT	NN	O	mt	nn	20	SENT_79	[p5l1572t1319r1691b1374],
20	X	NN	O	x	prep_with	17	SENT_79	[p5l1694t1319r1747b1373],
21	of	IN	O	of	_	0	SENT_79	[p5l1774t1316r1845b1374],
22	patients	NNS	O	patient	prep_of	20	SENT_79	[p5l1866t1319r2148b1392],
23	with	IN	O	with	_	0	SENT_79	[p5l7t1412r168b1470],
24	RA	NN	O	ra	prep_with	22	SENT_79	[p5l232t1414r329b1469],
25	was	VBD	O	be	auxpass	26	SENT_79	[p5l387t1429r515b1470],
26	examined	VBN	O	examine	_	0	SENT_79	[p5l579t1412r945b1470],
27	.	.	O	.	_	0	SENT_79	[p5l579t1412r945b1470],

1	The	DT	O	the	det	2	SENT_80	[p5l1010t1412r1143b1470],
2	patients	NNS	O	patient	nsubj	7	SENT_80	[p5l1206t1415r1488b1488],
3	with	IN	O	with	_	0	SENT_80	[p5l1550t1412r1711b1470],
4	RFC-1	NN	O	rfc-1	nn	6	SENT_80	[p5l1775t1414r1979b1470],
5	AA	NN	O	aa	nn	6	SENT_80	[p5l2046t1414r2150b1469],
6	genotype	NN	O	genotype	prep_with	2	SENT_80	[p5l9t1514r335b1582],
7	responded	VBD	O	respond	_	0	SENT_80	[p5l376t1507r744b1582],
8	to	TO	O	to	_	0	SENT_80	[p5l784t1514r854b1564],
9	the	DT	O	the	det	10	SENT_80	[p5l894t1507r1007b1564],
10	therapy	NN	O	therapy	prep_to	7	SENT_80	[p5l1048t1507r1322b1582],
11	more	RBR	O	more	advmod	12	SENT_80	[p5l1360t1523r1540b1564],
12	effectively	RB	O	effectively	advmod	7	SENT_80	[p5l1582t1506r1946b1582],
13	than	IN	O	than	_	0	SENT_80	[p5l1984t1507r2149b1564],
14	carriers	NNS	O	carrier	prep_than	7	SENT_80	[p5l9t1605r262b1660],
15	of	IN	O	of	_	0	SENT_80	[p5l312t1602r384b1660],
16	AG	NNP	O	AG	prep_of	14	SENT_80	[p5l427t1604r538b1660],
17	and	CC	O	and	_	0	SENT_80	[p5l588t1602r719b1660],
18	GG	NNS	O	gg	nn	19	SENT_80	[p5l769t1604r885b1660],
19	genotypes	NNS	O	genotype	prep_of	14	SENT_80	[p5l933t1609r1310b1678],
20	.	.	O	.	_	0	SENT_80	[p5l933t1609r1310b1678],

1	The	DT	O	the	det	2	SENT_81	[p5l1361t1602r1493b1660],
2	remission	NN	O	remission	nsubj	6	SENT_81	[p5l1543t1605r1886b1660],
3	of	IN	O	of	_	0	SENT_81	[p5l1935t1602r2007b1660],
4	RA	NN	O	ra	nn	5	SENT_81	[p5l2052t1604r2149b1659],
5	symptoms	NNS	O	symptom	prep_of	2	SENT_81	[p5l10t1704r374b1773],
6	was	VBD	O	be	ccomp	14	SENT_81	[p5l421t1714r549b1755],
7	significantly	RB	O	significantly	advmod	6	SENT_81	[p5l599t1697r1048b1773],
8	,	,	O	,	_	0	SENT_81	[p5l599t1697r1048b1773],
9	that	DT	O	that	nsubj	14	SENT_81	[p5l1101t1697r1244b1755],
10	is	VBZ	O	be	cop	14	SENT_81	[p5l1292t1700r1360b1767],
11	,	,	O	,	_	0	SENT_81	[p5l1292t1700r1360b1767],
12	3.32-fold	RB	O	3.32-fold	advmod	14	SENT_81	[p5l1414t1697r1747b1767],
13	,	,	O	,	_	0	SENT_81	[p5l1414t1697r1747b1767],
14	higher	JJR	O	higher	_	0	SENT_81	[p5l1800t1697r2031b1773],
15	in	IN	O	in	_	0	SENT_81	[p5l2078t1700r2149b1754],
16	8OAA	NN	O	8oaa	nn	17	SENT_81	[p5l10t1793r198b1849],
17	carriers	NNS	O	carrier	prep_in	14	SENT_81	[p5l228t1795r481b1849],
18	in	IN	O	in	_	0	SENT_81	[p5l511t1795r581b1849],
19	comparison	NN	O	comparison	prep_in	17	SENT_81	[p5l611t1795r1027b1867],
20	to	TO	O	to	_	0	SENT_81	[p5l1057t1799r1127b1849],
21	80GG	NN	O	80gg	nn	22	SENT_81	[p5l1159t1793r1362b1849],
22	individuals	NNS	O	individual	prep_to	14	SENT_81	[p5l1391t1792r1803b1849],
23	.	.	O	.	_	0	SENT_81	[p5l1391t1792r1803b1849],

1	Similarly	RB	O	similarly	advmod	30	SENT_82	[p5l86t1887r411b1963],
2	,	,	O	,	_	0	SENT_82	[p5l86t1887r411b1963],
3	in	IN	O	in	_	0	SENT_82	[p5l453t1890r524b1944],
4	a	DT	O	a	det	5	SENT_82	[p5l562t1904r597b1945],
5	series	NN	O	series	prep_in	8	SENT_82	[p5l635t1890r821b1945],
6	of	IN	O	of	_	0	SENT_82	[p5l861t1887r932b1945],
7	studies	NNS	O	study	prep_of	5	SENT_82	[p5l967t1887r1207b1945],
8	carried	VBD	O	carry	parataxis	30	SENT_82	[p5l1246t1887r1486b1945],
9	out	RP	O	out	prt	8	SENT_82	[p5l1524t1894r1641b1945],
10	to	TO	O	to	aux	11	SENT_82	[p5l1678t1894r1748b1945],
11	determine	VB	O	determine	xcomp	8	SENT_82	[p5l1787t1887r2148b1945],
12	the	DT	O	the	det	13	SENT_82	[p5l8t1981r121b2039],
13	association	NN	O	association	dobj	11	SENT_82	[p5l160t1984r550b2039],
14	of	IN	O	of	_	0	SENT_82	[p5l588t1981r660b2039],
15	RFC-1	NN	MISC	rfc-1	nn	16	SENT_82	[p5l688t1983r893b2039],
16	gene	NN	O	gene	prep_of	13	SENT_82	[p5l937t1998r1101b2057],
17	(	CD	NUMBER	(	num	20	SENT_82	[p5l1141t1981r1386b2054],
18	G8OA	NN	O	g8oa	nn	20	SENT_82	[p5l1141t1981r1386b2054],
19	)	CD	NUMBER	)	num	20	SENT_82	[p5l1141t1981r1386b2054],
20	polymorphism	NN	O	polymorphism	nsubj	8	SENT_82	[p5l1426t1981r1952b2057],
21	with	IN	O	with	_	0	SENT_82	[p5l1987t1981r2148b2039],
22	MTX	NN	O	mtx	nn	24	SENT_82	[p5l8t2077r180b2132],
23	treatment	NN	O	treatment	nn	24	SENT_82	[p5l203t2082r542b2133],
24	outcome	NN	O	outcome	prep_with	30	SENT_82	[p5l565t2082r883b2145],
25	,	,	O	,	_	0	SENT_82	[p5l565t2082r883b2145],
26	Dervieux	NNP	PERSON	Dervieux	appos	24	SENT_82	[p5l911t2077r1220b2133],
27	et	FW	O	et	nn	28	SENT_82	[p5l1241t2081r1300b2133],
28	al.	FW	O	al.	nsubj	30	SENT_82	[p5l1317t2068r1457b2133],
29	18	CD	NUMBER	18	dep	28	SENT_82	[p5l1317t2068r1457b2133],
30	evaluated	VBD	O	evaluate	_	0	SENT_82	[p5l1482t2075r1808b2133],
31	the	DT	O	the	det	32	SENT_82	[p5l1830t2075r1940b2133],
32	inﬂuence	NN	O	inﬂuence	dobj	30	SENT_82	[p5l1963t2075r2147b2133, p5l9t2187r168b2228],
33	of	IN	O	of	_	0	SENT_82	[p5l212t2170r284b2228],
34	the	DT	O	the	det	35	SENT_82	[p5l322t2171r435b2228],
35	polymorphism	NN	O	polymorphism	prep_of	32	SENT_82	[p5l478t2170r1003b2246],
36	on	IN	O	on	_	0	SENT_82	[p5l1048t2187r1139b2228],
37	MTX	NN	O	mtx	nn	39	SENT_82	[p5l1181t2173r1356b2228],
38	polyglutamate	NN	O	polyglutamate	nn	39	SENT_82	[p5l1398t2170r1910b2246],
39	levels	NNS	O	level	prep_on	30	SENT_82	[p5l1955t2170r2148b2228],
40	and	CC	O	and	_	0	SENT_82	[p5l9t2265r141b2323],
41	MTX	NN	O	mtx	nn	42	SENT_82	[p5l192t2268r368b2323],
42	effects	NNS	O	effect	conj_and	39	SENT_82	[p5l422t2265r643b2323],
43	in	IN	O	in	_	0	SENT_82	[p5l698t2268r768b2322],
44	RA	NN	O	ra	nn	45	SENT_82	[p5l822t2267r920b2322],
45	patients	NNS	O	patient	prep_in	39	SENT_82	[p5l971t2268r1273b2341],
46	.	.	O	.	_	0	SENT_82	[p5l971t2268r1273b2341],

1	The	DT	O	the	det	2	SENT_83	[p5l1329t2265r1461b2323],
2	authors	NNS	O	author	nsubj	4	SENT_83	[p5l1516t2266r1782b2323],
3	observed	VBN	O	observe	partmod	2	SENT_83	[p5l1836t2265r2149b2323],
4	increased	VBD	O	increase	_	0	SENT_83	[p5l9t2361r339b2419],
5	concentrations	NNS	O	concentration	dobj	4	SENT_83	[p5l387t2364r918b2419],
6	of	IN	O	of	_	0	SENT_83	[p5l967t2361r1039b2419],
7	MTX	NN	O	mtx	nn	8	SENT_83	[p5l1082t2363r1258b2418],
8	polyglutamates	NNS	O	polyglutamate	prep_of	5	SENT_83	[p5l1305t2361r1849b2437],
9	in	IN	O	in	_	0	SENT_83	[p5l1898t2364r1968b2418],
10	erythrocytes	NNS	O	erythrocyte	prep_in	4	SENT_83	[p5l2017t2378r2148b2437, p5l8t2456r336b2531],
11	from	IN	O	from	_	0	SENT_83	[p5l369t2455r538b2513],
12	patients	NNS	O	patient	prep_from	4	SENT_83	[p5l571t2459r853b2531],
13	with	IN	O	with	_	0	SENT_83	[p5l885t2456r1046b2513],
14	AA	NN	O	aa	nn	15	SENT_83	[p5l1078t2457r1181b2513],
15	genotype	NN	O	genotype	prep_with	12	SENT_83	[p5l1213t2463r1558b2531],
16	.	.	O	.	_	0	SENT_83	[p5l1213t2463r1558b2531],

1	Higher	JJR	O	higher	amod	2	SENT_84	[p5l1596t2456r1837b2531],
2	concentrations	NNS	O	concentration	nsubjpass	9	SENT_84	[p5l1868t2472r2148b2513, p5l8t2554r281b2608],
3	of	IN	O	of	_	0	SENT_84	[p5l350t2550r422b2608],
4	MTX	NN	O	mtx	nn	5	SENT_84	[p5l484t2553r660b2608],
5	polyglutamates	NNS	O	polyglutamate	prep_of	2	SENT_84	[p5l728t2551r1272b2626],
6	in	IN	O	in	_	0	SENT_84	[p5l1341t2554r1411b2608],
7	erythrocytes	NNS	O	erythrocyte	prep_in	5	SENT_84	[p5l1480t2551r1917b2626],
8	were	VBD	O	be	auxpass	9	SENT_84	[p5l1984t2567r2148b2608],
9	associated	VBN	O	associate	_	0	SENT_84	[p5l9t2646r365b2704],
10	with	IN	O	with	_	0	SENT_84	[p5l400t2646r562b2704],
11	a	DT	O	a	det	13	SENT_84	[p5l599t2663r633b2704],
12	lower	JJR	O	lower	amod	13	SENT_84	[p5l670t2646r864b2704],
13	score	NN	NUMBER	score	prep_with	9	SENT_84	[p5l902t2663r1077b2704],
14	for	IN	O	for	_	0	SENT_84	[p5l1114t2646r1213b2704],
15	physician	NN	O	physician	poss	18	SENT_84	[p5l1247t2646r1637b2722],
16	's	POS	O	's	_	0	SENT_84	[p5l1247t2646r1637b2722],
17	global	JJ	O	global	amod	18	SENT_84	[p5l1674t2646r1889b2722],
18	assessment	NN	O	assessment	prep_for	13	SENT_84	[p5l1926t2663r2148b2704, p5l9t2748r195b2799],
19	of	IN	O	of	_	0	SENT_84	[p5l239t2741r310b2799],
20	the	DT	O	the	det	22	SENT_84	[p5l350t2741r462b2799],
21	disease	NN	O	disease	nn	22	SENT_84	[p5l508t2741r750b2799],
22	activity	NN	O	activity	prep_of	18	SENT_84	[p5l796t2744r1060b2817],
23	and	CC	O	and	_	0	SENT_84	[p5l1103t2741r1234b2799],
24	lower	JJR	O	lower	amod	25	SENT_84	[p5l1277t2741r1472b2799],
25	score	NN	NUMBER	score	conj_and	18	SENT_84	[p5l1516t2758r1692b2799],
26	of	IN	O	of	_	0	SENT_84	[p5l1738t2741r1809b2799],
27	patient	NN	O	patient	poss	29	SENT_84	[p5l1848t2741r2148b2817],
28	’s	POS	O	’s	_	0	SENT_84	[p5l1848t2741r2148b2817],
29	response	NN	O	response	prep_of	25	SENT_84	[p5l9t2853r314b2912],
30	to	TO	O	to	_	0	SENT_84	[p5l340t2843r410b2894],
31	MTX	NNP	O	MTX	prep_to	9	SENT_84	[p5l435t2839r629b2894],
32	.	.	O	.	_	0	SENT_84	[p5l435t2839r629b2894],

1	Remission	NN	O	remission	nsubjpass	9	SENT_85	[p5l659t2839r1020b2894],
2	of	IN	O	of	_	0	SENT_85	[p5l1046t2836r1117b2894],
3	RA	NN	O	ra	nn	4	SENT_85	[p5l1139t2838r1237b2893],
4	symptoms	NNS	O	symptom	prep_of	1	SENT_85	[p5l1263t2843r1627b2912],
5	was	VBD	O	be	auxpass	9	SENT_85	[p5l1651t2853r1779b2894],
6	also	RB	O	also	advmod	9	SENT_85	[p5l1806t2836r1940b2894],
7	more	RBR	O	more	advmod	8	SENT_85	[p5l1966t2853r2147b2894],
8	frequently	RB	O	frequently	advmod	9	SENT_85	[p5l9t2930r378b3006],
9	achieved	VBN	O	achieve	_	0	SENT_85	[p5l408t2930r719b2988],
10	in	IN	O	in	_	0	SENT_85	[p5l750t2933r821b2987],
11	the	DT	O	the	det	12	SENT_85	[p5l852t2930r964b2988],
12	carriers	NNS	O	carrier	prep_in	9	SENT_85	[p5l997t2933r1250b2988],
13	of	IN	O	of	_	0	SENT_85	[p5l1283t2930r1355b2988],
14	the	DT	O	the	det	16	SENT_85	[p5l1381t2931r1494b2988],
15	AA	NNP	O	AA	nn	16	SENT_85	[p5l1526t2932r1629b2987],
16	genotype	NN	O	genotype	prep_of	12	SENT_85	[p5l1659t2938r2004b3006],
17	.	.	O	.	_	0	SENT_85	[p5l1659t2938r2004b3006],

1	On	IN	O	on	_	0	SENT_86	[p5l2042t2932r2149b2988],
2	the	DT	O	the	det	3	SENT_86	[p5l8t3025r121b3083],
3	basis	NN	O	basis	pobj	1	SENT_86	[p5l152t3025r320b3083],
4	of	IN	O	of	_	0	SENT_86	[p5l354t3025r425b3083],
5	the	DT	O	the	det	7	SENT_86	[p5l454t3025r567b3083],
6	aforementioned	JJ	O	aforementioned	amod	7	SENT_86	[p5l600t3025r1168b3083],
7	results	NNS	O	result	prep_of	3	SENT_86	[p5l1202t3025r1445b3095],
8	,	,	O	,	_	0	SENT_86	[p5l1202t3025r1445b3095],
9	as	RB	O	as	_	0	SENT_86	[p5l1483t3042r1548b3083],
10	well	RB	O	well	_	0	SENT_86	[p5l1579t3025r1724b3083],
11	as	IN	O	as	_	0	SENT_86	[p5l1758t3042r1822b3083],
12	observations	NNS	O	observation	pobj	1	SENT_86	[p5l1857t3025r2148b3083, p6l8t22r183b77],

1	from	IN	O	from	_	0	SENT_87	[p6l207t19r376b77],
2	the	DT	O	the	det	4	SENT_87	[p6l399t19r511b77],
3	present	JJ	DATE	present	amod	4	SENT_87	[p6l534t27r793b95],
4	study	NN	O	study	prep_from	9	SENT_87	[p6l817t19r1019b95],
5	,	,	O	,	_	0	SENT_87	[p6l817t19r1019b95],
6	it	PRP	O	it	nsubjpass	9	SENT_87	[p6l1046t22r1095b77],
7	may	MD	O	may	aux	9	SENT_87	[p6l1118t36r1270b95],
8	be	VB	O	be	auxpass	9	SENT_87	[p6l1288t19r1368b77],
9	suggested	VBN	O	suggest	_	0	SENT_87	[p6l1393t19r1731b95],
10	that	IN	O	that	complm	31	SENT_87	[p6l1753t20r1897b77],
11	higher	JJR	O	higher	amod	13	SENT_87	[p6l1919t19r2149b95],
12	plasma	NN	O	plasma	nn	13	SENT_87	[p6l8t114r257b190],
13	folate	NN	O	folate	nsubj	31	SENT_87	[p6l329t114r526b172],
14	and	CC	O	and	_	0	SENT_87	[p6l600t115r731b172],
15	MTX	NN	O	mtx	nn	16	SENT_87	[p6l801t117r977b172],
16	concentrations	NNS	O	concentration	nsubj	31	SENT_87	[p6l1050t117r1581b172],
17	and	CC	O	and	_	0	SENT_87	[p6l1654t114r1785b172],
18	elevated	JJ	O	elevated	amod	23	SENT_87	[p6l1858t114r2149b172],
19	erythrocyte	NN	O	erythrocyte	nn	23	SENT_87	[p6l9t210r415b286],
20	MT	NN	O	mt	nn	23	SENT_87	[p6l449t212r568b267],
21	X	NN	O	x	nn	23	SENT_87	[p6l570t212r625b267],
22	polyglutamate	NN	O	polyglutamate	nn	23	SENT_87	[p6l658t210r1170b286],
23	levels	NNS	O	level	nsubj	31	SENT_87	[p6l1206t210r1399b268],
24	in	IN	O	in	_	0	SENT_87	[p6l1433t213r1503b267],
25	patients	NNS	O	patient	prep_in	23	SENT_87	[p6l1537t213r1819b286],
26	with	IN	O	with	_	0	SENT_87	[p6l1852t210r2014b268],
27	AA	NN	O	aa	nn	28	SENT_87	[p6l2046t212r2150b267],
28	genotype	NN	O	genotype	prep_with	25	SENT_87	[p6l9t312r335b380],
29	may	MD	O	may	aux	31	SENT_87	[p6l358t321r510b380],
30	have	VB	O	have	aux	31	SENT_87	[p6l530t305r695b362],
31	contributed	VBN	O	contribute	ccomp	9	SENT_87	[p6l719t305r1135b362],
32	to	TO	O	to	_	0	SENT_87	[p6l1157t312r1227b362],
33	lower	JJR	O	lower	amod	35	SENT_87	[p6l1249t305r1444b362],
34	disease	NN	O	disease	nn	35	SENT_87	[p6l1466t305r1709b362],
35	activity	NN	O	activity	prep_to	31	SENT_87	[p6l1733t308r1997b380],
36	and	CC	O	and	_	0	SENT_87	[p6l2018t305r2149b362],
37	better	JJR	O	better	amod	39	SENT_87	[p6l7t400r214b457],
38	treatment	NN	O	treatment	nn	39	SENT_87	[p6l254t407r605b457],
39	outcome	NN	O	outcome	conj_and	35	SENT_87	[p6l646t407r955b457],
40	during	IN	O	during	_	0	SENT_87	[p6l998t400r1234b475],
41	MT	NN	O	mt	nn	43	SENT_87	[p6l1272t402r1392b457],
42	X	NN	O	x	nn	43	SENT_87	[p6l1394t402r1448b457],
43	therapy	NN	O	therapy	prep_during	31	SENT_87	[p6l1489t400r1772b475],
44	.	.	O	.	_	0	SENT_87	[p6l1489t400r1772b475],

1	However	RB	O	however	advmod	25	SENT_88	[p6l1818t402r2144b470],
2	,	,	O	,	_	0	SENT_88	[p6l1818t402r2144b470],
3	the	DT	O	the	det	4	SENT_88	[p6l8t495r121b553],
4	polymorphism	NN	O	polymorphism	nsubj	25	SENT_88	[p6l190t495r716b571],
5	could	MD	O	could	aux	25	SENT_88	[p6l787t495r982b553],
6	also	RB	O	also	advmod	25	SENT_88	[p6l1052t495r1186b553],
7	directly	RB	O	directly	advmod	25	SENT_88	[p6l1256t495r1525b571],
8	impact	NN	O	impact	nn	10	SENT_88	[p6l1591t498r1836b571],
9	disease	NN	O	disease	nn	10	SENT_88	[p6l1905t495r2148b553],
10	activity	NN	O	activity	pobj	7	SENT_88	[p6l9t593r274b666],
11	through	IN	O	through	_	0	SENT_88	[p6l315t590r604b666],
12	more	JJR	O	more	amod	14	SENT_88	[p6l649t607r830b648],
13	subtle	JJ	O	subtle	amod	14	SENT_88	[p6l877t590r1084b648],
14	alteration	NN	O	alteration	prep_through	10	SENT_88	[p6l1131t590r1473b648],
15	in	IN	O	in	_	0	SENT_88	[p6l1518t593r1588b647],
16	folate	JJ	O	folate	amod	17	SENT_88	[p6l1632t590r1829b648],
17	homeostasis	NN	O	homeostasis	prep_in	14	SENT_88	[p6l1875t590r2148b648, p6l10t676r359b741],
18	.15	CD	NUMBER	.15	number	19	SENT_88	[p6l1875t590r2148b648, p6l10t676r359b741],
19	'18	CD	NUMBER	'18	npadvmod	10	SENT_88	[p6l1875t590r2148b648, p6l10t676r359b741],
20	In	IN	O	in	_	0	SENT_88	[p6l408t686r481b740],
21	our	PRP$	O	we	poss	23	SENT_88	[p6l528t700r647b741],
22	study	NN	O	study	nn	23	SENT_88	[p6l694t683r887b759],
23	hepatotoxicity	NN	O	hepatotoxicity	prep_in	10	SENT_88	[p6l931t683r1461b759],
24	,	,	O	,	_	0	SENT_88	[p6l931t683r1461b759],
25	measured	VBN	O	measure	_	0	SENT_88	[p6l1513t683r1852b741],
26	as	IN	O	as	_	0	SENT_88	[p6l1900t700r1964b741],
27	ALT	NN	O	alt	prep_as	25	SENT_88	[p6l2011t685r2150b740],
28	and	CC	O	and	_	0	SENT_88	[p6l9t777r141b835],
29	AST	NNP	O	AST	nn	30	SENT_88	[p6l183t779r320b835],
30	activities	NNS	O	activity	prep_as	25	SENT_88	[p6l358t780r688b848],
31	,	,	O	,	_	0	SENT_88	[p6l358t780r688b848],
32	after	IN	O	after	mark	36	SENT_88	[p6l738t777r896b835],
33	MTX	NN	O	mtx	nn	34	SENT_88	[p6l938t780r1113b835],
34	treatment	NN	O	treatment	nsubjpass	48	SENT_88	[p6l1157t785r1508b835],
35	was	VBD	O	be	auxpass	36	SENT_88	[p6l1549t794r1677b835],
36	observed	VBN	O	observe	advcl	25	SENT_88	[p6l1722t777r2035b835],
37	in	IN	O	in	_	0	SENT_88	[p6l2078t780r2149b835],
38	some	DT	O	some	det	40	SENT_88	[p6l10t891r191b932],
39	4	CD	NUMBER	4	num	40	SENT_88	[p6l258t875r449b932],
40	—	NN	O	—	prep_in	36	SENT_88	[p6l258t875r449b932],
41	5	CD	PERCENT	5	number	42	SENT_88	[p6l258t875r449b932],
42	%	NN	PERCENT	%	amod	40	SENT_88	[p6l258t875r449b932],
43	of	IN	O	of	_	0	SENT_88	[p6l515t874r586b932],
44	patients	NNS	O	patient	prep_of	40	SENT_88	[p6l646t877r929b950],
45	and	CC	O	and	_	0	SENT_88	[p6l996t874r1127b932],
46	more	RBR	O	more	advmod	47	SENT_88	[p6l1193t891r1373b932],
47	frequently	RB	O	frequently	advmod	48	SENT_88	[p6l1440t874r1809b950],
48	affected	VBN	O	affect	advcl	25	SENT_88	[p6l1872t874r2149b932],
49	individuals	NNS	O	individual	dobj	48	SENT_88	[p6l9t968r402b1026],
50	with	IN	O	with	_	0	SENT_88	[p6l431t969r593b1026],
51	RFC-1	NN	O	rfc-1	nn	52	SENT_88	[p6l625t970r829b1026],
52	8OAA	NN	O	8oaa	prep_with	48	SENT_88	[p6l867t970r1055b1026],
53	(	CD	PERCENT	(	number	54	SENT_88	[p6l1089t969r1356b1041],
54	10.5	CD	PERCENT	10.5	num	55	SENT_88	[p6l1089t969r1356b1041],
55	%	NN	PERCENT	%	dep	52	SENT_88	[p6l1089t969r1356b1041],
56	)	CD	NUMBER	)	num	57	SENT_88	[p6l1089t969r1356b1041],
57	genotype	NN	O	genotype	dep	55	SENT_88	[p6l1390t976r1716b1044],
58	than	IN	O	than	_	0	SENT_88	[p6l1748t968r1912b1026],
59	80GG	NN	O	80gg	nn	60	SENT_88	[p6l1945t970r2149b1026],
60	genotype	NN	O	genotype	prep_than	48	SENT_88	[p6l9t1071r335b1139],
61	(	CD	PERCENT	(	number	62	SENT_88	[p6l389t1064r633b1136],
62	2.3	CD	PERCENT	2.3	dep	63	SENT_88	[p6l389t1064r633b1136],
63	%	NN	PERCENT	%	dep	60	SENT_88	[p6l389t1064r633b1136],
64	)	CD	NUMBER	)	dobj	36	SENT_88	[p6l389t1064r633b1136],
65	.	.	O	.	_	0	SENT_88	[p6l389t1064r633b1136],

1	An	DT	O	a	det	3	SENT_89	[p6l686t1065r786b1121],
2	increased	VBN	O	increase	amod	3	SENT_89	[p6l836t1064r1166b1121],
3	toxicity	NN	O	toxicity	nsubjpass	12	SENT_89	[p6l1215t1067r1488b1139],
4	observed	VBN	O	observe	partmod	3	SENT_89	[p6l1537t1064r1849b1121],
5	in	IN	O	in	_	0	SENT_89	[p6l1899t1067r1969b1121],
6	this	DT	O	this	det	7	SENT_89	[p6l2018t1064r2148b1121],
7	group	NN	O	group	prep_in	4	SENT_89	[p6l9t1176r214b1235],
8	of	IN	O	of	_	0	SENT_89	[p6l247t1159r318b1217],
9	patients	NNS	O	patient	prep_of	7	SENT_89	[p6l345t1162r627b1235],
10	may	MD	O	may	aux	12	SENT_89	[p6l660t1176r812b1235],
11	be	VB	O	be	auxpass	12	SENT_89	[p6l839t1159r919b1217],
12	related	VBN	O	relate	_	0	SENT_89	[p6l952t1159r1193b1217],
13	to	TO	O	to	_	0	SENT_89	[p6l1223t1166r1293b1217],
14	elevated	JJ	O	elevated	amod	15	SENT_89	[p6l1327t1159r1617b1217],
15	levels	NNS	O	level	prep_to	12	SENT_89	[p6l1649t1159r1842b1217],
16	of	IN	O	of	_	0	SENT_89	[p6l1875t1159r1946b1217],
17	MTX	NN	O	mtx	nn	18	SENT_89	[p6l1973t1161r2148b1216],
18	polyglutamates	NNS	O	polyglutamate	prep_of	15	SENT_89	[p6l8t1252r551b1327],
19	seen	VBN	O	see	dep	12	SENT_89	[p6l603t1269r755b1309],
20	in	IN	O	in	_	0	SENT_89	[p6l804t1255r874b1309],
21	RFC	NNP	O	RFC	prep_in	19	SENT_89	[p6l919t1253r1123b1309],
22	—	CD	NUMBER	—	number	23	SENT_89	[p6l919t1253r1123b1309],
23	1	CD	NUMBER	1	num	25	SENT_89	[p6l919t1253r1123b1309],
24	8OAA	NN	O	8oaa	nn	25	SENT_89	[p6l1181t1253r1369b1309],
25	individuals	NNS	O	individual	dobj	19	SENT_89	[p6l1417t1244r1898b1309],
26	.	.	O	.	_	0	SENT_89	[p6l1417t1244r1898b1309],

1	”	NN	O	”	_	0	SENT_90	[p6l1417t1244r1898b1309],
2	These	DT	O	these	det	3	SENT_90	[p6l1946t1252r2148b1309],
3	observations	NNS	O	observation	nsubj	4	SENT_90	[p6l9t1348r454b1405],
4	are	VBP	O	be	rcmod	1	SENT_90	[p6l499t1364r600b1405],
5	in	IN	O	in	_	0	SENT_90	[p6l644t1351r714b1405],
6	keeping	VBG	O	keep	prepc_in	4	SENT_90	[p6l757t1348r1035b1423],
7	with	IN	O	with	_	0	SENT_90	[p6l1075t1348r1236b1405],
8	previous	JJ	O	previous	amod	9	SENT_90	[p6l1279t1351r1579b1423],
9	studies	NNS	O	study	prep_with	6	SENT_90	[p6l1624t1348r1882b1418],
10	,	,	O	,	_	0	SENT_90	[p6l1624t1348r1882b1418],
11	which	WDT	O	which	nsubj	12	SENT_90	[p6l1928t1348r2148b1405],
12	demonstrated	VBD	O	demonstrate	rcmod	9	SENT_90	[p6l9t1443r499b1501],
13	an	DT	O	a	det	14	SENT_90	[p6l532t1460r617b1501],
14	association	NN	O	association	dobj	12	SENT_90	[p6l649t1446r1040b1501],
15	between	IN	O	between	_	0	SENT_90	[p6l1070t1443r1368b1501],
16	increased	VBN	O	increase	amod	19	SENT_90	[p6l1400t1443r1730b1501],
17	MTX	NN	O	mtx	nn	19	SENT_90	[p6l1761t1446r1937b1500],
18	polyglutamate	NN	O	polyglutamate	nn	19	SENT_90	[p6l1968t1443r2148b1519, p6l9t1536r362b1612],
19	levels	NNS	O	level	prep_between	14	SENT_90	[p6l393t1536r586b1594],
20	and	CC	O	and	_	0	SENT_90	[p6l617t1536r748b1594],
21	hepatotoxic	JJ	O	hepatotoxic	amod	22	SENT_90	[p6l777t1536r1201b1612],
22	effects	NNS	O	effect	conj_and	19	SENT_90	[p6l1231t1536r1452b1594],
23	of	IN	O	of	_	0	SENT_90	[p6l1483t1536r1555b1594],
24	the	DT	O	the	det	26	SENT_90	[p6l1580t1536r1692b1594],
25	drug	NN	O	drug	nn	26	SENT_90	[p6l1723t1528r2054b1612],
26	.19	NN	NUMBER	.19	prep_of	22	SENT_90	[p6l1723t1528r2054b1612],
27	'	''	O	'	_	0	SENT_90	[p6l1723t1528r2054b1612],
28	2	CD	NUMBER	2	number	29	SENT_90	[p6l1723t1528r2054b1612],
29	°	CD	NUMBER	°	num	22	SENT_90	[p6l1723t1528r2054b1612],

1	In	IN	O	in	_	0	SENT_91	[p6l86t1632r159b1687],
2	a	DT	O	a	det	5	SENT_91	[p6l222t1647r257b1688],
3	previous	JJ	O	previous	amod	5	SENT_91	[p6l319t1633r619b1706],
4	study	NN	O	study	nn	5	SENT_91	[p6l684t1630r876b1706],
5	Laverdiere	NNP	PERSON	Laverdiere	prep_in	9	SENT_91	[p6l938t1630r1301b1688],
6	et	FW	O	et	nn	7	SENT_91	[p6l1366t1636r1426b1688],
7	al.	FW	O	al.	nsubj	9	SENT_91	[p6l1483t1623r1597b1688],
8	8	CD	NUMBER	8	dep	7	SENT_91	[p6l1483t1623r1597b1688],
9	suggested	VBD	O	suggest	_	0	SENT_91	[p6l1662t1630r2001b1706],
10	an	DT	O	a	det	11	SENT_91	[p6l2065t1647r2149b1688],
11	inﬂuence	NN	O	inﬂuence	dep	18	SENT_91	[p6l9t1725r339b1783],
12	of	IN	O	of	_	0	SENT_91	[p6l387t1725r459b1783],
13	RFC-1	NN	O	rfc-1	nn	14	SENT_91	[p6l498t1727r702b1783],
14	gene	NN	O	gene	prep_of	11	SENT_91	[p6l755t1742r918b1801],
15	(	CD	NUMBER	(	num	16	SENT_91	[p6l970t1726r1214b1797],
16	G8OA	NN	O	g8oa	dep	18	SENT_91	[p6l970t1726r1214b1797],
17	)	CD	NUMBER	)	num	18	SENT_91	[p6l970t1726r1214b1797],
18	polymorphism	NN	O	polymorphism	dep	30	SENT_91	[p6l1263t1725r1789b1801],
19	on	IN	O	on	_	0	SENT_91	[p6l1836t1742r1928b1783],
20	MTX	NNP	O	MTX	nn	22	SENT_91	[p6l1973t1728r2148b1783],
21	plasma	NN	O	plasma	nn	22	SENT_91	[p6l8t1821r257b1897],
22	levels	NNS	O	level	prep_on	18	SENT_91	[p6l297t1821r490b1879],
23	and	CC	O	and	_	0	SENT_91	[p6l533t1821r664b1879],
24	treatment	NN	O	treatment	nn	25	SENT_91	[p6l704t1828r1055b1879],
25	outcome	NN	O	outcome	dep	30	SENT_91	[p6l1096t1828r1405b1879],
26	of	IN	O	of	_	0	SENT_91	[p6l1448t1821r1519b1879],
27	childhood	NN	O	childhood	prep_of	25	SENT_91	[p6l1557t1821r1921b1879],
28	acute	JJ	O	acute	amod	30	SENT_91	[p6l1962t1828r2147b1879],
29	lymphoblastic	JJ	O	lymphoblastic	amod	30	SENT_91	[p6l9t1915r514b1991],
30	leukemia	NN	O	leukemia	dep	9	SENT_91	[p6l537t1915r876b1973],
31	.	.	O	.	_	0	SENT_91	[p6l537t1915r876b1973],

1	In	IN	O	in	_	0	SENT_92	[p6l905t1918r978b1972],
2	contrast	NN	O	contrast	prep_in	11	SENT_92	[p6l1002t1923r1288b1973],
3	to	TO	O	to	_	0	SENT_92	[p6l1310t1923r1380b1973],
4	RA	NN	O	ra	nn	5	SENT_92	[p6l1405t1917r1502b1972],
5	patients	NNS	O	patient	prep_to	2	SENT_92	[p6l1524t1918r1824b1991],
6	,	,	O	,	_	0	SENT_92	[p6l1524t1918r1824b1991],
7	children	NNS	O	child	nsubj	11	SENT_92	[p6l1854t1915r2149b1973],
8	with	IN	O	with	_	0	SENT_92	[p6l7t2011r168b2068],
9	8OAA	NN	O	8oaa	nn	10	SENT_92	[p6l217t2012r405b2068],
10	genotype	NN	O	genotype	prep_with	7	SENT_92	[p6l452t2018r778b2086],
11	had	VBD	O	have	_	0	SENT_92	[p6l825t2011r957b2068],
12	worse	JJR	O	worse	amod	13	SENT_92	[p6l1003t2027r1204b2068],
13	prognoses	NNS	O	prognosis	dobj	11	SENT_92	[p6l1252t2027r1607b2086],
14	than	IN	O	than	_	0	SENT_92	[p6l1655t2011r1819b2068],
15	patients	NNS	O	patient	prep_than	13	SENT_92	[p6l1866t2014r2148b2086],
16	with	IN	O	with	_	0	SENT_92	[p6l7t2106r168b2164],
17	80GG	NN	O	80gg	nn	18	SENT_92	[p6l212t2108r415b2164],
18	genotype	NN	O	genotype	prep_with	11	SENT_92	[p6l458t2113r802b2182],
19	,	,	O	,	_	0	SENT_92	[p6l458t2113r802b2182],
20	and	CC	O	and	_	0	SENT_92	[p6l849t2106r981b2164],
21	80AA	NN	O	80aa	nn	22	SENT_92	[p6l1024t2108r1212b2164],
22	genotype	NN	O	genotype	nsubjpass	24	SENT_92	[p6l1254t2113r1580b2182],
23	was	VBD	O	be	auxpass	24	SENT_92	[p6l1621t2123r1749b2164],
24	associated	VBN	O	associate	conj_and	11	SENT_92	[p6l1793t2106r2149b2164],
25	with	IN	O	with	_	0	SENT_92	[p6l7t2201r168b2258],
26	higher	JJR	O	higher	amod	28	SENT_92	[p6l210t2201r440b2276],
27	plasma	NN	O	plasma	nn	28	SENT_92	[p6l480t2201r730b2276],
28	levels	NNS	O	level	prep_with	24	SENT_92	[p6l770t2201r964b2258],
29	of	IN	O	of	_	0	SENT_92	[p6l1007t2200r1079b2258],
30	MTX	NN	O	mtx	prep_of	28	SENT_92	[p6l1115t2203r1290b2258],
31	than	IN	O	than	_	0	SENT_92	[p6l1332t2201r1497b2258],
32	other	JJ	O	other	amod	33	SENT_92	[p6l1539t2201r1728b2258],
33	genotypes	NNS	O	genotype	prep_than	24	SENT_92	[p6l1768t2208r2144b2276],
34	.	.	O	.	_	0	SENT_92	[p6l1768t2208r2144b2276],

1	One	CD	NUMBER	one	num	3	SENT_93	[p6l10t2297r155b2353],
2	possible	JJ	O	possible	amod	3	SENT_93	[p6l177t2296r458b2371],
3	explanation	NN	O	explanation	nsubj	13	SENT_93	[p6l482t2296r907b2371],
4	for	IN	O	for	_	0	SENT_93	[p6l929t2295r1028b2353],
5	the	DT	O	the	det	7	SENT_93	[p6l1049t2296r1162b2353],
6	observed	VBN	O	observe	amod	7	SENT_93	[p6l1186t2296r1499b2353],
7	association	NN	O	association	prep_for	3	SENT_93	[p6l1522t2299r1912b2353],
8	might	MD	O	might	aux	13	SENT_93	[p6l1936t2296r2149b2371],
9	be	VB	O	be	cop	13	SENT_93	[p6l7t2391r87b2449],
10	the	DT	O	the	det	13	SENT_93	[p6l112t2391r224b2449],
11	decreased	VBN	O	decrease	amod	13	SENT_93	[p6l251t2391r591b2449],
12	MTX	NN	O	mtx	nn	13	SENT_93	[p6l615t2394r790b2448],
13	concentrations	NNS	O	concentration	_	0	SENT_93	[p6l816t2394r1346b2449],
14	in	IN	O	in	_	0	SENT_93	[p6l1372t2394r1442b2448],
15	lymphoblastic	JJ	O	lymphoblastic	amod	16	SENT_93	[p6l1467t2391r1973b2467],
16	cells	NNS	O	cell	prep_in	13	SENT_93	[p6l1999t2391r2148b2449],
17	in	IN	O	in	_	0	SENT_93	[p6l8t2875r79b2929],
18	carriers	NNS	O	carrier	prep_in	16	SENT_93	[p6l121t2875r374b2930],
19	of	IN	O	of	_	0	SENT_93	[p6l417t2872r489b2930],
20	80AA	NN	O	80aa	nn	21	SENT_93	[p6l527t2874r716b2930],
21	genotype	NN	O	genotype	prep_of	18	SENT_93	[p6l756t2879r1083b2948],
22	despite	IN	O	despite	_	0	SENT_93	[p6l1126t2872r1374b2948],
23	higher	JJR	O	higher	amod	26	SENT_93	[p6l1416t2872r1647b2948],
24	plasma	NN	O	plasma	nn	26	SENT_93	[p6l1687t2872r1936b2948],
25	MTX	NN	O	mtx	nn	26	SENT_93	[p6l1976t2875r2152b2929],
26	levels	NNS	O	level	prep_despite	13	SENT_93	[p6l8t2967r221b3024],
27	.	.	O	.	_	0	SENT_93	[p6l8t2967r221b3024],

1	The	DT	O	the	det	3	SENT_94	[p6l83t3063r216b3120],
2	present	JJ	DATE	present	amod	3	SENT_94	[p6l241t3070r501b3138],
3	data	NNS	O	datum	nsubj	5	SENT_94	[p6l526t3063r676b3120],
4	do	VBP	O	do	aux	5	SENT_94	[p6l701t3062r787b3120],
5	suggest	VB	O	suggest	_	0	SENT_94	[p6l815t3070r1069b3138],
6	that	IN	O	that	complm	19	SENT_94	[p6l1093t3063r1237b3120],
7	evaluation	NN	O	evaluation	nsubj	19	SENT_94	[p6l1262t3062r1637b3120],
8	of	IN	O	of	_	0	SENT_94	[p6l1662t3062r1734b3120],
9	RFC-1	NN	O	rfc-1	nn	11	SENT_94	[p6l1750t3064r1956b3120],
10	gene	NN	O	gene	nn	11	SENT_94	[p6l1988t3079r2152b3138],
11	8OG	NN	O	8og	prep_of	7	SENT_94	[p6l10t3160r283b3216],
12	>	JJR	O	>	amod	14	SENT_94	[p6l10t3160r283b3216],
13	A	DT	O	a	det	14	SENT_94	[p6l10t3160r283b3216],
14	polymorphism	NN	O	polymorphism	dep	11	SENT_94	[p6l325t3158r852b3234],
15	may	MD	O	may	aux	19	SENT_94	[p6l895t3175r1048b3234],
16	be	VB	O	be	cop	19	SENT_94	[p6l1087t3158r1167b3216],
17	a	DT	O	a	det	19	SENT_94	[p6l1212t3175r1247b3216],
18	useful	JJ	O	useful	amod	19	SENT_94	[p6l1289t3158r1500b3216],
19	tool	NN	O	tool	ccomp	5	SENT_94	[p6l1544t3159r1684b3216],
20	to	TO	O	to	aux	21	SENT_94	[p6l1727t3166r1797b3216],
21	optimize	VB	O	optimize	infmod	19	SENT_94	[p6l1842t3161r2151b3234],
22	MTX	NN	O	mtx	nn	23	SENT_94	[p6l7t3257r183b3312],
23	therapy	NN	O	therapy	dobj	21	SENT_94	[p6l218t3255r491b3331],
24	in	IN	O	in	_	0	SENT_94	[p6l523t3258r594b3312],
25	patients	NNS	O	patient	prep_in	21	SENT_94	[p6l628t3258r911b3331],
26	with	IN	O	with	_	0	SENT_94	[p6l944t3255r1106b3313],
27	RA	NN	O	ra	prep_with	25	SENT_94	[p6l1141t3257r1256b3313],
28	.	.	O	.	_	0	SENT_94	[p6l1141t3257r1256b3313],

1	The	DT	O	the	det	2	SENT_95	[p6l1293t3255r1426b3313],
2	evidence	NN	O	evidence	nsubj	3	SENT_95	[p6l1462t3255r1772b3313],
3	advocates	VBZ	O	advocate	_	0	SENT_95	[p6l1809t3255r2151b3313],
4	additional	JJ	O	additional	amod	5	SENT_95	[p6l9t3350r372b3408],
5	studies	NNS	O	study	dobj	3	SENT_95	[p6l436t3350r677b3408],
6	aimed	VBN	O	aim	partmod	5	SENT_95	[p6l741t3350r957b3408],
7	at	IN	O	at	_	0	SENT_95	[p6l1020t3358r1083b3408],
8	identifying	VBG	O	identify	prepc_at	6	SENT_95	[p6l1146t3350r1539b3426],
9	genetic	JJ	O	genetic	amod	10	SENT_95	[p6l1601t3353r1856b3426],
10	factors	NNS	O	factor	dobj	8	SENT_95	[p6l1918t3350r2151b3408],
11	associated	VBN	O	associate	partmod	10	SENT_95	[p6l9t3446r366b3503],
12	with	IN	O	with	_	0	SENT_95	[p6l393t3446r555b3503],
13	MTX	NN	O	mtx	nn	15	SENT_95	[p6l584t3448r760b3503],
14	treatment	NN	O	treatment	nn	15	SENT_95	[p6l788t3453r1140b3503],
15	outcome	NN	O	outcome	prep_with	11	SENT_95	[p6l1170t3453r1499b3503],
16	.	.	O	.	_	0	SENT_95	[p6l1170t3453r1499b3503],

1	Materials	NNPS	O	Materials	_	0	SENT_96	[p6l11t3657r368b3714],
2	and	CC	O	and	_	0	SENT_96	[p6l399t3657r540b3714],
3	methods	NNS	O	method	conj_and	1	SENT_96	[p6l574t3657r909b3714],

1	Patients	NNS	O	patient	_	0	SENT_97	[p7l12t78r264b134],

1	The	DT	O	the	det	2	SENT_98	[p7l7t172r139b230],
2	study	NN	O	study	nsubjpass	4	SENT_98	[p7l172t172r365b248],
3	was	VBD	O	be	auxpass	4	SENT_98	[p7l392t189r520b230],
4	carried	VBN	O	carry	_	0	SENT_98	[p7l552t172r792b230],
5	out	RP	O	out	prt	4	SENT_98	[p7l823t179r941b230],
6	on	IN	O	on	_	0	SENT_98	[p7l971t189r1063b230],
7	174	CD	NUMBER	174	num	8	SENT_98	[p7l1099t174r1220b229],
8	patients	NNS	O	patient	prep_on	4	SENT_98	[p7l1251t175r1534b248],
9	(	IN	O	(	_	0	SENT_98	[p7l1569t172r1719b244],
10	129	CD	NUMBER	129	num	11	SENT_98	[p7l1569t172r1719b244],
11	women	NNS	O	woman	prep_(	4	SENT_98	[p7l1750t189r2033b242],
12	,	,	O	,	_	0	SENT_98	[p7l1750t189r2033b242],
13	45	CD	NUMBER	45	num	14	SENT_98	[p7l2069t175r2148b230],
14	men	NNS	O	man	appos	11	SENT_98	[p7l8t284r183b337],
15	,	,	O	,	_	0	SENT_98	[p7l8t284r183b337],
16	aged	JJ	O	aged	advmod	27	SENT_98	[p7l239t267r399b343],
17	21-70	CD	NUMBER	21-70	num	18	SENT_98	[p7l450t268r659b325],
18	years	NNS	NUMBER	year	dep	16	SENT_98	[p7l706t284r902b343],
19	,	,	O	,	_	0	SENT_98	[p7l706t284r902b343],
20	disease	NN	O	disease	nn	21	SENT_98	[p7l958t267r1200b325],
21	duration	NN	O	duration	appos	18	SENT_98	[p7l1251t267r1558b325],
22	7.9	CD	NUMBER	7.9	num	23	SENT_98	[p7l1613t268r1897b333],
23	i4	NN	O	i4	dep	21	SENT_98	[p7l1613t268r1897b333],
24	.7	CD	DURATION	.7	num	25	SENT_98	[p7l1613t268r1897b333],
25	years	NNS	NUMBER	year	tmod	21	SENT_98	[p7l1946t267r2149b343],
26	)	RB	O	)	advmod	27	SENT_98	[p7l1946t267r2149b343],
27	diagnosed	VBD	O	diagnose	dep	4	SENT_98	[p7l9t361r368b437],
28	with	IN	O	with	_	0	SENT_98	[p7l394t362r556b419],
29	RA	NN	MISC	ra	prep_with	27	SENT_98	[p7l586t363r700b432],
30	,	,	O	,	_	0	SENT_98	[p7l586t363r700b432],
31	treated	VBN	O	treat	dep	27	SENT_98	[p7l734t362r980b419],
32	with	IN	O	with	_	0	SENT_98	[p7l1006t362r1168b419],
33	MTX	NN	O	mtx	prep_with	31	SENT_98	[p7l1196t364r1372b419],
34	(	CD	NUMBER	(	num	33	SENT_98	[p7l1404t361r1727b434],
35	7.5	CD	NUMBER	7.5	num	38	SENT_98	[p7l1404t361r1727b434],
36	—	NN	O	—	nn	38	SENT_98	[p7l1404t361r1727b434],
37	15.0	CD	NUMBER	15.0	num	38	SENT_98	[p7l1404t361r1727b434],
38	mg	NN	O	mg	nsubj	27	SENT_98	[p7l1744t378r1855b437],
39	weekly	JJ	SET	weekly	amod	40	SENT_98	[p7l1881t361r2149b437],
40	)	NN	O	)	dep	27	SENT_98	[p7l1881t361r2149b437],
41	plus	CC	O	plus	prep	27	SENT_98	[p7l8t456r152b532],
42	low	JJ	O	low	amod	43	SENT_98	[p7l182t456r311b514],
43	doses	NNS	O	dose	dep	41	SENT_98	[p7l339t456r526b514],
44	of	IN	O	of	_	0	SENT_98	[p7l557t456r629b514],
45	MP	NN	O	mp	prep_of	43	SENT_98	[p7l653t459r776b514],
46	.	.	O	.	_	0	SENT_98	[p7l653t459r776b514],

1	The	DT	O	the	det	2	SENT_99	[p7l83t552r216b610],
2	RA	NN	O	ra	nsubjpass	4	SENT_99	[p7l261t554r359b609],
3	was	VBD	O	be	auxpass	4	SENT_99	[p7l398t569r527b610],
4	diagnosed	VBN	O	diagnose	_	0	SENT_99	[p7l572t552r930b628],
5	according	VBG	O	accord	_	0	SENT_99	[p7l974t552r1322b628],
6	to	TO	O	to	prepc_according_to	4	SENT_99	[p7l1365t559r1435b610],
7	the	DT	O	the	det	8	SENT_99	[p7l1479t552r1592b610],
8	criteria	NNS	O	criterion	pobj	4	SENT_99	[p7l1637t555r1884b610],
9	of	IN	O	of	_	0	SENT_99	[p7l1928t552r1999b610],
10	the	DT	O	the	det	17	SENT_99	[p7l2039t552r2151b610],
11	American	NNP	ORGANIZATION	American	nn	12	SENT_99	[p7l7t648r348b704],
12	College	NNP	ORGANIZATION	College	nn	17	SENT_99	[p7l407t647r669b722],
13	of	IN	ORGANIZATION	of	_	0	SENT_99	[p7l727t646r799b704],
14	Rheumatology	NNP	ORGANIZATION	Rheumatology	nn	16	SENT_99	[p7l852t647r1374b722],
15	(	CD	NUMBER	(	num	16	SENT_99	[p7l1432t647r1655b719],
16	ACR	NN	ORGANIZATION	acr	prep_of	12	SENT_99	[p7l1432t647r1655b719],
17	)	NN	O	)	prep_of	8	SENT_99	[p7l1432t647r1655b719],
18	.	.	O	.	_	0	SENT_99	[p7l1432t647r1655b719],

1	All	DT	O	all	det	2	SENT_100	[p7l1714t647r1812b704],
2	patients	NNS	O	patient	nsubj	3	SENT_100	[p7l1869t650r2152b722],
3	underwent	VBD	O	undergo	_	0	SENT_100	[p7l7t743r395b801],
4	a	DT	O	a	det	6	SENT_100	[p7l444t760r478b801],
5	monthly	JJ	SET	monthly	amod	6	SENT_100	[p7l526t743r838b819],
6	evaluation	NN	O	evaluation	dobj	3	SENT_100	[p7l885t743r1259b801],
7	for	IN	O	for	_	0	SENT_100	[p7l1307t743r1405b801],
8	one	CD	DURATION	one	prep_for	3	SENT_100	[p7l1453t760r1581b801],
9	year	NN	NUMBER	year	tmod	3	SENT_100	[p7l1628t760r1790b819],
10	,	,	O	,	_	0	SENT_100	[p7l1628t760r1790b819],
11	applying	VBG	O	apply	partmod	3	SENT_100	[p7l1843t743r2154b819],
12	the	DT	O	the	det	16	SENT_100	[p7l8t838r121b896],
13	1995	CD	DATE	1995	num	16	SENT_100	[p7l152t840r313b896],
14	ACR	NNP	ORGANIZATION	ACR	nn	16	SENT_100	[p7l340t840r497b896],
15	preliminary	JJ	O	preliminary	amod	16	SENT_100	[p7l518t838r939b914],
16	definition	NN	O	definition	dobj	11	SENT_100	[p7l961t838r1314b896],
17	of	IN	O	of	_	0	SENT_100	[p7l1339t838r1410b896],
18	improvement	NN	O	improvement	prep_of	16	SENT_100	[p7l1430t841r1915b914],
19	in	IN	O	in	_	0	SENT_100	[p7l1938t841r2009b895],
20	RA	NN	O	ra	prep_in	11	SENT_100	[p7l2033t840r2148b896],
21	.	.	O	.	_	0	SENT_100	[p7l2033t840r2148b896],

1	Clinical	JJ	O	clinical	amod	2	SENT_101	[p7l10t933r283b990],
2	improvement	NN	O	improvement	nsubjpass	4	SENT_101	[p7l317t936r802b1008],
3	was	VBD	O	be	auxpass	4	SENT_101	[p7l833t949r961b990],
4	evaluated	VBN	O	evaluate	_	0	SENT_101	[p7l996t933r1335b990],
5	according	VBG	O	accord	_	0	SENT_101	[p7l1368t933r1716b1008],
6	to	TO	O	to	prepc_according_to	4	SENT_101	[p7l1748t940r1818b990],
7	the	DT	O	the	det	8	SENT_101	[p7l1851t933r1964b990],
8	ACR	NN	ORGANIZATION	acr	pobj	4	SENT_101	[p7l1997t934r2154b990],
9	20	CD	PERCENT	20	number	10	SENT_101	[p7l9t1030r161b1086],
10	%	NN	PERCENT	%	amod	12	SENT_101	[p7l9t1030r161b1086],
11	response	NN	O	response	nn	12	SENT_101	[p7l184t1045r490b1104],
12	criteria	NNS	O	criterion	dep	8	SENT_101	[p7l514t1031r778b1086],
13	.	.	O	.	_	0	SENT_101	[p7l514t1031r778b1086],

1	The	DT	O	the	det	4	SENT_102	[p7l803t1028r936b1086],
2	ACR	NNP	ORGANIZATION	ACR	nn	4	SENT_102	[p7l958t1030r1115b1086],
3	core	NN	O	core	nn	4	SENT_102	[p7l1136t1045r1281b1086],
4	set	NN	O	set	nsubj	7	SENT_102	[p7l1307t1035r1400b1086],
5	of	IN	O	of	_	0	SENT_102	[p7l1422t1028r1494b1086],
6	variables	NNS	O	variable	prep_of	4	SENT_102	[p7l1509t1028r1819b1086],
7	included	VBD	O	include	_	0	SENT_102	[p7l1842t1028r2153b1086],
8	the	DT	O	the	det	9	SENT_102	[p7l8t1123r121b1181],
9	number	NN	O	number	dobj	7	SENT_102	[p7l153t1123r433b1181],
10	of	IN	O	of	_	0	SENT_102	[p7l464t1123r536b1181],
11	swollen	JJ	O	swollen	amod	12	SENT_102	[p7l564t1123r833b1181],
12	joints	NNS	O	joint	prep_of	9	SENT_102	[p7l864t1126r1081b1199],
13	,	,	O	,	_	0	SENT_102	[p7l864t1126r1081b1199],
14	the	DT	O	the	det	15	SENT_102	[p7l1117t1123r1230b1181],
15	number	NN	O	number	dobj	7	SENT_102	[p7l1262t1123r1541b1181],
16	of	IN	O	of	_	0	SENT_102	[p7l1573t1123r1645b1181],
17	tender	NN	O	tender	nn	18	SENT_102	[p7l1671t1123r1900b1181],
18	joints	NNS	O	joint	prep_of	15	SENT_102	[p7l1931t1126r2147b1199],
19	,	,	O	,	_	0	SENT_102	[p7l1931t1126r2147b1199],
20	physician	NN	O	physician	poss	23	SENT_102	[p7l8t1218r397b1294],
21	's	POS	O	's	_	0	SENT_102	[p7l8t1218r397b1294],
22	global	JJ	O	global	amod	23	SENT_102	[p7l424t1218r638b1294],
23	assessment	NN	O	assessment	dobj	7	SENT_102	[p7l665t1225r1053b1276],
24	of	IN	O	of	_	0	SENT_102	[p7l1079t1218r1150b1276],
25	disease	NN	O	disease	nn	26	SENT_102	[p7l1172t1218r1414b1276],
26	activity	NN	O	activity	prep_of	23	SENT_102	[p7l1442t1221r1706b1294],
27	on	IN	O	on	_	0	SENT_102	[p7l1730t1235r1821b1276],
28	a	DT	O	a	det	29	SENT_102	[p7l1848t1235r1882b1276],
29	O	NN	O	o	prep_on	26	SENT_102	[p7l1907t1219r1947b1276],
30	to	TO	O	to	_	0	SENT_102	[p7l1973t1225r2042b1276],
31	10	CD	NUMBER	10	num	32	SENT_102	[p7l2074t1219r2152b1276],
32	scale	NN	O	scale	prep_to	29	SENT_102	[p7l10t1312r192b1383],
33	,	,	O	,	_	0	SENT_102	[p7l10t1312r192b1383],
34	patient	NN	O	patient	poss	37	SENT_102	[p7l220t1313r520b1388],
35	’s	POS	O	’s	_	0	SENT_102	[p7l220t1313r520b1388],
36	global	JJ	O	global	amod	37	SENT_102	[p7l545t1312r760b1388],
37	assessment	NN	O	assessment	dobj	7	SENT_102	[p7l785t1320r1173b1370],
38	of	IN	O	of	_	0	SENT_102	[p7l1197t1312r1269b1370],
39	disease	NN	O	disease	nn	40	SENT_102	[p7l1288t1313r1531b1370],
40	activity	NN	O	activity	prep_of	37	SENT_102	[p7l1557t1315r1822b1388],
41	on	IN	O	on	_	0	SENT_102	[p7l1844t1329r1935b1370],
42	a	DT	O	a	det	43	SENT_102	[p7l1960t1329r1995b1370],
43	o	NN	O	o	prep_on	40	SENT_102	[p7l2018t1314r2059b1370],
44	to	TO	O	to	_	0	SENT_102	[p7l2082t1320r2152b1370],
45	10	CD	NUMBER	10	num	46	SENT_102	[p7l14t1409r92b1465],
46	scale	NN	O	scale	prep_to	43	SENT_102	[p7l130t1408r312b1478],
47	,	,	O	,	_	0	SENT_102	[p7l130t1408r312b1478],
48	patient	NN	O	patient	poss	50	SENT_102	[p7l354t1407r654b1483],
49	’s	POS	O	’s	_	0	SENT_102	[p7l354t1407r654b1483],
50	assessment	NN	O	assessment	conj_and	9	SENT_102	[p7l692t1415r1079b1465],
51	of	IN	O	of	_	0	SENT_102	[p7l1116t1407r1188b1465],
52	pain	NN	O	pain	prep_of	50	SENT_102	[p7l1220t1410r1376b1483],
53	on	IN	O	on	_	0	SENT_102	[p7l1414t1424r1505b1465],
54	a	DT	O	a	det	58	SENT_102	[p7l1542t1424r1577b1465],
55	100-mm	JJ	O	100-mm	amod	58	SENT_102	[p7l1619t1409r1912b1465],
56	visual	JJ	O	visual	amod	58	SENT_102	[p7l1946t1407r2152b1465],
57	analog	NN	O	analog	nn	58	SENT_102	[p7l9t1503r245b1579],
58	scale	NN	O	scale	prep_on	52	SENT_102	[p7l291t1503r454b1561],
59	(	CD	NUMBER	(	num	60	SENT_102	[p7l505t1503r708b1575],
60	VAS	NNP	O	VAS	dep	58	SENT_102	[p7l505t1503r708b1575],
61	)	CD	NUMBER	)	num	60	SENT_102	[p7l505t1503r708b1575],
62	,	,	O	,	_	0	SENT_102	[p7l505t1503r708b1575],
63	and	CC	O	and	_	0	SENT_102	[p7l759t1503r890b1561],
64	the	DT	O	the	det	66	SENT_102	[p7l935t1503r1048b1561],
65	functional	JJ	O	functional	amod	66	SENT_102	[p7l1094t1503r1463b1561],
66	status	NN	O	status	dobj	7	SENT_102	[p7l1510t1510r1710b1561],
67	of	IN	O	of	_	0	SENT_102	[p7l1757t1503r1828b1561],
68	patients	NNS	O	patient	prep_of	66	SENT_102	[p7l1869t1506r2152b1579],
69	using	VBG	O	use	xcomp	7	SENT_102	[p7l7t1601r200b1673],
70	the	DT	O	the	det	75	SENT_102	[p7l239t1598r352b1655],
71	Health	NNP	O	Health	nn	75	SENT_102	[p7l394t1598r632b1655],
72	Assessment	NNP	O	Assessment	nn	75	SENT_102	[p7l671t1599r1074b1655],
73	Questionnaire	NNP	O	Questionnaire	nn	75	SENT_102	[p7l1116t1599r1618b1667],
74	(	CD	NUMBER	(	num	75	SENT_102	[p7l1664t1598r1884b1670],
75	HAQ	NNP	O	HAQ	dobj	69	SENT_102	[p7l1664t1598r1884b1670],
76	)	CD	NUMBER	)	nsubj	77	SENT_102	[p7l1664t1598r1884b1670],
77	scored	VBD	O	score	rcmod	75	SENT_102	[p7l1929t1598r2152b1655],
78	on	IN	O	on	_	0	SENT_102	[p7l9t1709r100b1750],
79	a	DT	O	a	det	81	SENT_102	[p7l133t1709r168b1750],
80	0-3	CD	NUMBER	0-3	num	81	SENT_102	[p7l200t1694r319b1750],
81	scale	NN	O	scale	prep_on	77	SENT_102	[p7l356t1693r538b1750],
82	.	.	O	.	_	0	SENT_102	[p7l356t1693r538b1750],

1	A	DT	O	a	det	4	SENT_103	[p7l574t1694r624b1750],
2	28-joint	JJ	O	28-joint	amod	4	SENT_103	[p7l657t1694r938b1768],
3	count	NN	O	count	nn	4	SENT_103	[p7l971t1700r1176b1750],
4	(	NN	O	(	nsubjpass	20	SENT_103	[p7l1211t1693r1577b1768],
5	including	VBG	O	include	_	0	SENT_103	[p7l1211t1693r1577b1768],
6	the	DT	O	the	det	8	SENT_103	[p7l1608t1693r1721b1750],
7	metacarpophalangeal	NN	O	metacarpophalangeal	nn	8	SENT_103	[p7l1753t1700r2151b1768, p7l8t1788r396b1864],
8	joints	NNS	O	joint	prep_including	4	SENT_103	[p7l461t1791r677b1864],
9	,	,	O	,	_	0	SENT_103	[p7l461t1791r677b1864],
10	the	DT	O	the	det	13	SENT_103	[p7l745t1788r858b1846],
11	proximal	JJ	O	proximal	amod	13	SENT_103	[p7l922t1788r1243b1864],
12	interphalangeal	NN	O	interphalangeal	nn	13	SENT_103	[p7l1307t1788r1866b1864],
13	joints	NNS	O	joint	prep_including	4	SENT_103	[p7l1931t1791r2147b1864],
14	,	,	O	,	_	0	SENT_103	[p7l1931t1791r2147b1864],
15	wrists	NNS	O	wrist	prep_including	4	SENT_103	[p7l7t1884r209b1938],
16	and	CC	O	and	_	0	SENT_103	[p7l241t1881r372b1938],
17	elbows	NNS	O	elbow	conj_and	8	SENT_103	[p7l403t1881r666b1953],
18	)	CD	NUMBER	)	num	17	SENT_103	[p7l403t1881r666b1953],
19	was	VBD	O	be	auxpass	20	SENT_103	[p7l699t1898r827b1938],
20	used	VBN	O	use	_	0	SENT_103	[p7l857t1873r1188b1938],
21	.21	CD	NUMBER	.21	number	22	SENT_103	[p7l857t1873r1188b1938],
22	'22	CD	NUMBER	'22	dobj	20	SENT_103	[p7l857t1873r1188b1938],
23	A	DT	O	a	det	24	SENT_103	[p7l1217t1882r1268b1938],
24	patient	NN	O	patient	nsubjpass	26	SENT_103	[p7l1297t1884r1550b1957],
25	was	VBD	O	be	auxpass	26	SENT_103	[p7l1578t1898r1706b1939],
26	classified	VBN	O	classify	rcmod	22	SENT_103	[p7l1738t1881r2056b1939],
27	as	IN	O	as	mark	58	SENT_103	[p7l2087t1898r2151b1939],
28	a	DT	O	a	det	30	SENT_103	[p7l9t1994r44b2035],
29	good	JJ	O	good	amod	30	SENT_103	[p7l69t1977r245b2053],
30	responder	NN	O	responder	nsubjpass	58	SENT_103	[p7l270t1977r623b2053],
31	when	WRB	O	when	advmod	45	SENT_103	[p7l647t1977r844b2035],
32	both	CC	O	both	preconj	36	SENT_103	[p7l868t1977r1036b2035],
33	the	DT	O	the	det	36	SENT_103	[p7l1062t1977r1174b2035],
34	tender	NN	O	tender	nn	36	SENT_103	[p7l1201t1977r1430b2035],
35	joint	NN	O	joint	nn	36	SENT_103	[p7l1456t1980r1624b2053],
36	count	NN	O	count	nsubj	45	SENT_103	[p7l1651t1984r1855b2035],
37	and	CC	O	and	_	0	SENT_103	[p7l1882t1977r2013b2035],
38	the	DT	O	the	det	41	SENT_103	[p7l2039t1977r2151b2035],
39	swollen	JJ	O	swollen	amod	41	SENT_103	[p7l10t2071r278b2129],
40	joint	JJ	O	joint	amod	41	SENT_103	[p7l302t2074r470b2147],
41	count	NN	O	count	nsubj	45	SENT_103	[p7l493t2079r697b2129],
42	were	VBD	O	be	cop	45	SENT_103	[p7l717t2088r881b2129],
43	2	CD	PERCENT	2	number	44	SENT_103	[p7l916t2081r965b2136],
44	20	CD	PERCENT	20	num	45	SENT_103	[p7l981t2073r1133b2129],
45	%	NN	PERCENT	%	dep	30	SENT_103	[p7l981t2073r1133b2129],
46	improved	VBN	O	improve	partmod	45	SENT_103	[p7l1156t2071r1498b2147],
47	from	IN	O	from	_	0	SENT_103	[p7l1519t2071r1689b2129],
48	baseline	NN	O	baseline	prep_from	46	SENT_103	[p7l1710t2071r1997b2129],
49	and	CC	O	and	_	0	SENT_103	[p7l2021t2071r2153b2129],
50	at	IN	O	at	quantmod	52	SENT_103	[p7l9t2174r73b2225],
51	least	JJS	O	least	mwe	50	SENT_103	[p7l119t2167r277b2225],
52	three	CD	NUMBER	three	dep	30	SENT_103	[p7l324t2167r504b2225],
53	of	IN	O	of	_	0	SENT_103	[p7l553t2167r625b2225],
54	the	DT	O	the	det	56	SENT_103	[p7l668t2167r780b2225],
55	following	VBG	O	follow	amod	56	SENT_103	[p7l828t2167r1168b2243],
56	criteria	NNS	O	criterion	prep_of	52	SENT_103	[p7l1215t2170r1461b2225],
57	were	VBD	O	be	auxpass	58	SENT_103	[p7l1506t2184r1670b2225],
58	met	VBN	O	meet	advcl	26	SENT_103	[p7l1718t2174r1872b2225],
59	:	:	O	:	_	0	SENT_103	[p7l1718t2174r1872b2225],
60	220	CD	PERCENT	220	num	62	SENT_103	[p7l1935t2169r2152b2232],
61	%	NN	PERCENT	%	nn	62	SENT_103	[p7l1935t2169r2152b2232],
62	improvement	NN	O	improvement	dep	22	SENT_103	[p7l8t2264r494b2337],
63	in	IN	O	in	_	0	SENT_103	[p7l544t2264r615b2318],
64	VAS	NNP	O	VAS	prep_in	62	SENT_103	[p7l665t2263r819b2332],
65	,	,	O	,	_	0	SENT_103	[p7l665t2263r819b2332],
66	in	IN	O	in	_	0	SENT_103	[p7l875t2264r945b2318],
67	erythrocyte	NN	O	erythrocyte	nn	72	SENT_103	[p7l997t2262r1403b2337],
68	sedimentation	NN	O	sedimentation	nn	72	SENT_103	[p7l1458t2262r1969b2319],
69	rate	NN	O	rate	nn	72	SENT_103	[p7l2020t2269r2151b2319],
70	(	CD	NUMBER	(	num	72	SENT_103	[p7l12t2357r207b2429],
71	ESR	NN	ORGANIZATION	esr	nn	72	SENT_103	[p7l12t2357r207b2429],
72	)	NN	O	)	prep_in	22	SENT_103	[p7l12t2357r207b2429],
73	,	,	O	,	_	0	SENT_103	[p7l12t2357r207b2429],
74	in	IN	O	in	_	0	SENT_103	[p7l239t2360r309b2414],
75	physician	NN	O	physician	poss	78	SENT_103	[p7l335t2357r725b2432],
76	's	POS	O	's	_	0	SENT_103	[p7l335t2357r725b2432],
77	global	JJ	O	global	amod	78	SENT_103	[p7l753t2357r967b2432],
78	assessment	NN	O	assessment	prep_in	72	SENT_103	[p7l995t2364r1383b2414],
79	of	IN	O	of	_	0	SENT_103	[p7l1410t2356r1482b2414],
80	disease	NN	O	disease	nn	81	SENT_103	[p7l1505t2357r1748b2414],
81	activity	NN	O	activity	prep_of	78	SENT_103	[p7l1776t2360r2050b2432],
82	,	,	O	,	_	0	SENT_103	[p7l1776t2360r2050b2432],
83	in	IN	O	in	_	0	SENT_103	[p7l2082t2360r2152b2414],
84	patient	NN	O	patient	poss	87	SENT_103	[p7l8t2452r308b2528],
85	’s	POS	O	’s	_	0	SENT_103	[p7l8t2452r308b2528],
86	global	JJ	O	global	amod	87	SENT_103	[p7l340t2452r555b2528],
87	assessment	NN	O	assessment	prep_in	72	SENT_103	[p7l587t2459r975b2510],
88	of	IN	O	of	_	0	SENT_103	[p7l1007t2452r1078b2510],
89	disease	NN	O	disease	nn	90	SENT_103	[p7l1106t2452r1349b2510],
90	activity	NN	O	activity	prep_of	87	SENT_103	[p7l1383t2455r1656b2528],
91	,	,	O	,	_	0	SENT_103	[p7l1383t2455r1656b2528],
92	and	CC	O	and	_	0	SENT_103	[p7l1693t2452r1825b2510],
93	in	IN	O	in	_	0	SENT_103	[p7l1855t2455r1926b2509],
94	HAQ	NNP	O	HAQ	prep_in	72	SENT_103	[p7l1958t2454r2148b2522],
95	.	.	O	.	_	0	SENT_103	[p7l1958t2454r2148b2522],

1	The	DT	O	the	det	2	SENT_104	[p7l6t2547r139b2604],
2	group	NN	O	group	nsubj	25	SENT_104	[p7l168t2563r374b2622],
3	‘	RB	O	‘	advmod	4	SENT_104	[p7l405t2547r600b2622],
4	good	JJ	O	good	amod	6	SENT_104	[p7l405t2547r600b2622],
5	responders	NNS	O	responder	nn	6	SENT_104	[p7l628t2547r1030b2622],
6	’	NN	O	’	nsubj	7	SENT_104	[p7l628t2547r1030b2622],
7	included	VBD	O	include	rcmod	2	SENT_104	[p7l1061t2547r1371b2604],
8	patients	NNS	O	patient	dobj	7	SENT_104	[p7l1399t2550r1682b2622],
9	in	IN	O	in	_	0	SENT_104	[p7l1711t2550r1781b2604],
10	remission	NN	O	remission	prep_in	7	SENT_104	[p7l1809t2550r2152b2604],
11	for	IN	O	for	_	0	SENT_104	[p7l8t2639r107b2697],
12	at	IN	DURATION	at	quantmod	14	SENT_104	[p7l141t2647r205b2697],
13	least	JJS	DURATION	least	mwe	12	SENT_104	[p7l238t2640r396b2697],
14	6	CD	DURATION	6	num	15	SENT_104	[p7l433t2641r469b2697],
15	months	NNS	NUMBER	month	prep_for	7	SENT_104	[p7l505t2633r950b2697],
16	.23	CD	NUMBER	.23	number	17	SENT_104	[p7l505t2633r950b2697],
17	'24	CD	NUMBER	'24	dep	15	SENT_104	[p7l505t2633r950b2697],
18	The	DT	O	the	det	24	SENT_104	[p7l982t2640r1115b2697],
19	second	JJ	ORDINAL	second	amod	24	SENT_104	[p7l1153t2640r1396b2697],
20	group	NN	O	group	nn	24	SENT_104	[p7l1430t2656r1636b2715],
21	‘	CD	NUMBER	‘	num	24	SENT_104	[p7l1673t2640r1856b2715],
22	poor	JJ	O	poor	amod	24	SENT_104	[p7l1673t2640r1856b2715],
23	responders	NNS	O	responder	nn	24	SENT_104	[p7l1889t2657r2151b2715, p7l9t2736r169b2794],
24	’	NN	O	’	dep	17	SENT_104	[p7l1889t2657r2151b2715, p7l9t2736r169b2794],
25	included	VBD	O	include	_	0	SENT_104	[p7l198t2736r508b2794],
26	patients	NNS	O	patient	dobj	25	SENT_104	[p7l534t2739r817b2812],
27	with	IN	O	with	_	0	SENT_104	[p7l842t2736r1004b2794],
28	active	JJ	O	active	amod	29	SENT_104	[p7l1031t2739r1235b2794],
29	disease	NN	O	disease	prep_with	25	SENT_104	[p7l1264t2736r1506b2794],
30	despite	IN	O	despite	dep	25	SENT_104	[p7l1535t2736r1782b2812],
31	of	IN	O	of	_	0	SENT_104	[p7l1811t2736r1882b2794],
32	at	IN	DURATION	at	quantmod	34	SENT_104	[p7l1905t2743r1969b2794],
33	least	JJS	DURATION	least	mwe	32	SENT_104	[p7l1995t2736r2153b2794],
34	6	CD	DURATION	6	num	35	SENT_104	[p7l11t2832r47b2889],
35	months	NNS	NUMBER	month	prep_of	25	SENT_104	[p7l78t2831r352b2889],
36	of	IN	O	of	_	0	SENT_104	[p7l383t2831r455b2889],
37	therapy	NN	O	therapy	prep_of	35	SENT_104	[p7l480t2831r753b2907],
38	with	IN	O	with	_	0	SENT_104	[p7l778t2831r940b2889],
39	MTX	NN	O	mtx	prep_with	37	SENT_104	[p7l968t2833r1162b2889],
40	.	.	O	.	_	0	SENT_104	[p7l968t2833r1162b2889],

1	The	DT	O	the	det	2	SENT_105	[p7l83t2926r216b2983],
2	study	NN	O	study	nsubjpass	4	SENT_105	[p7l257t2925r450b3001],
3	was	VBD	O	be	auxpass	4	SENT_105	[p7l485t2942r613b2983],
4	approved	VBN	O	approve	_	0	SENT_105	[p7l654t2925r984b3001],
5	by	IN	O	by	_	0	SENT_105	[p7l1020t2925r1108b3001],
6	the	DT	O	the	det	9	SENT_105	[p7l1144t2925r1257b2983],
7	local	JJ	O	local	amod	9	SENT_105	[p7l1297t2925r1462b2983],
8	ethics	NNS	O	ethic	nn	9	SENT_105	[p7l1503t2925r1707b2983],
9	committee	NN	O	committee	agent	4	SENT_105	[p7l1748t2928r2147b2996],
10	,	,	O	,	_	0	SENT_105	[p7l1748t2928r2147b2996],
11	and	CC	O	and	_	0	SENT_105	[p7l9t3019r141b3077],
12	written	VBN	O	write	amod	14	SENT_105	[p7l203t3022r462b3077],
13	informed	JJ	O	informed	amod	14	SENT_105	[p7l526t3019r856b3077],
14	consent	NN	O	consent	nsubjpass	16	SENT_105	[p7l922t3027r1199b3077],
15	was	VBD	O	be	auxpass	16	SENT_105	[p7l1262t3036r1390b3077],
16	obtained	VBN	O	obtain	conj_and	4	SENT_105	[p7l1457t3019r1769b3077],
17	from	IN	O	from	_	0	SENT_105	[p7l1834t3019r2004b3077],
18	all	DT	O	all	det	19	SENT_105	[p7l2070t3019r2152b3077],
19	subjects	NNS	O	subject	prep_from	16	SENT_105	[p7l10t3116r305b3192],
20	.	.	O	.	_	0	SENT_105	[p7l10t3116r305b3192],

1	Genotyping	VBG	O	genotype	_	0	SENT_106	[p8l14t84r382b159],
2	Genomic	JJ	O	genomic	amod	3	SENT_106	[p8l10t179r334b236],
3	DNA	NN	O	dna	dobj	1	SENT_106	[p8l370t179r540b235],
4	was	VBD	O	be	auxpass	5	SENT_106	[p8l572t195r700b236],
5	extracted	VBN	O	extract	aux	1	SENT_106	[p8l738t178r1064b236],
6	manually	RB	O	manually	advmod	5	SENT_106	[p8l1099t178r1437b254],
7	(	CD	NUMBER	(	num	8	SENT_106	[p8l1474t178r1956b254],
8	precipitation	NN	O	precipitation	nsubj	1	SENT_106	[p8l1474t178r1956b254],
9	with	IN	O	with	_	0	SENT_106	[p8l1991t178r2153b236],
10	trimethylammonium	NN	O	trimethylammonium	nn	12	SENT_106	[p8l8t273r767b349],
11	bromide	NN	O	bromide	nn	12	SENT_106	[p8l813t273r1111b331],
12	salts	NNS	O	salt	prep_with	8	SENT_106	[p8l1163t273r1310b331],
13	from	IN	O	from	_	0	SENT_106	[p8l1359t273r1529b331],
14	leukocytes	NNS	O	leukocyte	prep_from	12	SENT_106	[p8l1578t273r1948b349],
15	contained	VBN	O	contain	partmod	14	SENT_106	[p8l1998t290r2152b331, p8l8t367r232b425],
16	in	IN	O	in	_	0	SENT_106	[p8l277t370r347b424],
17	450	CD	NUMBER	450	num	18	SENT_106	[p8l394t369r521b425],
18	Ml	NN	O	ml	prep_in	15	SENT_106	[p8l537t367r600b440],
19	of	IN	O	of	_	0	SENT_106	[p8l647t367r718b425],
20	Venous	JJ	O	venous	amod	21	SENT_106	[p8l757t384r1009b425],
21	blood	NN	O	blood	prep_of	18	SENT_106	[p8l1053t367r1258b425],
22	with	IN	O	with	_	0	SENT_106	[p8l1302t367r1463b425],
23	ethylene	NN	O	ethylene	nn	26	SENT_106	[p8l1510t368r1815b443],
24	diamine	NN	O	diamine	nn	26	SENT_106	[p8l1862t367r2152b425],
25	tetraacetic	JJ	O	tetraacetic	amod	26	SENT_106	[p8l8t466r375b521],
26	acid	NN	O	acid	prep_with	15	SENT_106	[p8l444t463r587b521],
27	as	IN	O	as	_	0	SENT_106	[p8l656t480r721b521],
28	an	DT	O	a	det	30	SENT_106	[p8l791t480r876b521],
29	anticoagulant	JJ	O	anticoagulant	amod	30	SENT_106	[p8l946t463r1482b539],
30	)	NN	O	)	prep_as	15	SENT_106	[p8l946t463r1482b539],
31	.	.	O	.	_	0	SENT_106	[p8l946t463r1482b539],

1	DNA	NN	O	dna	nsubjpass	4	SENT_107	[p8l1556t464r1726b520],
2	was	VBD	O	be	auxpass	4	SENT_107	[p8l1791t480r1919b521],
3	then	RB	O	then	advmod	4	SENT_107	[p8l1988t463r2152b521],
4	precipitated	VBN	O	precipitate	_	0	SENT_107	[p8l8t557r432b633],
5	in	IN	O	in	_	0	SENT_107	[p8l476t560r547b614],
6	95	CD	PERCENT	95	number	7	SENT_107	[p8l592t559r744b615],
7	%	NN	PERCENT	%	amod	8	SENT_107	[p8l592t559r744b615],
8	ethanol	NN	O	ethanol	prep_in	4	SENT_107	[p8l790t557r1079b628],
9	,	,	O	,	_	0	SENT_107	[p8l790t557r1079b628],
10	dissolved	VBN	O	dissolve	conj_and	4	SENT_107	[p8l1129t557r1454b615],
11	in	IN	O	in	_	0	SENT_107	[p8l1499t560r1569b614],
12	distilled	JJ	O	distilled	amod	13	SENT_107	[p8l1614t557r1896b615],
13	water	NN	O	water	prep_in	10	SENT_107	[p8l1939t565r2147b628],
14	,	,	O	,	_	0	SENT_107	[p8l1939t565r2147b628],
15	and	CC	O	and	_	0	SENT_107	[p8l9t653r141b710],
16	stored	VBD	O	store	conj_and	4	SENT_107	[p8l194t653r409b710],
17	at	IN	O	at	_	0	SENT_107	[p8l461t660r525b710],
18	—	CD	NUMBER	—	number	19	SENT_107	[p8l581t654r806b710],
19	20	CD	NUMBER	20	num	21	SENT_107	[p8l581t654r806b710],
20	°	NN	O	°	nn	21	SENT_107	[p8l581t654r806b710],
21	C	NN	O	c	prep_at	16	SENT_107	[p8l581t654r806b710],
22	until	IN	O	until	_	0	SENT_107	[p8l857t653r1029b710],
23	analysis	NN	O	analysis	prep_until	16	SENT_107	[p8l1082t653r1377b728],
24	.	.	O	.	_	0	SENT_107	[p8l1082t653r1377b728],

1	The	DT	O	the	det	3	SENT_108	[p8l1431t653r1564b710],
2	RFC-1	NN	O	rfc-1	nn	3	SENT_108	[p8l1614t654r1818b710],
3	80G	NN	O	80g	npadvmod	4	SENT_108	[p8l1880t654r2153b710],
4	>	JJR	O	>	amod	7	SENT_108	[p8l1880t654r2153b710],
5	A	DT	O	a	det	7	SENT_108	[p8l1880t654r2153b710],
6	polymorphism	NN	O	polymorphism	nn	7	SENT_108	[p8l8t748r535b824],
7	(	NN	O	(	nsubjpass	22	SENT_108	[p8l565t748r901b824],
8	resulting	VBG	O	result	partmod	7	SENT_108	[p8l565t748r901b824],
9	in	IN	O	in	_	0	SENT_108	[p8l927t751r997b805],
10	a	DT	O	a	det	12	SENT_108	[p8l1024t765r1059b806],
11	histidine-to-arginine	JJ	O	histidine-to-arginine	amod	12	SENT_108	[p8l1085t748r1820b824],
12	substitution	NN	O	substitution	prep_in	8	SENT_108	[p8l1850t748r2152b806, p8l8t846r153b900],
13	at	IN	O	at	_	0	SENT_108	[p8l181t850r244b900],
14	codon	NN	O	codon	prep_at	12	SENT_108	[p8l271t843r492b900],
15	27	CD	NUMBER	27	num	14	SENT_108	[p8l520t844r601b900],
16	of	IN	O	of	_	0	SENT_108	[p8l630t842r702b900],
17	RFC	NNP	O	RFC	prep_of	12	SENT_108	[p8l726t843r959b915],
18	—	CD	NUMBER	—	num	17	SENT_108	[p8l726t843r959b915],
19	1	CD	NUMBER	1	num	20	SENT_108	[p8l726t843r959b915],
20	)	NN	O	)	dep	12	SENT_108	[p8l726t843r959b915],
21	was	VBD	O	be	auxpass	22	SENT_108	[p8l988t859r1116b900],
22	detected	VBN	O	detect	_	0	SENT_108	[p8l1145t843r1443b900],
23	using	VBG	O	use	xcomp	22	SENT_108	[p8l1469t846r1661b918],
24	a	DT	O	a	det	31	SENT_108	[p8l1688t859r1722b900],
25	polymerase	NN	O	polymerase	nn	31	SENT_108	[p8l1748t843r2151b918],
26	chain	NN	O	chain	nn	31	SENT_108	[p8l9t938r205b995],
27	reaction-restriction	NN	O	reaction-restriction	nn	31	SENT_108	[p8l252t941r934b995],
28	fragment	NN	O	fragment	nn	31	SENT_108	[p8l981t937r1304b1013],
29	length	NN	O	length	nn	31	SENT_108	[p8l1350t938r1579b1013],
30	polymorphism	NN	O	polymorphism	nn	31	SENT_108	[p8l1625t938r2152b1013],
31	method	NN	O	method	dobj	23	SENT_108	[p8l8t1031r304b1101],
32	,	,	O	,	_	0	SENT_108	[p8l8t1031r304b1101],
33	as	IN	O	as	mark	34	SENT_108	[p8l339t1048r404b1089],
34	described	VBN	O	describe	dep	31	SENT_108	[p8l435t1031r767b1089],
35	preViously	RB	DATE	previously	advmod	34	SENT_108	[p8l795t1024r1213b1107],
36	.6	CD	NUMBER	.6	num	38	SENT_108	[p8l795t1024r1213b1107],
37	Statistical	JJ	O	statistical	amod	38	SENT_108	[p8l12t1126r324b1184],
38	analysis	NN	O	analysis	dobj	34	SENT_108	[p8l350t1126r601b1202],
39	The	DT	O	the	det	40	SENT_108	[p8l7t1222r140b1280],
40	associations	NNS	O	association	nsubjpass	45	SENT_108	[p8l167t1225r589b1280],
41	between	IN	O	between	_	0	SENT_108	[p8l614t1222r912b1280],
42	categorical	JJ	O	categorical	amod	43	SENT_108	[p8l939t1222r1319b1298],
43	Variables	NNS	O	variable	prep_between	40	SENT_108	[p8l1343t1222r1653b1280],
44	were	VBD	O	be	auxpass	45	SENT_108	[p8l1678t1239r1842b1280],
45	assessed	VBN	O	assess	rcmod	38	SENT_108	[p8l1871t1222r2153b1280],
46	by	IN	O	by	_	0	SENT_108	[p8l7t1315r94b1391],
47	X2-test	NN	O	x2-test	agent	45	SENT_108	[p8l155t1308r376b1388],
48	and	CC	O	and	_	0	SENT_108	[p8l440t1315r571b1373],
49	Fisher	NNP	PERSON	Fisher	poss	52	SENT_108	[p8l635t1315r892b1373],
50	's	POS	O	's	_	0	SENT_108	[p8l635t1315r892b1373],
51	exact	JJ	O	exact	amod	52	SENT_108	[p8l957t1322r1141b1373],
52	test	NN	O	test	agent	45	SENT_108	[p8l1204t1322r1344b1385],
53	,	,	O	,	_	0	SENT_108	[p8l1204t1322r1344b1385],
54	using	VBG	O	use	dep	34	SENT_108	[p8l1411t1318r1605b1391],
55	Statistica	NNP	O	Statistica	nsubj	59	SENT_108	[p8l1668t1317r1983b1373],
56	6.0	CD	NUMBER	6.0	number	57	SENT_108	[p8l2049t1317r2153b1373],
57	(	CD	NUMBER	(	num	59	SENT_108	[p8l12t1409r344b1482],
58	Statsoft	NN	O	statsoft	nn	59	SENT_108	[p8l12t1409r344b1482],
59	)	NN	O	)	xcomp	54	SENT_108	[p8l12t1409r344b1482],
60	.	.	O	.	_	0	SENT_108	[p8l12t1409r344b1482],

1	Odds	NNS	O	odds	nn	2	SENT_109	[p8l383t1410r563b1467],
2	ratios	NNS	O	ratio	nsubjpass	7	SENT_109	[p8l596t1413r790b1467],
3	and	CC	O	and	_	0	SENT_109	[p8l824t1410r956b1467],
4	confidence	NN	O	confidence	nn	5	SENT_109	[p8l989t1409r1378b1467],
5	intervals	NNS	O	interval	conj_and	2	SENT_109	[p8l1412t1410r1716b1467],
6	were	VBD	O	be	auxpass	7	SENT_109	[p8l1747t1426r1912b1467],
7	calculated	VBN	O	calculate	_	0	SENT_109	[p8l1946t1410r2151b1467, p8l9t1506r182b1564],
8	using	VBG	O	use	xcomp	7	SENT_109	[p8l226t1509r419b1582],
9	the	DT	O	the	det	11	SENT_109	[p8l464t1506r577b1564],
10	Newcombe-Wilson	NN	MISC	newcombe-wilson	nn	11	SENT_109	[p8l623t1506r1299b1564],
11	method	NN	O	method	dobj	8	SENT_109	[p8l1345t1506r1623b1564],
12	without	IN	O	without	_	0	SENT_109	[p8l1668t1506r1951b1564],
13	continuity	NN	O	continuity	nn	14	SENT_109	[p8l1998t1523r2151b1564, p8l8t1604r253b1677],
14	correction	NN	O	correction	prep_without	8	SENT_109	[p8l280t1604r660b1659],
15	.	.	O	.	_	0	SENT_109	[p8l280t1604r660b1659],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_110	[p8l7t1790r730b1866],

1	The	DT	O	the	det	2	SENT_111	[p8l7t1974r125b2026],
2	study	NN	O	study	nsubjpass	4	SENT_111	[p8l149t1974r320b2042],
3	was	VBD	O	be	auxpass	4	SENT_111	[p8l338t1989r452b2026],
4	supported	VBN	O	support	_	0	SENT_111	[p8l476t1974r790b2042],
5	by	IN	O	by	_	0	SENT_111	[p8l810t1974r888b2042],
6	Grant	NNP	O	Grant	nn	7	SENT_111	[p8l909t1976r1090b2026],
7	2P05B1	NNP	O	2P05B1	agent	4	SENT_111	[p8l1113t1976r1340b2026],
8	1029	CD	DATE	1029	num	7	SENT_111	[p8l1354t1976r1498b2026],
9	for	IN	O	for	_	0	SENT_111	[p8l1522t1974r1610b2026],
10	years	NNS	DURATION	year	prep_for	4	SENT_111	[p8l1630t1989r1788b2042],
11	2005-2008	CD	DATE	2005-2008	num	10	SENT_111	[p8l1812t1976r2152b2026],
12	from	IN	O	from	_	0	SENT_111	[p8l8t2059r159b2111],
13	the	DT	O	the	det	14	SENT_111	[p8l185t2060r286b2111],
14	Ministry	NNP	ORGANIZATION	Ministry	prep_from	10	SENT_111	[p8l311t2062r581b2127],
15	of	IN	ORGANIZATION	of	_	0	SENT_111	[p8l606t2059r669b2111],
16	Education	NNP	ORGANIZATION	Education	nn	20	SENT_111	[p8l692t2060r1010b2111],
17	and	CC	ORGANIZATION	and	_	0	SENT_111	[p8l1037t2060r1153b2111],
18	Science	NNP	ORGANIZATION	Science	nn	20	SENT_111	[p8l1179t2061r1410b2111],
19	(	CD	NUMBER	(	num	20	SENT_111	[p8l1439t2060r1711b2124],
20	Warsaw	NNP	LOCATION	Warsaw	prep_of	14	SENT_111	[p8l1439t2060r1711b2124],
21	,	,	O	,	_	0	SENT_111	[p8l1439t2060r1711b2124],
22	Poland	NNP	LOCATION	Poland	appos	20	SENT_111	[p8l1742t2060r1999b2124],
23	)	CD	NUMBER	)	num	22	SENT_111	[p8l1742t2060r1999b2124],
24	.	.	O	.	_	0	SENT_111	[p8l1742t2060r1999b2124],

1	Duality	NN	O	duality	_	0	SENT_112	[p8l11t2268r287b2344],
2	of	IN	O	of	_	0	SENT_112	[p8l315t2268r396b2326],
3	interest	NN	O	interest	prep_of	1	SENT_112	[p8l424t2268r743b2326],
4	:	:	O	:	_	0	SENT_112	[p8l424t2268r743b2326],

1	None	NN	O	none	nsubj	2	SENT_113	[p8l13t2449r192b2504],
2	declared	VBD	O	declare	_	0	SENT_113	[p8l222t2447r525b2504],
3	.	.	O	.	_	0	SENT_113	[p8l222t2447r525b2504],

1	References	NNS	O	reference	_	0	SENT_114	[p8l11t2635r425b2692],

1	1	CD	NUMBER	1	num	3	SENT_115	[p8l44t2815r61b2862],
2	Chan	NNP	O	Chan	nn	3	SENT_115	[p8l142t2814r285b2863],
3	ES	NN	O	e	_	0	SENT_115	[p8l323t2816r397b2873],
4	,	,	O	,	_	0	SENT_115	[p8l323t2816r397b2873],
5	Cronstein	NN	O	cronstein	nn	6	SENT_115	[p8l434t2815r699b2863],
6	BN	NN	O	bn	appos	3	SENT_115	[p8l738t2816r833b2863],
7	.	.	O	.	_	0	SENT_115	[p8l738t2816r833b2863],

1	Molecular	JJ	MISC	molecular	amod	2	SENT_116	[p8l872t2814r1148b2863],
2	action	NN	O	action	_	0	SENT_116	[p8l1179t2815r1346b2863],
3	of	IN	O	of	_	0	SENT_116	[p8l1382t2814r1436b2863],
4	methotrexate	NN	O	methotrexate	prep_of	2	SENT_116	[p8l1468t2814r1844b2863],
5	in	IN	O	in	_	0	SENT_116	[p8l1879t2815r1924b2862],
6	inflammatory	JJ	O	inflammatory	prep_in	2	SENT_116	[p8l1961t2814r2152b2863, p8l143t2897r340b2955],

1	diseases	NNS	O	disease	_	0	SENT_117	[p8l364t2891r601b2940],
2	.	.	O	.	_	0	SENT_117	[p8l364t2891r601b2940],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_118	[p8l628t2891r839b2940],
2	Res	NNP	O	Res	_	0	SENT_118	[p8l864t2893r949b2940],
3	2002	CD	DATE	2002	num	2	SENT_118	[p8l972t2893r1129b2950],
4	;	:	O	;	_	0	SENT_118	[p8l972t2893r1129b2950],
5	4	CD	NUMBER	4	num	7	SENT_118	[p8l1158t2893r1207b2940],
6	:	:	O	:	_	0	SENT_118	[p8l1158t2893r1207b2940],
7	266-273	CD	NUMBER	266-273	dep	2	SENT_118	[p8l1236t2893r1499b2940],
8	.	.	O	.	_	0	SENT_118	[p8l1236t2893r1499b2940],

1	2	CD	NUMBER	2	num	3	SENT_119	[p8l41t2968r72b3015],
2	Wang	NNP	PERSON	Wang	nn	3	SENT_119	[p8l139t2969r301b3030],
3	Y	NN	PERSON	y	_	0	SENT_119	[p8l323t2969r371b3026],
4	,	,	O	,	_	0	SENT_119	[p8l323t2969r371b3026],
5	Zhao	NNP	PERSON	Zhao	nn	6	SENT_119	[p8l396t2967r537b3015],
6	R	NNP	PERSON	R	appos	3	SENT_119	[p8l562t2969r606b3026],
7	,	,	O	,	_	0	SENT_119	[p8l562t2969r606b3026],
8	Wang	NNP	PERSON	Wang	nn	9	SENT_119	[p8l629t2969r791b3030],
9	Y	NN	PERSON	y	appos	6	SENT_119	[p8l813t2968r861b3026],
10	,	,	O	,	_	0	SENT_119	[p8l813t2968r861b3026],
11	Zhao	NNP	PERSON	Zhao	nn	12	SENT_119	[p8l886t2967r1027b3015],
12	R	NNP	PERSON	R	appos	6	SENT_119	[p8l1052t2969r1096b3026],
13	,	,	O	,	_	0	SENT_119	[p8l1052t2969r1096b3026],
14	Russell	NNP	PERSON	Russell	nn	15	SENT_119	[p8l1124t2967r1299b3015],
15	RC	NNP	O	RC	appos	6	SENT_119	[p8l1326t2968r1417b3026],
16	,	,	O	,	_	0	SENT_119	[p8l1326t2968r1417b3026],
17	Goldman	NNP	ORGANIZATION	Goldman	nn	18	SENT_119	[p8l1443t2967r1699b3015],
18	ID	NNP	ORGANIZATION	ID	appos	6	SENT_119	[p8l1727t2969r1799b3015],
19	.	.	O	.	_	0	SENT_119	[p8l1727t2969r1799b3015],

1	Localization	NN	O	localization	nsubj	9	SENT_120	[p8l1827t2967r2150b3015],
2	of	IN	O	of	_	0	SENT_120	[p8l141t3042r195b3091],
3	the	DT	O	the	det	7	SENT_120	[p8l234t3042r322b3091],
4	murine	JJ	O	murine	amod	7	SENT_120	[p8l367t3044r562b3091],
5	reduced	VBN	O	reduce	amod	7	SENT_120	[p8l607t3042r828b3091],
6	folate	NN	O	folate	nn	7	SENT_120	[p8l871t3042r1026b3091],
7	carrier	NN	O	carrier	prep_of	1	SENT_120	[p8l1069t3044r1244b3091],
8	as	IN	O	as	prep	7	SENT_120	[p8l1284t3057r1336b3091],
9	assessed	VBN	O	assess	_	0	SENT_120	[p8l1379t3042r1606b3091],
10	by	IN	O	by	_	0	SENT_120	[p8l1653t3042r1718b3106],
11	immunohistochemical	JJ	O	immunohistochemical	amod	12	SENT_120	[p8l1761t3042r2152b3091, p8l141t3119r386b3168],
12	analysis	NN	O	analysis	prep_by	9	SENT_120	[p8l414t3119r638b3183],
13	.	.	O	.	_	0	SENT_120	[p8l414t3119r638b3183],

1	Biophys	NNP	O	Biophys	nn	2	SENT_121	[p8l670t3119r871b3183],
2	Acta	NNP	O	Acta	_	0	SENT_121	[p8l893t3121r1012b3168],
3	2001	CD	DATE	2001	num	2	SENT_121	[p8l1036t3120r1193b3178],
4	;	:	DATE	;	_	0	SENT_121	[p8l1036t3120r1193b3178],
5	1513	CD	DATE	1513	num	7	SENT_121	[p8l1226t3120r1380b3168],
6	:	:	O	:	_	0	SENT_121	[p8l1226t3120r1380b3168],
7	49-54	CD	NUMBER	49-54	dep	2	SENT_121	[p8l1407t3120r1599b3168],
8	.	.	O	.	_	0	SENT_121	[p8l1407t3120r1599b3168],

1	3	CD	NUMBER	3	num	3	SENT_122	[p8l44t3196r71b3243],
2	Trippett	NN	ORGANIZATION	trippett	nn	3	SENT_122	[p8l139t3196r364b3259],
3	TM	NN	ORGANIZATION	tm	_	0	SENT_122	[p8l389t3197r498b3254],
4	,	,	O	,	_	0	SENT_122	[p8l389t3197r498b3254],
5	Bertino	NNP	PERSON	Bertino	nn	6	SENT_122	[p8l533t3196r728b3243],
6	JR.	NNP	O	JR.	appos	3	SENT_122	[p8l756t3197r821b3255],
7	.	.	O	.	_	0	SENT_122	[p8l756t3197r821b3255],

1	Therapeutic	JJ	O	therapeutic	amod	2	SENT_123	[p8l852t3195r1185b3259],
2	strategies	NNS	O	strategy	_	0	SENT_123	[p8l1213t3196r1476b3258],
3	targeting	VBG	O	target	partmod	2	SENT_123	[p8l1504t3196r1758b3258],
4	proteins	NNS	O	protein	dobj	3	SENT_123	[p8l1791t3196r2014b3259],
5	that	WDT	O	that	nsubj	9	SENT_123	[p8l2042t3195r2154b3243],
6	regulate	VBP	O	regulate	rcmod	4	SENT_123	[p8l143t3270r368b3334],
7	folate	NN	O	folate	dobj	6	SENT_123	[p8l401t3270r557b3319],
8	and	CC	O	and	_	0	SENT_123	[p8l593t3270r694b3319],
9	reduced	VBD	O	reduce	rcmod	4	SENT_123	[p8l734t3270r956b3319],
10	folate	NN	O	folate	nn	11	SENT_123	[p8l992t3270r1147b3319],
11	transport	NN	O	transport	dobj	9	SENT_123	[p8l1182t3276r1451b3334],
12	.	.	O	.	_	0	SENT_123	[p8l1182t3276r1451b3334],

1	/	:	O	/	punct	2	SENT_124	[p8l1486t3273r1507b3330],
2	Chemother	NNP	O	Chemother	_	0	SENT_124	[p8l1543t3270r1839b3319],
3	1999	CD	DATE	1999	dep	2	SENT_124	[p8l1871t3272r2025b3329],
4	;	:	O	;	_	0	SENT_124	[p8l1871t3272r2025b3329],
5	11	CD	NUMBER	11	dep	2	SENT_124	[p8l2068t3272r2150b3319],
6	:	:	O	:	_	0	SENT_124	[p8l2068t3272r2150b3319],
7	3-10	CD	NUMBER	3-10	dep	5	SENT_124	[p8l144t3348r294b3394],
8	.	.	O	.	_	0	SENT_124	[p8l144t3348r294b3394],

1	Reduced	VBN	O	reduce	_	0	SENT_125	[p9l9t2305r209b2350],
2	folate	JJ	O	folate	amod	5	SENT_125	[p9l227t2305r370b2350],
3	carrier-1	NN	O	carrier-1	nn	5	SENT_125	[p9l388t2305r587b2350],
4	M	NN	O	m	nn	5	SENT_125	[p9l10t2378r46b2417],
5	Drozdzik	NNP	O	Drozdzik	tmod	1	SENT_125	[p9l69t2376r247b2418],
6	et	FW	O	et	nn	7	SENT_125	[p9l265t2381r301b2418],
7	al	FW	O	al	dep	5	SENT_125	[p9l318t2376r355b2418],

1	Drori	NNP	PERSON	Drori	nn	2	SENT_126	[p9l144t22r278b70],
2	S	NNP	O	S	_	0	SENT_126	[p9l317t23r359b80],
3	,	,	O	,	_	0	SENT_126	[p9l317t23r359b80],
4	Sprecher	NNP	PERSON	Sprecher	nn	5	SENT_126	[p9l400t21r645b85],
5	H	NNP	O	H	appos	2	SENT_126	[p9l681t23r734b80],
6	,	,	O	,	_	0	SENT_126	[p9l681t23r734b80],
7	Shemer	NNP	PERSON	Shemer	nn	8	SENT_126	[p9l774t21r986b70],
8	G	NNP	PERSON	G	appos	5	SENT_126	[p9l1019t23r1076b80],
9	,	,	O	,	_	0	SENT_126	[p9l1019t23r1076b80],
10	Jansen	NNP	PERSON	Jansen	nn	11	SENT_126	[p9l1114t23r1290b81],
11	G	NNP	PERSON	G	appos	5	SENT_126	[p9l1328t23r1385b80],
12	,	,	O	,	_	0	SENT_126	[p9l1328t23r1385b80],
13	Goldman	NNP	ORGANIZATION	Goldman	nn	14	SENT_126	[p9l1424t21r1681b70],
14	ID	NNP	ORGANIZATION	ID	appos	5	SENT_126	[p9l1722t23r1794b80],
15	,	,	O	,	_	0	SENT_126	[p9l1722t23r1794b80],
16	Assaraf	NNP	PERSON	Assaraf	nn	17	SENT_126	[p9l1830t21r2024b70],
17	YG	NNP	O	YG	appos	5	SENT_126	[p9l2054t23r2149b70],
18	.	.	O	.	_	0	SENT_126	[p9l2054t23r2149b70],

1	Characterization	NN	O	characterization	nsubj	7	SENT_127	[p9l142t97r597b145],
2	of	IN	O	of	_	0	SENT_127	[p9l635t97r690b145],
3	a	DT	O	a	det	4	SENT_127	[p9l723t111r750b145],
4	human	JJ	O	human	prep_of	1	SENT_127	[p9l789t97r981b145],
5	alternatively	RB	O	alternatively	advmod	6	SENT_127	[p9l1020t97r1359b161],
6	spliced	VBN	O	splice	partmod	4	SENT_127	[p9l1393t97r1581b161],
7	truncated	VBN	O	truncate	_	0	SENT_127	[p9l1620t97r1887b145],
8	reduced	VBN	O	reduce	amod	10	SENT_127	[p9l1929t97r2150b145],
9	folate	JJ	O	folate	amod	10	SENT_127	[p9l139t172r294b221],
10	carrier	NN	O	carrier	dobj	7	SENT_127	[p9l321t174r496b221],
11	increasing	VBG	O	increase	partmod	10	SENT_127	[p9l523t174r800b236],
12	folate	NN	O	folate	nn	13	SENT_127	[p9l827t172r982b221],
13	accumulation	NN	O	accumulation	dobj	11	SENT_127	[p9l1009t172r1384b221],
14	in	IN	O	in	_	0	SENT_127	[p9l1416t174r1461b220],
15	parental	JJ	O	parental	amod	17	SENT_127	[p9l1492t172r1715b236],
16	leukemia	NN	O	leukemia	nn	17	SENT_127	[p9l1746t172r1991b221],
17	cells	NNS	O	cell	prep_in	13	SENT_127	[p9l2019t172r2149b221],
18	.	.	O	.	_	0	SENT_127	[p9l2019t172r2149b221],

1	Eur	NNP	MISC	Eur	nn	3	SENT_128	[p9l144t251r265b309],
2	]	NNP	O	]	nn	3	SENT_128	[p9l144t251r265b309],
3	Biochem	NNP	O	Biochem	_	0	SENT_128	[p9l289t249r510b298],
4	2000	CD	DATE	2000	num	3	SENT_128	[p9l534t250r691b308],
5	;	:	O	;	_	0	SENT_128	[p9l534t250r691b308],
6	267	CD	NUMBER	267	num	8	SENT_128	[p9l721t251r842b298],
7	:	:	O	:	_	0	SENT_128	[p9l721t251r842b298],
8	690-702	CD	NUMBER	690-702	dep	3	SENT_128	[p9l871t250r1134b298],
9	.	.	O	.	_	0	SENT_128	[p9l871t250r1134b298],

1	Tolner	NN	O	tolner	nn	2	SENT_129	[p9l139t326r319b374],
2	B	NN	O	b	_	0	SENT_129	[p9l349t328r393b384],
3	,	,	O	,	_	0	SENT_129	[p9l349t328r393b384],
4	Roy	NNP	PERSON	Roy	nn	5	SENT_129	[p9l430t328r528b389],
5	K	NNP	PERSON	K	appos	2	SENT_129	[p9l559t327r605b384],
6	,	,	O	,	_	0	SENT_129	[p9l559t327r605b384],
7	Sirotnak	NNP	O	Sirotnak	nn	8	SENT_129	[p9l640t326r865b374],
8	FM	NNP	O	FM	appos	5	SENT_129	[p9l896t328r994b374],
9	.	.	O	.	_	0	SENT_129	[p9l896t328r994b374],

1	Structural	JJ	MISC	structural	amod	2	SENT_130	[p9l1029t326r1293b374],
2	analysis	NN	O	analysis	nsubj	17	SENT_130	[p9l1326t326r1535b389],
3	of	IN	O	of	_	0	SENT_130	[p9l1564t326r1618b374],
4	the	DT	O	the	det	7	SENT_130	[p9l1644t326r1732b374],
5	human	JJ	O	human	amod	7	SENT_130	[p9l1765t326r1957b374],
6	RFC-1	NN	MISC	rfc-1	nn	7	SENT_130	[p9l1992t327r2140b374],
7	gene	NN	O	gene	prep_of	2	SENT_130	[p9l141t416r277b465],
8	encoding	VBG	O	encode	partmod	7	SENT_130	[p9l318t401r577b465],
9	a	DT	O	a	det	11	SENT_130	[p9l620t416r646b450],
10	folate	NN	O	folate	nn	11	SENT_130	[p9l685t401r840b450],
11	transporter	NN	O	transporter	dobj	8	SENT_130	[p9l879t407r1190b465],
12	reveals	VBZ	O	reveal	_	0	SENT_130	[p9l1229t401r1414b450],
13	multiple	JJ	O	multiple	amod	14	SENT_130	[p9l1456t401r1681b465],
14	promoters	NNS	O	promoter	dobj	12	SENT_130	[p9l1724t407r2010b465],
15	and	CC	O	and	_	0	SENT_130	[p9l2050t401r2150b450],
16	alternatively	RB	O	alternatively	advmod	12	SENT_130	[p9l141t477r481b541],
17	spliced	VBN	O	splice	conj_and	12	SENT_130	[p9l506t477r694b541],
18	transcripts	NNS	O	transcript	dobj	17	SENT_130	[p9l723t479r1011b541],
19	with	IN	O	with	_	0	SENT_130	[p9l1036t477r1156b526],
20	5	CD	NUMBER	5	number	21	SENT_130	[p9l1186t476r1233b526],
21	’	CD	NUMBER	’	num	23	SENT_130	[p9l1186t476r1233b526],
22	end	NN	O	end	nn	23	SENT_130	[p9l1262t477r1364b526],
23	heterogeneity	NN	O	heterogeneity	prep_with	17	SENT_130	[p9l1396t477r1799b541],
24	.	.	O	.	_	0	SENT_130	[p9l1396t477r1799b541],

1	Gene	NN	O	gene	_	0	SENT_131	[p9l1833t479r1968b526],
2	1998	CD	DATE	1998	num	1	SENT_131	[p9l1995t479r2149b536],
3	;	:	O	;	_	0	SENT_131	[p9l1995t479r2149b536],
4	211	CD	NUMBER	211	num	6	SENT_131	[p9l141t556r263b602],
5	:	:	O	:	_	0	SENT_131	[p9l141t556r263b602],
6	331-341	CD	NUMBER	331-341	dep	1	SENT_131	[p9l294t556r555b602],
7	.	.	O	.	_	0	SENT_131	[p9l294t556r555b602],

1	Dervieux	JJ	ORGANIZATION	dervieux	amod	2	SENT_132	[p9l144t631r389b678],
2	T	NN	ORGANIZATION	t	_	0	SENT_132	[p9l427t632r475b689],
3	,	,	O	,	_	0	SENT_132	[p9l427t632r475b689],
4	Furst	NN	ORGANIZATION	furst	nn	5	SENT_132	[p9l523t632r654b678],
5	D	NN	ORGANIZATION	d	appos	2	SENT_132	[p9l696t632r751b689],
6	,	,	O	,	_	0	SENT_132	[p9l696t632r751b689],
7	Lein	NNP	PERSON	Lein	nn	8	SENT_132	[p9l798t631r905b678],
8	DO	NNP	O	DO	appos	2	SENT_132	[p9l951t631r1057b689],
9	,	,	O	,	_	0	SENT_132	[p9l951t631r1057b689],
10	Capps	NNP	PERSON	Capps	nn	11	SENT_132	[p9l1102t631r1274b694],
11	R	NNP	PERSON	R	appos	2	SENT_132	[p9l1317t632r1361b689],
12	,	,	O	,	_	0	SENT_132	[p9l1317t632r1361b689],
13	Smith	NNP	PERSON	Smith	nn	14	SENT_132	[p9l1407t630r1564b678],
14	K	NNP	O	K	appos	2	SENT_132	[p9l1611t632r1656b689],
15	,	,	O	,	_	0	SENT_132	[p9l1611t632r1656b689],
16	Walsh	NNP	PERSON	Walsh	nn	17	SENT_132	[p9l1698t630r1863b678],
17	M	NNP	O	M	appos	2	SENT_132	[p9l1909t632r1958b678],
18	et	FW	O	et	nn	19	SENT_132	[p9l2004t635r2053b678],
19	al.	FW	O	al.	dep	17	SENT_132	[p9l2091t630r2149b678],
20	.	.	O	.	_	0	SENT_132	[p9l2091t630r2149b678],

1	Polyglutamation	NN	O	polyglutamation	nsubjpass	21	SENT_133	[p9l144t706r598b770],
2	of	IN	O	of	_	0	SENT_133	[p9l646t706r700b755],
3	methotrexate	NN	O	methotrexate	prep_of	1	SENT_133	[p9l744t706r1120b755],
4	with	IN	O	with	_	0	SENT_133	[p9l1163t706r1283b755],
5	common	JJ	O	common	amod	6	SENT_133	[p9l1331t721r1580b755],
6	polymorphisms	NNS	O	polymorphism	prep_with	3	SENT_133	[p9l1630t706r2058b770],
7	in	IN	O	in	_	0	SENT_133	[p9l2105t708r2150b754],
8	reduced	VBN	O	reduce	amod	15	SENT_133	[p9l143t782r365b831],
9	folate	NN	O	folate	nn	15	SENT_133	[p9l410t782r565b831],
10	carrier	NN	O	carrier	nn	15	SENT_133	[p9l612t783r798b841],
11	,	,	O	,	_	0	SENT_133	[p9l612t783r798b841],
12	aminoimidazole	NN	O	aminoimidazole	dep	15	SENT_133	[p9l848t782r1293b831],
13	carboxamide	NN	O	carboxamide	nn	15	SENT_133	[p9l1339t782r1701b831],
14	ribonucleotide	NN	O	ribonucleotide	nn	15	SENT_133	[p9l1749t782r2152b831],
15	transformylase	NN	O	transformylase	prep_in	6	SENT_133	[p9l140t859r562b922],
16	,	,	O	,	_	0	SENT_133	[p9l140t859r562b922],
17	and	CC	O	and	_	0	SENT_133	[p9l636t859r737b907],
18	thymidylate	NN	O	thymidylate	nn	19	SENT_133	[p9l810t859r1142b922],
19	synthase	NN	O	synthase	prep_in	6	SENT_133	[p9l1213t859r1451b922],
20	are	VBP	O	be	auxpass	21	SENT_133	[p9l1523t873r1605b907],
21	associated	VBN	O	associate	_	0	SENT_133	[p9l1676t859r1958b907],
22	with	IN	O	with	_	0	SENT_133	[p9l2030t859r2150b907],
23	methotrexate	NN	O	methotrexate	nn	24	SENT_133	[p9l143t935r520b984],
24	effects	NNS	O	effect	prep_with	21	SENT_133	[p9l547t935r723b984],
25	in	IN	O	in	_	0	SENT_133	[p9l751t936r796b983],
26	rheumatoid	JJ	O	rheumatoid	amod	27	SENT_133	[p9l828t935r1149b984],
27	arthritis	NN	O	arthritis	prep_in	24	SENT_133	[p9l1178t935r1402b984],
28	.	.	O	.	_	0	SENT_133	[p9l1178t935r1402b984],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_134	[p9l1431t935r1642b984],
2	Rheum	NNP	O	Rheum	_	0	SENT_134	[p9l1669t935r1851b984],
3	2004	CD	DATE	2004	num	2	SENT_134	[p9l1877t936r2034b994],
4	;	:	O	;	_	0	SENT_134	[p9l1877t936r2034b994],
5	50	CD	NUMBER	50	num	7	SENT_134	[p9l2064t936r2150b984],
6	:	:	O	:	_	0	SENT_134	[p9l2064t936r2150b984],
7	2766-2774	CD	DATE	2766-2774	dep	2	SENT_134	[p9l141t1013r478b1059],
8	.	.	O	.	_	0	SENT_134	[p9l141t1013r478b1059],

1	Dervieux	JJ	ORGANIZATION	dervieux	amod	2	SENT_135	[p9l144t1089r389b1137],
2	T	NN	ORGANIZATION	t	_	0	SENT_135	[p9l425t1090r473b1147],
3	,	,	O	,	_	0	SENT_135	[p9l425t1090r473b1147],
4	Furst	NN	ORGANIZATION	furst	nn	5	SENT_135	[p9l518t1090r649b1137],
5	D	NN	ORGANIZATION	d	appos	2	SENT_135	[p9l689t1090r744b1147],
6	,	,	O	,	_	0	SENT_135	[p9l689t1090r744b1147],
7	Lein	NNP	PERSON	Lein	nn	8	SENT_135	[p9l788t1089r895b1137],
8	DO	NNP	O	DO	appos	2	SENT_135	[p9l939t1089r1044b1147],
9	,	,	O	,	_	0	SENT_135	[p9l939t1089r1044b1147],
10	Capps	NNP	PERSON	Capps	nn	11	SENT_135	[p9l1087t1089r1259b1152],
11	R	NNP	PERSON	R	appos	2	SENT_135	[p9l1301t1090r1344b1147],
12	,	,	O	,	_	0	SENT_135	[p9l1301t1090r1344b1147],
13	Smith	NNP	PERSON	Smith	nn	14	SENT_135	[p9l1387t1088r1544b1137],
14	K	NNP	O	K	appos	2	SENT_135	[p9l1588t1090r1634b1147],
15	,	,	O	,	_	0	SENT_135	[p9l1588t1090r1634b1147],
16	Caldwell	NNP	PERSON	Caldwell	nn	17	SENT_135	[p9l1677t1088r1912b1137],
17	J	NNP	O	J	appos	2	SENT_135	[p9l1952t1090r1963b1148],
18	et	FW	O	et	nn	19	SENT_135	[p9l2006t1094r2055b1137],
19	al.	FW	O	al.	dep	17	SENT_135	[p9l2091t1088r2149b1137],
20	.	.	O	.	_	0	SENT_135	[p9l2091t1088r2149b1137],

1	Pharmacogenetic	JJ	PERSON	pharmacogenetic	amod	4	SENT_136	[p9l144t1164r629b1227],
2	and	CC	O	and	_	0	SENT_136	[p9l666t1164r767b1212],
3	metabolite	NN	O	metabolite	conj_and	1	SENT_136	[p9l809t1164r1107b1212],
4	measurements	NNS	O	measurement	nsubjpass	6	SENT_136	[p9l1147t1169r1551b1212],
5	are	VBP	O	be	auxpass	6	SENT_136	[p9l1590t1178r1672b1212],
6	associated	VBN	O	associate	_	0	SENT_136	[p9l1710t1164r1992b1212],
7	with	IN	O	with	_	0	SENT_136	[p9l2030t1164r2150b1212],
8	clinical	JJ	O	clinical	amod	9	SENT_136	[p9l141t1239r326b1288],
9	status	NN	O	status	prep_with	6	SENT_136	[p9l382t1245r540b1288],
10	in	IN	O	in	_	0	SENT_136	[p9l595t1241r640b1287],
11	patients	NNS	O	patient	prep_in	6	SENT_136	[p9l697t1241r914b1303],
12	with	IN	O	with	_	0	SENT_136	[p9l966t1239r1086b1288],
13	rheumatoid	JJ	O	rheumatoid	amod	14	SENT_136	[p9l1144t1239r1464b1288],
14	arthritis	NN	O	arthritis	prep_with	6	SENT_136	[p9l1520t1239r1728b1288],
15	treated	VBN	O	treat	partmod	14	SENT_136	[p9l1781t1239r1976b1288],
16	with	IN	O	with	_	0	SENT_136	[p9l2030t1239r2150b1288],
17	methotrexate	NN	O	methotrexate	prep_with	15	SENT_136	[p9l143t1316r535b1364],
18	:	:	O	:	_	0	SENT_136	[p9l143t1316r535b1364],
19	results	NNS	O	result	nn	26	SENT_136	[p9l577t1316r749b1364],
20	of	IN	O	of	_	0	SENT_136	[p9l785t1316r839b1364],
21	a	DT	O	a	det	23	SENT_136	[p9l873t1330r900b1364],
22	multicentred	JJ	O	multicentred	amod	23	SENT_136	[p9l939t1316r1293b1364],
23	cross	NN	O	cross	prep_of	19	SENT_136	[p9l1331t1330r1465b1364],
24	sectional	JJ	O	sectional	amod	25	SENT_136	[p9l1501t1316r1741b1364],
25	observational	JJ	O	observational	amod	26	SENT_136	[p9l1781t1316r2150b1364],
26	study	NN	O	study	dobj	6	SENT_136	[p9l141t1392r306b1455],
27	.	.	O	.	_	0	SENT_136	[p9l141t1392r306b1455],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_137	[p9l333t1394r440b1440],
2	Rheum	NNP	PERSON	Rheum	nn	3	SENT_137	[p9l466t1392r647b1440],
3	Dis	NNP	O	Dis	_	0	SENT_137	[p9l674t1393r754b1440],
4	2005	CD	DATE	2005	num	3	SENT_137	[p9l777t1393r934b1450],
5	;	:	O	;	_	0	SENT_137	[p9l777t1393r934b1450],
6	64	CD	NUMBER	64	num	8	SENT_137	[p9l962t1393r1048b1440],
7	:	:	O	:	_	0	SENT_137	[p9l962t1393r1048b1440],
8	1180-1185	CD	DATE	1180-1185	dep	3	SENT_137	[p9l1080t1393r1413b1440],
9	.	.	O	.	_	0	SENT_137	[p9l1080t1393r1413b1440],

1	Laverdiere	NNP	PERSON	Laverdiere	nn	2	SENT_138	[p9l144t1468r426b1516],
2	C	NNP	O	C	_	0	SENT_138	[p9l480t1469r535b1527],
3	,	,	O	,	_	0	SENT_138	[p9l480t1469r535b1527],
4	Chiasson	NNP	PERSON	Chiasson	nn	5	SENT_138	[p9l593t1468r837b1516],
5	S	NNP	O	S	appos	2	SENT_138	[p9l894t1469r937b1527],
6	,	,	O	,	_	0	SENT_138	[p9l894t1469r937b1527],
7	Costea	NNP	O	Costea	nn	11	SENT_138	[p9l995t1469r1181b1516],
8	I	PRP	O	I	dep	11	SENT_138	[p9l1238t1470r1263b1527],
9	,	,	O	,	_	0	SENT_138	[p9l1238t1470r1263b1527],
10	Moghrabi	NNP	PERSON	Moghrabi	dep	11	SENT_138	[p9l1323t1468r1593b1531],
11	A	NNP	O	A	appos	2	SENT_138	[p9l1646t1470r1698b1527],
12	,	,	O	,	_	0	SENT_138	[p9l1646t1470r1698b1527],
13	Krajinovic	NNP	O	Krajinovic	nn	16	SENT_138	[p9l1758t1469r2025b1531],
14	M.	NNP	O	M.	nn	16	SENT_138	[p9l2081t1470r2149b1516],
15	Polymorphism	NN	O	polymorphism	nn	16	SENT_138	[p9l144t1543r542b1607],
16	G80A	NN	O	g80a	appos	2	SENT_138	[p9l597t1545r754b1592],
17	in	IN	O	in	_	0	SENT_138	[p9l806t1545r850b1591],
18	the	DT	O	the	det	22	SENT_138	[p9l903t1543r992b1592],
19	reduced	VBN	O	reduce	amod	22	SENT_138	[p9l1046t1543r1268b1592],
20	folate	NN	O	folate	nn	22	SENT_138	[p9l1319t1543r1474b1592],
21	carrier	NN	O	carrier	nn	22	SENT_138	[p9l1527t1545r1702b1592],
22	gene	NN	O	gene	prep_in	16	SENT_138	[p9l1751t1558r1887b1607],
23	and	CC	O	and	_	0	SENT_138	[p9l1940t1543r2041b1592],
24	its	PRP$	O	its	poss	25	SENT_138	[p9l2096t1545r2152b1592],
25	relationship	NN	O	relationship	prep_in	16	SENT_138	[p9l143t1620r466b1684],
26	to	TO	O	to	_	0	SENT_138	[p9l494t1626r548b1669],
27	methotrexate	NN	O	methotrexate	nn	29	SENT_138	[p9l579t1620r955b1669],
28	plasma	NN	O	plasma	nn	29	SENT_138	[p9l986t1620r1178b1684],
29	levels	NNS	O	level	prep_to	25	SENT_138	[p9l1210t1620r1355b1669],
30	and	CC	O	and	_	0	SENT_138	[p9l1384t1620r1485b1669],
31	outcome	NN	O	outcome	conj_and	22	SENT_138	[p9l1515t1626r1763b1669],
32	of	IN	O	of	_	0	SENT_138	[p9l1792t1620r1846b1669],
33	childhood	NN	O	childhood	nn	36	SENT_138	[p9l1872t1620r2150b1669],
34	acute	JJ	O	acute	amod	36	SENT_138	[p9l141t1701r291b1744],
35	lymphoblastic	JJ	O	lymphoblastic	amod	36	SENT_138	[p9l319t1696r707b1760],
36	leukemia	NN	O	leukemia	prep_of	31	SENT_138	[p9l735t1696r996b1744],
37	.	.	O	.	_	0	SENT_138	[p9l735t1696r996b1744],

1	Blood	NN	O	blood	_	0	SENT_139	[p9l1027t1696r1176b1744],
2	2002	CD	DATE	2002	num	1	SENT_139	[p9l1196t1697r1353b1754],
3	;	:	O	;	_	0	SENT_139	[p9l1196t1697r1353b1754],
4	100	CD	NUMBER	100	num	6	SENT_139	[p9l1386t1697r1504b1744],
5	:	:	O	:	_	0	SENT_139	[p9l1386t1697r1504b1744],
6	3832-3834	CD	DURATION	3832-3834	dep	1	SENT_139	[p9l1536t1697r1869b1744],
7	.	.	O	.	_	0	SENT_139	[p9l1536t1697r1869b1744],

1	Warren	NNP	PERSON	Warren	nn	2	SENT_140	[p9l139t1773r340b1820],
2	MD	NNP	PERSON	MD	_	0	SENT_140	[p9l379t1774r493b1830],
3	,	,	O	,	_	0	SENT_140	[p9l379t1774r493b1830],
4	Nichols	NNP	ORGANIZATION	Nichols	nn	5	SENT_140	[p9l532t1771r735b1820],
5	AP	NNP	ORGANIZATION	AP	appos	2	SENT_140	[p9l766t1774r853b1830],
6	,	,	O	,	_	0	SENT_140	[p9l766t1774r853b1830],
7	Bender	NNP	PERSON	Bender	nn	8	SENT_140	[p9l893t1771r1087b1820],
8	RA	NN	O	ra	appos	5	SENT_140	[p9l1121t1774r1204b1820],
9	.	.	O	.	_	0	SENT_140	[p9l1121t1774r1204b1820],

1	Membrane	NN	O	membrane	nn	2	SENT_141	[p9l1243t1771r1546b1820],
2	transport	NN	O	transport	_	0	SENT_141	[p9l1579t1777r1834b1835],
3	of	IN	O	of	_	0	SENT_141	[p9l1865t1771r1919b1820],
4	methotrexate	NN	O	methotrexate	prep_of	2	SENT_141	[p9l1952t1771r2152b1820, p9l140t1854r333b1897],
5	in	IN	O	in	_	0	SENT_141	[p9l360t1849r405b1896],
6	human	JJ	O	human	amod	8	SENT_141	[p9l434t1848r626b1897],
7	lymphoblastoid	JJ	O	lymphoblastoid	amod	8	SENT_141	[p9l655t1848r1085b1912],
8	cells	NNS	O	cell	prep_in	2	SENT_141	[p9l1113t1848r1242b1897],
9	.	.	O	.	_	0	SENT_141	[p9l1113t1848r1242b1897],

1	Cancer	NNP	O	Cancer	nn	2	SENT_142	[p9l1274t1850r1461b1897],
2	Res	NNP	O	Res	_	0	SENT_142	[p9l1480t1850r1565b1897],
3	1978	CD	DATE	1978	num	2	SENT_142	[p9l1591t1849r1745b1907],
4	;	:	O	;	_	0	SENT_142	[p9l1591t1849r1745b1907],
5	38	CD	NUMBER	38	num	7	SENT_142	[p9l1775t1849r1858b1897],
6	:	:	O	:	_	0	SENT_142	[p9l1775t1849r1858b1897],
7	668-671	CD	NUMBER	668-671	dep	2	SENT_142	[p9l1887t1849r2150b1897],
8	.	.	O	.	_	0	SENT_142	[p9l1887t1849r2150b1897],

1	Shaw	NNP	ORGANIZATION	Shaw	nn	2	SENT_143	[p9l147t1924r296b1973],
2	GM	NNP	ORGANIZATION	GM	_	0	SENT_143	[p9l321t1926r437b1983],
3	,	,	O	,	_	0	SENT_143	[p9l321t1926r437b1983],
4	Lammer	NNP	PERSON	Lammer	nn	6	SENT_143	[p9l470t1926r697b1973],
5	E	NNP	O	E	nn	6	SENT_143	[p9l723t1926r780b1984],
6	]	NN	O	]	appos	2	SENT_143	[p9l723t1926r780b1984],
7	,	,	O	,	_	0	SENT_143	[p9l723t1926r780b1984],
8	Zhu	NNP	PERSON	Zhu	nn	9	SENT_143	[p9l810t1924r916b1973],
9	H	NNP	O	H	appos	6	SENT_143	[p9l947t1926r1001b1983],
10	,	,	O	,	_	0	SENT_143	[p9l947t1926r1001b1983],
11	Baker	NNP	PERSON	Baker	nn	12	SENT_143	[p9l1033t1924r1182b1973],
12	MW	NNP	O	MW	appos	6	SENT_143	[p9l1208t1926r1335b1983],
13	,	,	O	,	_	0	SENT_143	[p9l1208t1926r1335b1983],
14	Neri	NNP	PERSON	Neri	nn	15	SENT_143	[p9l1367t1925r1478b1973],
15	E	NNP	O	E	appos	6	SENT_143	[p9l1509t1926r1548b1983],
16	,	,	O	,	_	0	SENT_143	[p9l1509t1926r1548b1983],
17	Finnell	NNP	PERSON	Finnell	nn	18	SENT_143	[p9l1581t1924r1755b1973],
18	RH	NNP	O	RH	appos	6	SENT_143	[p9l1786t1926r1875b1973],
19	.	.	O	.	_	0	SENT_143	[p9l1786t1926r1875b1973],

1	Maternal	JJ	O	maternal	amod	4	SENT_144	[p9l1907t1924r2150b1973],
2	periconceptional	JJ	O	periconceptional	amod	4	SENT_144	[p9l148t2001r612b2065],
3	vitamin	NN	O	vitamin	nn	4	SENT_144	[p9l636t2002r843b2049],
4	use	NN	O	use	nsubj	10	SENT_144	[p9l870t2015r973b2060],
5	,	,	O	,	_	0	SENT_144	[p9l870t2015r973b2060],
6	genetic	JJ	O	genetic	amod	7	SENT_144	[p9l1000t2002r1206b2064],
7	variation	NN	O	variation	appos	4	SENT_144	[p9l1227t2002r1466b2049],
8	of	IN	O	of	_	0	SENT_144	[p9l1492t2001r1546b2049],
9	infant	NN	O	infant	prep_of	7	SENT_144	[p9l1568t2001r1727b2049],
10	reduced	VBD	O	reduce	_	0	SENT_144	[p9l1751t2001r1973b2049],
11	folate	JJ	O	folate	amod	12	SENT_144	[p9l1997t2001r2152b2049],
12	carrier	NN	O	carrier	iobj	10	SENT_144	[p9l146t2078r321b2125],
13	(	CD	NUMBER	(	num	15	SENT_144	[p9l341t2077r556b2137],
14	A80G	NN	O	a80g	nn	15	SENT_144	[p9l341t2077r556b2137],
15	)	NN	O	)	dobj	10	SENT_144	[p9l341t2077r556b2137],
16	,	,	O	,	_	0	SENT_144	[p9l341t2077r556b2137],
17	and	CC	O	and	_	0	SENT_144	[p9l581t2076r682b2125],
18	risk	NN	O	risk	dobj	10	SENT_144	[p9l709t2076r796b2125],
19	of	IN	O	of	_	0	SENT_144	[p9l816t2076r870b2125],
20	spina	NN	O	spina	nn	21	SENT_144	[p9l888t2078r1031b2140],
21	bifida	NN	O	bifida	prep_of	18	SENT_144	[p9l1056t2076r1222b2125],
22	.	.	O	.	_	0	SENT_144	[p9l1056t2076r1222b2125],

1	Am	VBP	O	be	dep	4	SENT_145	[p9l1246t2079r1371b2136],
2	]	CD	NUMBER	]	num	4	SENT_145	[p9l1246t2079r1371b2136],
3	Med	NNP	O	Med	nn	4	SENT_145	[p9l1390t2076r1509b2125],
4	Genet	NNP	O	Genet	_	0	SENT_145	[p9l1530t2078r1687b2125],
5	2002	CD	DATE	2002	num	4	SENT_145	[p9l1704t2078r1862b2135],
6	;	:	O	;	_	0	SENT_145	[p9l1704t2078r1862b2135],
7	108	CD	NUMBER	108	dep	4	SENT_145	[p9l1890t2078r2008b2125],
8	:	:	O	:	_	0	SENT_145	[p9l1890t2078r2008b2125],
9	1-6	CD	NUMBER	1-6	dep	7	SENT_145	[p9l2036t2078r2150b2125],
10	.	.	O	.	_	0	SENT_145	[p9l2036t2078r2150b2125],

1	Ding	VBG	O	ding	_	0	SENT_146	[p9l148t2674r277b2736],
2	BC	NNP	O	BC	dobj	1	SENT_146	[p9l303t2674r391b2731],
3	,	,	O	,	_	0	SENT_146	[p9l303t2674r391b2731],
4	Ding	NNP	O	Ding	nn	5	SENT_146	[p9l419t2674r547b2736],
5	BC	NNP	O	BC	appos	2	SENT_146	[p9l573t2674r661b2731],
6	,	,	O	,	_	0	SENT_146	[p9l573t2674r661b2731],
7	Witt	NNP	PERSON	Witt	nn	8	SENT_146	[p9l683t2674r802b2721],
8	TL	NNP	O	TL	appos	2	SENT_146	[p9l819t2675r898b2731],
9	,	,	O	,	_	0	SENT_146	[p9l819t2675r898b2731],
10	Hukku	NNP	PERSON	Hukku	nn	11	SENT_146	[p9l924t2672r1094b2721],
11	B	NNP	PERSON	B	appos	2	SENT_146	[p9l1121t2675r1165b2731],
12	,	,	O	,	_	0	SENT_146	[p9l1121t2675r1165b2731],
13	Heng	NNP	PERSON	Heng	nn	14	SENT_146	[p9l1193t2675r1336b2736],
14	H	NNP	PERSON	H	appos	2	SENT_146	[p9l1363t2675r1416b2731],
15	,	,	O	,	_	0	SENT_146	[p9l1363t2675r1416b2731],
16	Zhang	NNP	PERSON	Zhang	nn	17	SENT_146	[p9l1440t2672r1617b2736],
17	L	NNP	O	L	appos	2	SENT_146	[p9l1643t2675r1668b2720],
18	et	FW	O	et	nn	19	SENT_146	[p9l1690t2678r1738b2721],
19	al.	FW	O	al.	dep	17	SENT_146	[p9l1756t2672r1814b2721],
20	.	.	O	.	_	0	SENT_146	[p9l1756t2672r1814b2721],

1	Association	NNP	O	Association	_	0	SENT_147	[p9l1836t2674r2146b2721],
2	of	IN	O	of	_	0	SENT_147	[p9l145t2749r199b2798],
3	deletions	NNS	O	deletion	prep_of	1	SENT_147	[p9l226t2749r476b2798],
4	and	CC	O	and	_	0	SENT_147	[p9l505t2749r606b2798],
5	translocation	NN	O	translocation	conj_and	3	SENT_147	[p9l636t2749r994b2798],
6	of	IN	O	of	_	0	SENT_147	[p9l1026t2749r1080b2798],
7	the	DT	O	the	det	11	SENT_147	[p9l1106t2749r1194b2798],
8	reduced	VBN	O	reduce	amod	11	SENT_147	[p9l1225t2749r1447b2798],
9	folate	NN	O	folate	nn	11	SENT_147	[p9l1476t2749r1631b2798],
10	carrier	NN	O	carrier	nn	11	SENT_147	[p9l1661t2750r1835b2798],
11	gene	NN	O	gene	prep_of	3	SENT_147	[p9l1862t2763r1998b2813],
12	with	IN	O	with	_	0	SENT_147	[p9l2026t2749r2146b2798],
13	profound	JJ	O	profound	amod	14	SENT_147	[p9l148t2825r402b2888],
14	loss	NN	O	loss	prep_with	1	SENT_147	[p9l456t2825r551b2873],
15	of	IN	O	of	_	0	SENT_147	[p9l600t2825r654b2873],
16	gene	NN	O	gene	nn	17	SENT_147	[p9l700t2839r836b2888],
17	expression	NN	O	expression	prep_of	1	SENT_147	[p9l885t2826r1175b2888],
18	in	IN	O	in	_	0	SENT_147	[p9l1229t2826r1273b2873],
19	methotrexate-resistant	JJ	O	methotrexate-resistant	amod	23	SENT_147	[p9l1327t2825r1957b2873],
20	K562	NN	O	k562	nn	23	SENT_147	[p9l2008t2826r2147b2873],
21	human	JJ	O	human	amod	23	SENT_147	[p9l148t2900r339b2949],
22	erythroleukemia	NN	O	erythroleukemia	nn	23	SENT_147	[p9l367t2900r817b2964],
23	cells	NNS	O	cell	prep_in	1	SENT_147	[p9l845t2900r974b2949],
24	.	.	O	.	_	0	SENT_147	[p9l845t2900r974b2949],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	2	SENT_148	[p9l1006t2900r1226b2949],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_148	[p9l1252t2900r1537b2949],
3	2001	CD	DATE	2001	num	2	SENT_148	[p9l1558t2902r1715b2959],
4	;	:	O	;	_	0	SENT_148	[p9l1558t2902r1715b2959],
5	61	CD	NUMBER	61	num	7	SENT_148	[p9l1743t2902r1828b2949],
6	:	:	O	:	_	0	SENT_148	[p9l1743t2902r1828b2949],
7	665-675	CD	NUMBER	665-675	dep	2	SENT_148	[p9l1859t2902r2120b2949],
8	.	.	O	.	_	0	SENT_148	[p9l1859t2902r2120b2949],

1	Gorlick	NNP	PERSON	Gorlick	nn	2	SENT_149	[p9l146t2976r340b3025],
2	R	NNP	PERSON	R	_	0	SENT_149	[p9l365t2979r409b3035],
3	,	,	O	,	_	0	SENT_149	[p9l365t2979r409b3035],
4	Goker	NNP	O	Goker	nn	5	SENT_149	[p9l436t2976r602b3025],
5	E	NNP	O	E	appos	2	SENT_149	[p9l626t2979r666b3035],
6	,	,	O	,	_	0	SENT_149	[p9l626t2979r666b3035],
7	Trippett	NNP	ORGANIZATION	Trippett	nn	8	SENT_149	[p9l690t2978r915b3040],
8	T	NN	ORGANIZATION	t	appos	2	SENT_149	[p9l934t2979r983b3035],
9	,	,	O	,	_	0	SENT_149	[p9l934t2979r983b3035],
10	Steinherz	NNP	ORGANIZATION	Steinherz	nn	11	SENT_149	[p9l1011t2976r1267b3025],
11	P	NN	ORGANIZATION	p	appos	2	SENT_149	[p9l1292t2979r1335b3035],
12	,	,	O	,	_	0	SENT_149	[p9l1292t2979r1335b3035],
13	Elisseyeff	NNP	O	Elisseyeff	nn	14	SENT_149	[p9l1365t2976r1606b3040],
14	Y	NN	O	y	appos	2	SENT_149	[p9l1625t2978r1672b3035],
15	,	,	O	,	_	0	SENT_149	[p9l1625t2978r1672b3035],
16	Mazumdar	NNP	PERSON	Mazumdar	nn	17	SENT_149	[p9l1702t2976r2003b3025],
17	M	NNP	O	M	appos	2	SENT_149	[p9l2026t2979r2075b3024],
18	et	FW	O	et	nn	19	SENT_149	[p9l2104t2982r2153b3025],
19	al.	FW	O	al.	dep	17	SENT_149	[p9l147t3053r205b3102],
20	.	.	O	.	_	0	SENT_149	[p9l147t3053r205b3102],

1	Defective	JJ	O	defective	amod	2	SENT_150	[p9l245t3053r500b3102],
2	transport	NN	O	transport	nsubjpass	17	SENT_150	[p9l533t3059r788b3117],
3	is	VBZ	O	be	cop	6	SENT_150	[p9l821t3054r855b3102],
4	a	DT	O	a	det	6	SENT_150	[p9l888t3067r915b3102],
5	common	JJ	O	common	amod	6	SENT_150	[p9l949t3067r1198b3102],
6	mechanism	NN	O	mechanism	_	0	SENT_150	[p9l1236t3053r1551b3102],
7	of	IN	O	of	_	0	SENT_150	[p9l1587t3053r1641b3102],
8	acquired	VBN	O	acquire	amod	10	SENT_150	[p9l1671t3053r1909b3117],
9	methotrexate	NN	O	methotrexate	nn	10	SENT_150	[p9l1948t3053r2147b3102, p9l144t3134r337b3177],
10	resistance	NN	O	resistance	prep_of	6	SENT_150	[p9l381t3130r648b3177],
11	in	IN	O	in	_	0	SENT_150	[p9l691t3130r736b3177],
12	acute	JJ	O	acute	amod	14	SENT_150	[p9l779t3134r928b3177],
13	lymphocytic	JJ	O	lymphocytic	amod	14	SENT_150	[p9l972t3129r1313b3193],
14	leukemia	NN	O	leukemia	prep_in	10	SENT_150	[p9l1356t3129r1600b3177],
15	and	CC	O	and	_	0	SENT_150	[p9l1643t3129r1743b3177],
16	is	VBZ	O	be	auxpass	17	SENT_150	[p9l1789t3130r1823b3177],
17	associated	VBN	O	associate	conj_and	6	SENT_150	[p9l1864t3129r2146b3177],
18	with	IN	O	with	_	0	SENT_150	[p9l144t3204r263b3253],
19	decreased	VBN	O	decrease	prep_with	17	SENT_150	[p9l328t3204r604b3253],
20	reduced	VBN	O	reduce	partmod	19	SENT_150	[p9l671t3204r893b3253],
21	folate	JJ	O	folate	amod	23	SENT_150	[p9l955t3204r1110b3253],
22	carrier	NN	O	carrier	nn	23	SENT_150	[p9l1172t3206r1347b3253],
23	expression	NN	O	expression	dobj	20	SENT_150	[p9l1407t3206r1714b3268],
24	.	.	O	.	_	0	SENT_150	[p9l1407t3206r1714b3268],

1	Blood	NN	O	blood	_	0	SENT_151	[p9l1783t3204r1930b3253],
2	1997	CD	DATE	1997	num	1	SENT_151	[p9l1991t3206r2145b3263],
3	;	:	O	;	_	0	SENT_151	[p9l1991t3206r2145b3263],
4	89	CD	NUMBER	89	num	6	SENT_151	[p9l144t3282r230b3329],
5	:	:	O	:	_	0	SENT_151	[p9l144t3282r230b3329],
6	1013-1018	CD	DATE	1013-1018	dep	1	SENT_151	[p9l262t3282r594b3329],
7	.	.	O	.	_	0	SENT_151	[p9l262t3282r594b3329],

1	Rothem	NNP	PERSON	Rothem	nn	2	SENT_152	[p9l148t3357r359b3405],
2	L	NNP	PERSON	L	_	0	SENT_152	[p9l405t3359r444b3415],
3	,	,	O	,	_	0	SENT_152	[p9l405t3359r444b3415],
4	lfergan	NN	O	lfergan	nn	5	SENT_152	[p9l491t3357r678b3420],
5	I	NN	O	i	appos	2	SENT_152	[p9l723t3359r748b3415],
6	,	,	O	,	_	0	SENT_152	[p9l723t3359r748b3415],
7	Kaufman	NNP	PERSON	Kaufman	nn	8	SENT_152	[p9l795t3357r1036b3405],
8	Y	NN	PERSON	y	appos	5	SENT_152	[p9l1077t3358r1124b3416],
9	,	,	O	,	_	0	SENT_152	[p9l1077t3358r1124b3416],
10	Priest	NNP	O	Priest	nn	11	SENT_152	[p9l1171t3358r1317b3405],
11	DG	NNS	O	dg	appos	5	SENT_152	[p9l1358t3358r1460b3416],
12	,	,	O	,	_	0	SENT_152	[p9l1358t3358r1460b3416],
13	Jansen	NNP	PERSON	Jansen	nn	14	SENT_152	[p9l1503t3359r1679b3416],
14	G	NNP	O	G	appos	5	SENT_152	[p9l1722t3358r1779b3415],
15	,	,	O	,	_	0	SENT_152	[p9l1722t3358r1779b3415],
16	Assaraf	NNP	PERSON	Assaraf	nn	17	SENT_152	[p9l1821t3357r2015b3405],
17	YG	NNP	O	YG	appos	5	SENT_152	[p9l2050t3358r2145b3405],
18	.	.	O	.	_	0	SENT_152	[p9l2050t3358r2145b3405],

1	Resistance	NN	O	resistance	nsubjpass	7	SENT_153	[p9l148t3434r427b3481],
2	to	TO	O	to	_	0	SENT_153	[p9l455t3438r510b3481],
3	multiple	JJ	O	multiple	amod	5	SENT_153	[p9l541t3433r766b3497],
4	novel	JJ	O	novel	amod	5	SENT_153	[p9l797t3433r941b3481],
5	antifolates	NNS	O	antifolate	prep_to	1	SENT_153	[p9l971t3433r1255b3481],
6	is	VBZ	O	be	auxpass	7	SENT_153	[p9l1285t3434r1319b3481],
7	mediated	VBN	O	mediate	_	0	SENT_153	[p9l1349t3433r1608b3481],
8	via	IN	O	via	_	0	SENT_153	[p9l1637t3434r1712b3481],
9	defective	JJ	O	defective	amod	11	SENT_153	[p9l1741t3433r1989b3481],
10	drug	NN	O	drug	nn	11	SENT_153	[p9l2018t3433r2146b3496],
11	transport	NN	O	transport	prep_via	7	SENT_153	[p9l144t3514r399b3572],
12	resulting	VBG	O	result	partmod	11	SENT_153	[p9l442t3508r676b3572],
13	from	IN	O	from	_	0	SENT_153	[p9l719t3508r849b3557],
14	clustered	VBN	O	cluster	amod	15	SENT_153	[p9l893t3508r1141b3557],
15	mutations	NNS	O	mutation	prep_from	12	SENT_153	[p9l1188t3510r1464b3557],
16	in	IN	O	in	_	0	SENT_153	[p9l1508t3510r1553b3556],
17	the	DT	O	the	det	21	SENT_153	[p9l1596t3508r1685b3557],
18	reduced	VBN	O	reduce	amod	21	SENT_153	[p9l1730t3508r1950b3557],
19	folate	NN	O	folate	nn	21	SENT_153	[p9l1993t3508r2148b3557],
20	carrier	NN	O	carrier	nn	21	SENT_153	[p9l145t3586r320b3634],
21	gene	NN	O	gene	prep_in	15	SENT_153	[p9l360t3599r496b3649],
22	in	IN	O	in	_	0	SENT_153	[p9l540t3586r584b3633],
23	human	JJ	O	human	amod	26	SENT_153	[p9l631t3585r822b3634],
24	leukaemia	NN	O	leukaemia	nn	26	SENT_153	[p9l869t3585r1145b3634],
25	cell	NN	O	cell	nn	26	SENT_153	[p9l1189t3585r1276b3634],
26	lines	NNS	O	line	prep_in	21	SENT_153	[p9l1323t3585r1456b3634],
27	.	.	O	.	_	0	SENT_153	[p9l1323t3585r1456b3634],

1	Biochem	NNP	LOCATION	Biochem	_	0	SENT_154	[p9l1505t3585r1725b3634],
2	/	:	O	/	punct	3	SENT_154	[p9l1762t3587r1782b3645],
3	2002	CD	DATE	2002	dep	1	SENT_154	[p9l1822t3586r1979b3644],
4	;	:	O	;	_	0	SENT_154	[p9l1822t3586r1979b3644],
5	367	CD	NUMBER	367	num	7	SENT_154	[p9l2025t3587r2145b3634],
6	:	:	O	:	_	0	SENT_154	[p9l2025t3587r2145b3634],
7	741-750	CD	NUMBER	741-750	dep	3	SENT_154	[p9l148t3663r409b3709],
8	.	.	O	.	_	0	SENT_154	[p9l148t3663r409b3709],

1	Wong	NNP	ORGANIZATION	Wong	nn	2	SENT_155	[p10l143t22r310b84],
2	SC	NNP	ORGANIZATION	SC	_	0	SENT_155	[p10l350t22r437b79],
3	,	,	O	,	_	0	SENT_155	[p10l350t22r437b79],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_155	[p10l477t20r655b84],
5	L	NNP	PERSON	L	appos	2	SENT_155	[p10l697t23r735b79],
6	,	,	O	,	_	0	SENT_155	[p10l697t23r735b79],
7	Witt	NNP	PERSON	Witt	nn	8	SENT_155	[p10l773t22r892b69],
8	TL	NNP	O	TL	appos	5	SENT_155	[p10l925t23r1003b79],
9	,	,	O	,	_	0	SENT_155	[p10l925t23r1003b79],
10	Proefke	NNP	ORGANIZATION	Proefke	nn	11	SENT_155	[p10l1047t20r1247b69],
11	SA	NNP	ORGANIZATION	SA	appos	5	SENT_155	[p10l1286t22r1368b79],
12	,	,	O	,	_	0	SENT_155	[p10l1286t22r1368b79],
13	Bhushan	NNP	PERSON	Bhushan	nn	14	SENT_155	[p10l1411t20r1643b69],
14	A	NNP	O	A	appos	5	SENT_155	[p10l1680t23r1733b79],
15	,	,	O	,	_	0	SENT_155	[p10l1680t23r1733b79],
16	Matherly	NNP	PERSON	Matherly	nn	17	SENT_155	[p10l1776t20r2022b84],
17	LH	NNP	O	LH	appos	5	SENT_155	[p10l2061t23r2145b69],
18	.	.	O	.	_	0	SENT_155	[p10l2061t23r2145b69],

1	Impaired	JJ	O	impaired	amod	3	SENT_156	[p10l148t97r390b161],
2	membrane	NN	O	membrane	nn	3	SENT_156	[p10l438t97r739b146],
3	transport	NN	O	transport	nsubj	13	SENT_156	[p10l782t102r1037b161],
4	in	IN	O	in	_	0	SENT_156	[p10l1079t98r1123b145],
5	methotrexate-resistant	JJ	O	methotrexate-resistant	amod	7	SENT_156	[p10l1171t97r1802b146],
6	CCRF-CEM	NN	O	ccrf-cem	nn	7	SENT_156	[p10l1843t98r2145b146],
7	cells	NNS	O	cell	prep_in	3	SENT_156	[p10l145t173r260b221],
8	involves	VBZ	O	involve	_	0	SENT_156	[p10l289t173r506b221],
9	early	JJ	O	early	amod	11	SENT_156	[p10l534t173r664b236],
10	translation	NN	O	translation	nn	11	SENT_156	[p10l690t173r980b221],
11	termination	NN	O	termination	dobj	8	SENT_156	[p10l1009t174r1332b221],
12	and	CC	O	and	_	0	SENT_156	[p10l1362t173r1462b221],
13	increased	VBD	O	increase	conj_and	8	SENT_156	[p10l1493t173r1750b221],
14	turnover	NN	O	turnover	dobj	13	SENT_156	[p10l1779t178r2018b221],
15	of	IN	O	of	_	0	SENT_156	[p10l2042t173r2096b221],
16	a	DT	O	a	det	19	SENT_156	[p10l2120t187r2147b221],
17	mutant	JJ	O	mutant	amod	19	SENT_156	[p10l148t253r350b296],
18	reduced	VBN	O	reduce	amod	19	SENT_156	[p10l376t248r598b296],
19	folate	NN	O	folate	prep_of	14	SENT_156	[p10l623t248r778b296],
20	carrier	NN	O	carrier	dobj	8	SENT_156	[p10l803t249r991b296],
21	.	.	O	.	_	0	SENT_156	[p10l803t249r991b296],

1	/	:	O	/	punct	3	SENT_157	[p10l1016t250r1037b307],
2	Biol	NNP	O	Biol	nn	3	SENT_157	[p10l1061t248r1155b296],
3	Chem	NNP	O	Chem	_	0	SENT_157	[p10l1179t248r1329b296],
4	1999	CD	DATE	1999	dep	3	SENT_157	[p10l1356t249r1510b306],
5	;	:	O	;	_	0	SENT_157	[p10l1356t249r1510b306],
6	274	CD	NUMBER	274	dep	3	SENT_157	[p10l1540t249r1660b296],
7	:	:	O	:	_	0	SENT_157	[p10l1540t249r1660b296],
8	10388-10394	CD	NUMBER	10388-10394	dep	6	SENT_157	[p10l1692t249r2098b296],
9	.	.	O	.	_	0	SENT_157	[p10l1692t249r2098b296],

1	Chango	NNP	MISC	Chango	nn	2	SENT_158	[p10l146t323r366b387],
2	A	NNP	MISC	A	_	0	SENT_158	[p10l407t326r459b382],
3	,	,	O	,	_	0	SENT_158	[p10l407t326r459b382],
4	Emery	NNP	PERSON	Emery	appos	2	SENT_158	[p10l508t323r847b387],
5	.	.	O	.	_	0	SENT_158	[p10l508t323r847b387],

1	—	NN	O	—	_	0	SENT_159	[p10l508t323r847b387],
2	.	.	O	.	_	0	SENT_159	[p10l508t323r847b387],

1	Fi	NNP	O	Fi	nn	3	SENT_160	[p10l508t323r847b387],
2	|	NNP	O	|	nn	3	SENT_160	[p10l508t323r847b387],
3	|	NN	O	|	_	0	SENT_160	[p10l508t323r847b387],
4	on	IN	O	on	_	0	SENT_160	[p10l508t323r847b387],
5	N	NN	O	n	prep_on	3	SENT_160	[p10l895t326r953b382],
6	,	,	O	,	_	0	SENT_160	[p10l895t326r953b382],
7	de	FW	O	de	nn	9	SENT_160	[p10l1000t323r1066b372],
8	Courcy	FW	O	courcy	nn	9	SENT_160	[p10l1110t325r1307b387],
9	GP	NN	O	gp	appos	3	SENT_160	[p10l1349t325r1442b382],
10	,	,	O	,	_	0	SENT_160	[p10l1349t325r1442b382],
11	Lambert	NNP	PERSON	Lambert	nn	12	SENT_160	[p10l1491t323r1720b372],
12	D	NNP	O	D	appos	3	SENT_160	[p10l1764t326r1820b382],
13	,	,	O	,	_	0	SENT_160	[p10l1764t326r1820b382],
14	Pfister	NNP	O	Pfister	nn	15	SENT_160	[p10l1869t323r2034b372],
15	M	NNP	O	M	appos	3	SENT_160	[p10l2078t326r2145b382],
16	,	,	O	,	_	0	SENT_160	[p10l2078t326r2145b382],
17	Rosenblatt	NNP	PERSON	Rosenblatt	nn	18	SENT_160	[p10l148t400r439b449],
18	DS	NN	O	d	appos	3	SENT_160	[p10l470t402r542b449],
19	et	FW	O	et	nn	20	SENT_160	[p10l576t406r625b449],
20	al.	FW	O	al.	dep	18	SENT_160	[p10l653t400r710b449],
21	.	.	O	.	_	0	SENT_160	[p10l653t400r710b449],

1	A	DT	O	a	det	4	SENT_161	[p10l743t402r782b448],
2	polymorphism	NN	O	polymorphism	nn	4	SENT_161	[p10l812t400r1214b464],
3	(	NN	O	(	nn	4	SENT_161	[p10l1247t400r1510b461],
4	80G	NN	O	80g	dep	5	SENT_161	[p10l1247t400r1510b461],
5	>	JJR	O	>	_	0	SENT_161	[p10l1247t400r1510b461],
6	A	DT	O	a	det	7	SENT_161	[p10l1247t400r1510b461],
7	)	NN	O	)	dep	5	SENT_161	[p10l1247t400r1510b461],
8	in	IN	O	in	_	0	SENT_161	[p10l1543t401r1588b448],
9	the	DT	O	the	det	13	SENT_161	[p10l1620t400r1708b449],
10	reduced	VBN	O	reduce	amod	13	SENT_161	[p10l1741t400r1962b449],
11	folate	NN	O	folate	nn	13	SENT_161	[p10l1993t400r2148b449],
12	carrier	NN	O	carrier	nn	13	SENT_161	[p10l145t477r320b524],
13	gene	NN	O	gene	prep_in	7	SENT_161	[p10l347t490r483b539],
14	and	CC	O	and	_	0	SENT_161	[p10l512t476r613b524],
15	its	PRP$	O	its	poss	16	SENT_161	[p10l646t477r702b524],
16	associations	NNS	O	association	prep_in	7	SENT_161	[p10l731t477r1058b524],
17	with	IN	O	with	_	0	SENT_161	[p10l1085t476r1205b524],
18	folate	JJ	O	folate	amod	19	SENT_161	[p10l1234t476r1389b524],
19	status	NN	O	status	prep_with	16	SENT_161	[p10l1417t481r1576b524],
20	and	CC	O	and	_	0	SENT_161	[p10l1605t476r1705b524],
21	homocysteinemia	NN	O	homocysteinemia	conj_and	19	SENT_161	[p10l1739t476r2147b539, p10l148t552r261b598],
22	.	.	O	.	_	0	SENT_161	[p10l1739t476r2147b539, p10l148t552r261b598],

1	Mol	NNP	ORGANIZATION	Mol	nn	3	SENT_162	[p10l292t550r395b598],
2	Genet	NNP	O	Genet	nn	3	SENT_162	[p10l419t552r575b598],
3	Metab	NNP	O	Metab	_	0	SENT_162	[p10l599t550r771b598],
4	2000	CD	DATE	2000	num	3	SENT_162	[p10l795t552r952b608],
5	;	:	O	;	_	0	SENT_162	[p10l795t552r952b608],
6	70	CD	NUMBER	70	num	8	SENT_162	[p10l983t552r1065b598],
7	:	:	O	:	_	0	SENT_162	[p10l983t552r1065b598],
8	310-315	CD	NUMBER	310-315	dep	3	SENT_162	[p10l1096t552r1357b598],
9	.	.	O	.	_	0	SENT_162	[p10l1096t552r1357b598],

1	Morin	NNP	PERSON	Morin	nn	2	SENT_163	[p10l148t628r309b676],
2	I	NNP	O	I	_	0	SENT_163	[p10l340t629r365b686],
3	,	,	O	,	_	0	SENT_163	[p10l340t629r365b686],
4	Devlin	NNP	PERSON	Devlin	nn	5	SENT_163	[p10l396t627r566b676],
5	AM	NNP	O	AM	appos	2	SENT_163	[p10l591t629r703b686],
6	,	,	O	,	_	0	SENT_163	[p10l591t629r703b686],
7	Leclerc	NNP	ORGANIZATION	Leclerc	nn	8	SENT_163	[p10l734t627r922b676],
8	D	NNP	ORGANIZATION	D	appos	2	SENT_163	[p10l950t629r1005b686],
9	,	,	O	,	_	0	SENT_163	[p10l950t629r1005b686],
10	Sabbaghian	NNP	LOCATION	Sabbaghian	nn	11	SENT_163	[p10l1036t627r1360b691],
11	N	NNP	LOCATION	N	appos	2	SENT_163	[p10l1390t629r1449b686],
12	,	,	O	,	_	0	SENT_163	[p10l1390t629r1449b686],
13	Halsted	NNP	O	Halsted	nn	14	SENT_163	[p10l1481t627r1681b676],
14	GH	NN	O	gh	appos	2	SENT_163	[p10l1709t628r1812b686],
15	,	,	O	,	_	0	SENT_163	[p10l1709t628r1812b686],
16	Finnell	NNP	PERSON	Finnell	nn	17	SENT_163	[p10l1843t627r2018b676],
17	R	NNP	O	R	appos	2	SENT_163	[p10l2048t629r2078b675],
18	et	FW	O	et	nn	19	SENT_163	[p10l2104t633r2153b676],
19	al.	FW	O	al.	dep	17	SENT_163	[p10l147t703r205b752],
20	.	.	O	.	_	0	SENT_163	[p10l147t703r205b752],

1	Evaluation	NN	O	evaluation	_	0	SENT_164	[p10l243t703r524b752],
2	of	IN	O	of	_	0	SENT_164	[p10l557t703r611b752],
3	genetic	JJ	O	genetic	amod	4	SENT_164	[p10l640t704r845b767],
4	veriants	NNS	O	veriant	prep_of	1	SENT_164	[p10l874t704r1089b752],
5	in	IN	O	in	_	0	SENT_164	[p10l1122t704r1166b751],
6	the	DT	O	the	det	9	SENT_164	[p10l1200t703r1288b752],
7	reduced	VBN	O	reduce	amod	9	SENT_164	[p10l1322t703r1543b752],
8	folate	NN	O	folate	nn	9	SENT_164	[p10l1575t703r1729b752],
9	carrier	NN	O	carrier	prep_in	4	SENT_164	[p10l1762t704r1936b752],
10	and	CC	O	and	_	0	SENT_164	[p10l1965t703r2066b752],
11	in	IN	O	in	_	0	SENT_164	[p10l2102t704r2146b751],
12	glutamate	JJ	O	glutamate	amod	13	SENT_164	[p10l145t779r428b842],
13	carboxypeptidase	NN	O	carboxypeptidase	prep_in	4	SENT_164	[p10l462t779r953b843],
14	II	CD	NUMBER	ii	num	13	SENT_164	[p10l990t781r1013b827],
15	for	IN	O	for	_	0	SENT_164	[p10l1046t779r1124b827],
16	spina	NN	O	spina	nn	18	SENT_164	[p10l1154t780r1296b843],
17	bifida	NN	O	bifida	nn	18	SENT_164	[p10l1332t779r1481b827],
18	risk	NN	O	risk	prep_for	13	SENT_164	[p10l1518t779r1619b827],
19	.	.	O	.	_	0	SENT_164	[p10l1518t779r1619b827],

1	Mol	NNP	ORGANIZATION	Mol	nn	3	SENT_165	[p10l1657t779r1760b827],
2	Genet	NNP	O	Genet	nn	3	SENT_165	[p10l1791t780r1948b827],
3	Metab	NNP	O	Metab	_	0	SENT_165	[p10l1978t779r2150b827],
4	2003	CD	DATE	2003	num	3	SENT_165	[p10l146t855r303b911],
5	;	:	O	;	_	0	SENT_165	[p10l146t855r303b911],
6	79	CD	NUMBER	79	num	8	SENT_165	[p10l335t855r416b901],
7	:	:	O	:	_	0	SENT_165	[p10l335t855r416b901],
8	197-200	CD	NUMBER	197-200	dep	3	SENT_165	[p10l448t855r708b901],
9	.	.	O	.	_	0	SENT_165	[p10l448t855r708b901],

1	Whetstine	NNP	O	Whetstine	nn	2	SENT_166	[p10l143t930r423b979],
2	JR	NNP	O	JR	_	0	SENT_166	[p10l455t932r519b990],
3	,	,	O	,	_	0	SENT_166	[p10l455t932r519b990],
4	Gifford	NNP	PERSON	Gifford	nn	6	SENT_166	[p10l555t930r745b979],
5	A	NNP	O	A	nn	6	SENT_166	[p10l776t932r846b990],
6	]	NNP	O	]	appos	2	SENT_166	[p10l776t932r846b990],
7	,	,	O	,	_	0	SENT_166	[p10l776t932r846b990],
8	Witt	NNP	PERSON	Witt	nn	9	SENT_166	[p10l879t931r997b979],
9	T	NN	O	t	appos	2	SENT_166	[p10l1026t932r1074b989],
10	,	,	O	,	_	0	SENT_166	[p10l1026t932r1074b989],
11	Liu	NNP	ORGANIZATION	Liu	nn	12	SENT_166	[p10l1112t931r1185b979],
12	XY	NN	ORGANIZATION	xy	appos	2	SENT_166	[p10l1219t932r1306b989],
13	,	,	O	,	_	0	SENT_166	[p10l1219t932r1306b989],
14	Flateley	NN	O	flateley	nn	15	SENT_166	[p10l1344t930r1550b994],
15	RM	NN	O	rm	appos	2	SENT_166	[p10l1584t932r1687b989],
16	,	,	O	,	_	0	SENT_166	[p10l1584t932r1687b989],
17	Norris	NNP	PERSON	Norris	nn	18	SENT_166	[p10l1725t931r1888b979],
18	M	NNP	O	M	appos	2	SENT_166	[p10l1923t932r1972b978],
19	et	FW	O	et	nn	20	SENT_166	[p10l2009t936r2058b979],
20	al.	FW	O	al.	dep	18	SENT_166	[p10l2087t930r2145b979],
21	.	.	O	.	_	0	SENT_166	[p10l2087t930r2145b979],

1	Single	JJ	O	single	amod	3	SENT_167	[p10l147t1006r313b1069],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_167	[p10l341t1006r631b1054],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_167	[p10l660t1006r1088b1069],
4	in	IN	O	in	_	0	SENT_167	[p10l1116t1007r1161b1054],
5	the	DT	O	the	det	9	SENT_167	[p10l1189t1006r1277b1054],
6	human	JJ	O	human	amod	9	SENT_167	[p10l1306t1006r1497b1054],
7	reduced	VBN	O	reduce	amod	9	SENT_167	[p10l1528t1006r1749b1054],
8	folate	NN	O	folate	nn	9	SENT_167	[p10l1776t1006r1931b1054],
9	carrier	NN	O	carrier	prep_in	3	SENT_167	[p10l1958t1007r2145b1054],
10	:	:	O	:	_	0	SENT_167	[p10l1958t1007r2145b1054],
11	characterisation	NN	O	characterisation	dep	9	SENT_167	[p10l145t1082r583b1131],
12	of	IN	O	of	_	0	SENT_167	[p10l620t1082r674b1131],
13	a	DT	O	a	det	17	SENT_167	[p10l706t1096r732b1131],
14	high	JJ	O	high	amod	17	SENT_167	[p10l770t1082r889b1146],
15	frequency	NN	O	frequency	nn	17	SENT_167	[p10l924t1082r1203b1146],
16	G/A	NN	O	g/a	nn	17	SENT_167	[p10l1238t1082r1346b1137],
17	variant	NN	O	variant	prep_of	11	SENT_167	[p10l1377t1083r1568b1131],
18	at	IN	O	at	_	0	SENT_167	[p10l1601t1088r1653b1131],
19	position	NN	O	position	prep_at	17	SENT_167	[p10l1688t1083r1904b1146],
20	80	CD	NUMBER	80	num	19	SENT_167	[p10l1943t1084r2010b1131],
21	and	CC	O	and	_	0	SENT_167	[p10l2045t1082r2146b1131],
22	transport	NN	O	transport	nn	23	SENT_167	[p10l144t1163r399b1221],
23	properties	NNS	O	property	prep_of	11	SENT_167	[p10l423t1159r700b1221],
24	of	IN	O	of	_	0	SENT_167	[p10l723t1157r777b1206],
25	the	DT	O	the	det	29	SENT_167	[p10l797t1157r885b1206],
26	His	PRP$	O	he	poss	28	SENT_167	[p10l912t1158r1108b1218],
27	(	CD	NUMBER	(	number	28	SENT_167	[p10l912t1158r1108b1218],
28	27	CD	NUMBER	27	nn	29	SENT_167	[p10l912t1158r1108b1218],
29	)	NN	O	)	prep_of	23	SENT_167	[p10l912t1158r1108b1218],
30	and	CC	O	and	_	0	SENT_167	[p10l1132t1157r1233b1206],
31	Arg	NN	O	arg	prep_of	23	SENT_167	[p10l1257t1158r1471b1221],
32	(	CD	NUMBER	(	number	33	SENT_167	[p10l1257t1158r1471b1221],
33	27	CD	NUMBER	27	num	35	SENT_167	[p10l1257t1158r1471b1221],
34	)	NN	O	)	nn	35	SENT_167	[p10l1257t1158r1471b1221],
35	carriers	NNS	O	carrier	dep	31	SENT_167	[p10l1496t1159r1707b1206],
36	.	.	O	.	_	0	SENT_167	[p10l1496t1159r1707b1206],

1	Clin	NNP	O	Clin	nn	3	SENT_168	[p10l1738t1157r1836b1206],
2	Cancer	NNP	O	Cancer	nn	3	SENT_168	[p10l1862t1159r2048b1206],
3	Res	NNP	O	Res	_	0	SENT_168	[p10l2067t1160r2151b1206],
4	2001	CD	DATE	2001	num	3	SENT_168	[p10l146t1234r303b1291],
5	;	:	O	;	_	0	SENT_168	[p10l146t1234r303b1291],
6	7	CD	NUMBER	7	num	8	SENT_168	[p10l335t1235r379b1281],
7	:	:	O	:	_	0	SENT_168	[p10l335t1235r379b1281],
8	3416-3422	CD	DURATION	3416-3422	dep	3	SENT_168	[p10l412t1234r744b1281],
9	.	.	O	.	_	0	SENT_168	[p10l412t1234r744b1281],

1	Dervieux	JJ	ORGANIZATION	dervieux	amod	2	SENT_169	[p10l148t1310r392b1357],
2	T	NN	ORGANIZATION	t	_	0	SENT_169	[p10l424t1311r472b1367],
3	,	,	O	,	_	0	SENT_169	[p10l424t1311r472b1367],
4	Kremer	NNP	PERSON	Kremer	nn	5	SENT_169	[p10l512t1310r712b1357],
5	J	NNP	PERSON	J	appos	2	SENT_169	[p10l742t1311r772b1369],
6	,	,	O	,	_	0	SENT_169	[p10l742t1311r772b1369],
7	Lein	NNP	PERSON	Lein	nn	8	SENT_169	[p10l812t1310r918b1357],
8	DO	NNP	O	DO	appos	2	SENT_169	[p10l958t1310r1063b1367],
9	,	,	O	,	_	0	SENT_169	[p10l958t1310r1063b1367],
10	Capps	NNP	PERSON	Capps	nn	11	SENT_169	[p10l1101t1310r1273b1372],
11	R	NNP	PERSON	R	appos	2	SENT_169	[p10l1309t1311r1353b1367],
12	,	,	O	,	_	0	SENT_169	[p10l1309t1311r1353b1367],
13	Barham	NNP	PERSON	Barham	nn	14	SENT_169	[p10l1393t1309r1600b1357],
14	R	NNP	PERSON	R	appos	2	SENT_169	[p10l1640t1311r1683b1367],
15	,	,	O	,	_	0	SENT_169	[p10l1640t1311r1683b1367],
16	Meyer	NNP	PERSON	Meyer	nn	17	SENT_169	[p10l1723t1311r1897b1372],
17	G	NNP	O	G	appos	2	SENT_169	[p10l1929t1310r1969b1357],
18	et	FW	O	et	nn	19	SENT_169	[p10l2007t1314r2056b1357],
19	al.	FW	O	al.	dep	17	SENT_169	[p10l2087t1309r2145b1357],
20	.	.	O	.	_	0	SENT_169	[p10l2087t1309r2145b1357],

1	Contribution	NN	O	contribution	_	0	SENT_170	[p10l146t1385r502b1434],
2	of	IN	O	of	_	0	SENT_170	[p10l530t1385r584b1434],
3	common	JJ	O	common	amod	4	SENT_170	[p10l607t1400r856b1434],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_170	[p10l887t1385r1315b1449],
5	in	IN	O	in	_	0	SENT_170	[p10l1343t1387r1388b1433],
6	reduced	VBN	O	reduce	amod	8	SENT_170	[p10l1418t1385r1639b1434],
7	folate	NN	O	folate	nn	8	SENT_170	[p10l1666t1385r1820b1434],
8	carrier	NN	O	carrier	prep_in	4	SENT_170	[p10l1847t1387r2021b1434],
9	and	CC	O	and	_	0	SENT_170	[p10l2045t1385r2146b1434],
10	gamma-glutamylhydrolase	NN	O	gamma-glutamylhydrolase	prep_in	4	SENT_170	[p10l145t1461r896b1525],
11	to	TO	O	to	_	0	SENT_170	[p10l963t1467r1018b1510],
12	methotrexate	NN	O	methotrexate	nn	14	SENT_170	[p10l1087t1461r1461b1510],
13	polyglutamate	NN	O	polyglutamate	nn	14	SENT_170	[p10l1532t1461r1933b1525],
14	levels	NNS	O	level	prep_to	1	SENT_170	[p10l2003t1461r2148b1510],
15	in	IN	O	in	_	0	SENT_170	[p10l147t1538r192b1585],
16	patients	NNS	O	patient	prep_in	1	SENT_170	[p10l243t1538r460b1600],
17	with	IN	O	with	_	0	SENT_170	[p10l506t1537r625b1585],
18	rheumatoid	JJ	O	rheumatoid	amod	19	SENT_170	[p10l677t1537r997b1585],
19	arthritis	NN	O	arthritis	prep_with	1	SENT_170	[p10l1048t1537r1271b1585],
20	.	.	O	.	_	0	SENT_170	[p10l1048t1537r1271b1585],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_171	[p10l1324t1537r1808b1600],
2	2004	CD	DATE	2004	num	1	SENT_171	[p10l1853t1538r2010b1595],
3	;	:	O	;	_	0	SENT_171	[p10l1853t1538r2010b1595],
4	14	CD	NUMBER	14	num	6	SENT_171	[p10l2064t1538r2145b1585],
5	:	:	O	:	_	0	SENT_171	[p10l2064t1538r2145b1585],
6	733-739	CD	NUMBER	733-739	dep	1	SENT_171	[p10l148t1615r409b1661],
7	.	.	O	.	_	0	SENT_171	[p10l148t1615r409b1661],

1	Rhee	NNP	PERSON	Rhee	nn	2	SENT_172	[p10l148t1688r279b1737],
2	MS	NN	O	m	_	0	SENT_172	[p10l311t1690r412b1747],
3	,	,	O	,	_	0	SENT_172	[p10l311t1690r412b1747],
4	Galivan	NNP	O	Galivan	nn	6	SENT_172	[p10l446t1688r649b1737],
5	J.	NNP	O	J.	nn	6	SENT_172	[p10l680t1691r709b1748],
6	Conversion	NNP	O	Conversion	appos	2	SENT_172	[p10l743t1690r1053b1737],
7	of	IN	O	of	_	0	SENT_172	[p10l1085t1688r1139b1737],
8	methotrexate	NN	O	methotrexate	prep_of	6	SENT_172	[p10l1168t1688r1542b1737],
9	to	TO	O	to	_	0	SENT_172	[p10l1572t1694r1627b1737],
10	7	CD	NUMBER	7	number	11	SENT_172	[p10l1660t1688r2147b1752],
11	—	CD	NUMBER	—	num	14	SENT_172	[p10l1660t1688r2147b1752],
12	hydroxymetho	NN	O	hydroxymetho	nn	14	SENT_172	[p10l1660t1688r2147b1752],
13	—	NN	O	—	nn	14	SENT_172	[p10l1660t1688r2147b1752],
14	trexate	NN	O	trexate	prep_to	8	SENT_172	[p10l144t1771r337b1814],
15	and	CC	O	and	_	0	SENT_172	[p10l381t1765r482b1814],
16	7-hydroxymethotrexate	JJ	O	7-hydroxymethotrexate	amod	17	SENT_172	[p10l531t1765r1194b1829],
17	polyglutamates	NNS	O	polyglutamate	prep_to	8	SENT_172	[p10l1241t1765r1667b1829],
18	in	IN	O	in	_	0	SENT_172	[p10l1713t1766r1757b1813],
19	cultured	VBN	O	culture	prepc_in	14	SENT_172	[p10l1804t1765r2030b1814],
20	rat	NN	O	rat	nn	22	SENT_172	[p10l2079t1771r2150b1814],
21	hepatic	JJ	O	hepatic	amod	22	SENT_172	[p10l148t1841r349b1904],
22	cells	NNS	O	cell	dobj	19	SENT_172	[p10l375t1841r504b1889],
23	.	.	O	.	_	0	SENT_172	[p10l375t1841r504b1889],

1	Cancer	NNP	O	Cancer	nn	2	SENT_173	[p10l537t1842r723b1889],
2	Res	NNP	O	Res	_	0	SENT_173	[p10l744t1843r828b1889],
3	1986	CD	DATE	1986	num	2	SENT_173	[p10l854t1842r1008b1899],
4	;	:	O	;	_	0	SENT_173	[p10l854t1842r1008b1899],
5	46	CD	NUMBER	46	num	7	SENT_173	[p10l1036t1842r1121b1889],
6	:	:	O	:	_	0	SENT_173	[p10l1036t1842r1121b1889],
7	3793-3797	CD	DURATION	3793-3797	dep	2	SENT_173	[p10l1153t1842r1486b1889],
8	.	.	O	.	_	0	SENT_173	[p10l1153t1842r1486b1889],

1	Kremer	NNP	PERSON	Kremer	nn	2	SENT_174	[p10l148t1917r348b1963],
2	JM	NN	O	jm	_	0	SENT_174	[p10l366t1918r455b1974],
3	,	,	O	,	_	0	SENT_174	[p10l366t1918r455b1974],
4	Galivan	NNP	PERSON	Galivan	nn	5	SENT_174	[p10l481t1915r685b1963],
5	J	NNP	PERSON	J	appos	2	SENT_174	[p10l708t1918r737b1974],
6	,	,	O	,	_	0	SENT_174	[p10l708t1918r737b1974],
7	Streckfuss	NNP	O	Streckfuss	nn	8	SENT_174	[p10l764t1915r1034b1963],
8	A	NNP	O	A	appos	2	SENT_174	[p10l1054t1918r1106b1973],
9	,	,	O	,	_	0	SENT_174	[p10l1054t1918r1106b1973],
10	Kamen	NNP	PERSON	Kamen	nn	14	SENT_174	[p10l1135t1917r1322b1963],
11	B.	NNP	O	B.	nn	14	SENT_174	[p10l1349t1918r1394b1963],
12	Methotrexate	NNP	O	Methotrexate	nn	14	SENT_174	[p10l1423t1915r1800b1963],
13	metabolism	NN	O	metabolism	nn	14	SENT_174	[p10l1824t1915r2146b1963],
14	analysis	NN	O	analysis	appos	2	SENT_174	[p10l145t1992r354b2056],
15	in	IN	O	in	_	0	SENT_174	[p10l382t1993r427b2040],
16	blood	NN	O	blood	prep_in	14	SENT_174	[p10l458t1992r614b2041],
17	and	CC	O	and	_	0	SENT_174	[p10l642t1992r743b2041],
18	liver	NN	O	liver	prep_in	14	SENT_174	[p10l774t1992r886b2041],
19	of	IN	O	of	_	0	SENT_174	[p10l911t1992r964b2041],
20	rheumatoid	JJ	O	rheumatoid	amod	22	SENT_174	[p10l990t1992r1310b2041],
21	arthritis	NN	O	arthritis	nn	22	SENT_174	[p10l1339t1992r1547b2041],
22	patients	NNS	O	patient	prep_of	14	SENT_174	[p10l1576t1993r1808b2056],
23	.	.	O	.	_	0	SENT_174	[p10l1576t1993r1808b2056],

1	Association	NNP	O	Association	_	0	SENT_175	[p10l1836t1993r2146b2041],
2	with	IN	O	with	_	0	SENT_175	[p10l143t2068r263b2116],
3	hepatic	JJ	O	hepatic	amod	5	SENT_175	[p10l289t2068r490b2131],
4	folate	NN	O	folate	nn	5	SENT_175	[p10l508t2068r663b2116],
5	deficiency	NN	O	deficiency	prep_with	1	SENT_175	[p10l684t2068r964b2131],
6	and	CC	O	and	_	0	SENT_175	[p10l984t2068r1084b2116],
7	formation	NN	O	formation	conj_and	5	SENT_175	[p10l1104t2068r1377b2116],
8	of	IN	O	of	_	0	SENT_175	[p10l1401t2068r1455b2116],
9	polyglutamates	NNS	O	polyglutamate	prep_of	1	SENT_175	[p10l1474t2068r1918b2131],
10	.	.	O	.	_	0	SENT_175	[p10l1474t2068r1918b2131],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_176	[p10l1940t2068r2151b2116],
2	Rheum	NNP	O	Rheum	_	0	SENT_176	[p10l148t2143r329b2191],
3	1986	CD	DATE	1986	num	2	SENT_176	[p10l356t2144r510b2201],
4	;	:	O	;	_	0	SENT_176	[p10l356t2144r510b2201],
5	29	CD	NUMBER	29	num	7	SENT_176	[p10l540t2144r624b2191],
6	:	:	O	:	_	0	SENT_176	[p10l540t2144r624b2191],
7	832-835	CD	NUMBER	832-835	dep	2	SENT_176	[p10l653t2144r915b2191],
8	.	.	O	.	_	0	SENT_176	[p10l653t2144r915b2191],

1	Wolfe	NNP	PERSON	Wolfe	nn	2	SENT_177	[p10l143t2218r303b2267],
2	F	NN	O	f	_	0	SENT_177	[p10l329t2221r368b2277],
3	,	,	O	,	_	0	SENT_177	[p10l329t2221r368b2277],
4	O’De	NN	O	o’de	nn	7	SENT_177	[p10l394t2218r566b2267],
5	|	CD	NUMBER	|	num	7	SENT_177	[p10l394t2218r566b2267],
6	|	NN	O	|	nn	7	SENT_177	[p10l394t2218r566b2267],
7	JR	NN	O	jr	appos	2	SENT_177	[p10l590t2221r655b2278],
8	,	,	O	,	_	0	SENT_177	[p10l590t2221r655b2278],
9	Kavanaugh	NNP	PERSON	Kavanaugh	nn	10	SENT_177	[p10l684t2218r988b2282],
10	A	NNP	O	A	appos	2	SENT_177	[p10l1011t2221r1064b2277],
11	,	,	O	,	_	0	SENT_177	[p10l1011t2221r1064b2277],
12	Wilske	NNP	PERSON	Wilske	nn	13	SENT_177	[p10l1087t2218r1263b2267],
13	K	NNP	PERSON	K	appos	2	SENT_177	[p10l1289t2220r1334b2277],
14	,	,	O	,	_	0	SENT_177	[p10l1289t2220r1334b2277],
15	Pincus	NNP	PERSON	Pincus	nn	16	SENT_177	[p10l1364t2220r1535b2267],
16	T.	NNP	O	T.	nsubj	17	SENT_177	[p10l1556t2221r1605b2267],
17	Evaluating	VBG	O	evaluate	dep	2	SENT_177	[p10l1633t2218r1915b2282],
18	severity	NN	O	severity	dobj	17	SENT_177	[p10l1940t2220r2149b2282],
19	and	CC	O	and	_	0	SENT_177	[p10l145t2294r246b2342],
20	status	NN	O	status	dobj	17	SENT_177	[p10l273t2300r431b2342],
21	in	IN	O	in	_	0	SENT_177	[p10l458t2295r503b2341],
22	rheumatoid	JJ	O	rheumatoid	amod	23	SENT_177	[p10l533t2294r853b2342],
23	arthritis	NN	O	arthritis	prep_in	17	SENT_177	[p10l881t2294r1104b2342],
24	.	.	O	.	_	0	SENT_177	[p10l881t2294r1104b2342],

1	/	:	O	/	punct	2	SENT_178	[p10l1130t2296r1150b2353],
2	Rheumatol	NNP	O	Rheumatol	_	0	SENT_178	[p10l1174t2294r1463b2342],
3	2001	CD	DATE	2001	dep	2	SENT_178	[p10l1484t2295r1641b2352],
4	;	:	O	;	_	0	SENT_178	[p10l1484t2295r1641b2352],
5	28	CD	NUMBER	28	dep	2	SENT_178	[p10l1670t2295r1754b2342],
6	:	:	O	:	_	0	SENT_178	[p10l1670t2295r1754b2342],
7	1453-1462	CD	DATE	1453-1462	dep	5	SENT_178	[p10l1786t2295r2118b2342],
8	.	.	O	.	_	0	SENT_178	[p10l1786t2295r2118b2342],

1	Pincus	NNP	ORGANIZATION	Pincus	nn	2	SENT_179	[p10l148t2371r320b2418],
2	T	NN	ORGANIZATION	t	_	0	SENT_179	[p10l366t2372r414b2428],
3	,	,	O	,	_	0	SENT_179	[p10l366t2372r414b2428],
4	Summey	NNP	PERSON	Summey	nn	5	SENT_179	[p10l467t2371r711b2433],
5	JA	NNP	O	JA	appos	2	SENT_179	[p10l758t2372r826b2429],
6	,	,	O	,	_	0	SENT_179	[p10l758t2372r826b2429],
7	Soraci	NNP	ORGANIZATION	Soraci	nn	9	SENT_179	[p10l879t2371r1041b2418],
8	Jr	NNP	ORGANIZATION	Jr	nn	9	SENT_179	[p10l1090t2372r1129b2429],
9	SA	NNP	ORGANIZATION	SA	appos	2	SENT_179	[p10l1176t2371r1258b2428],
10	,	,	O	,	_	0	SENT_179	[p10l1176t2371r1258b2428],
11	Wallston	NNP	LOCATION	Wallston	nn	12	SENT_179	[p10l1307t2370r1546b2418],
12	KA	NN	LOCATION	ka	appos	2	SENT_179	[p10l1598t2371r1684b2428],
13	,	,	O	,	_	0	SENT_179	[p10l1598t2371r1684b2428],
14	Hummon	NNP	PERSON	Hummon	nn	15	SENT_179	[p10l1739t2372r1999b2418],
15	NP	NNP	O	NP	appos	2	SENT_179	[p10l2052t2372r2145b2418],
16	.	.	O	.	_	0	SENT_179	[p10l2052t2372r2145b2418],

1	Assessment	NNP	O	Assessment	_	0	SENT_180	[p10l143t2448r462b2495],
2	of	IN	O	of	_	0	SENT_180	[p10l496t2446r549b2495],
3	patient	NN	O	patient	nn	4	SENT_180	[p10l584t2447r778b2510],
4	satisfaction	NN	O	satisfaction	prep_of	1	SENT_180	[p10l810t2446r1114b2495],
5	in	IN	O	in	_	0	SENT_180	[p10l1154t2447r1198b2494],
6	activities	NNS	O	activity	prep_in	1	SENT_180	[p10l1235t2447r1472b2495],
7	of	IN	O	of	_	0	SENT_180	[p10l1506t2446r1560b2495],
8	daily	JJ	SET	daily	amod	9	SENT_180	[p10l1592t2446r1722b2510],
9	living	NN	O	living	prep_of	1	SENT_180	[p10l1757t2446r1901b2510],
10	using	VBG	O	use	_	0	SENT_180	[p10l1940t2447r2083b2510],
11	a	DT	O	a	det	14	SENT_180	[p10l2120t2460r2147b2495],
12	modified	VBN	O	modify	amod	14	SENT_180	[p10l148t2521r390b2569],
13	Stanford	NNP	ORGANIZATION	Stanford	nn	14	SENT_180	[p10l432t2521r663b2569],
14	Health	NNP	ORGANIZATION	Health	prep_using	1	SENT_180	[p10l707t2521r881b2569],
15	Assessment	NNP	ORGANIZATION	Assessment	nn	16	SENT_180	[p10l919t2523r1239b2569],
16	Questionnaire	NNP	O	Questionnaire	dep	14	SENT_180	[p10l1276t2522r1680b2578],
17	.	.	O	.	_	0	SENT_180	[p10l1276t2522r1680b2578],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_181	[p10l1720t2521r1930b2569],
2	Rheum	NNP	O	Rheum	_	0	SENT_181	[p10l1969t2521r2150b2569],
3	1983	CD	DATE	1983	num	2	SENT_181	[p10l148t2597r303b2653],
4	;	:	O	;	_	0	SENT_181	[p10l148t2597r303b2653],
5	26	CD	NUMBER	26	num	7	SENT_181	[p10l332t2597r416b2643],
6	:	:	O	:	_	0	SENT_181	[p10l332t2597r416b2643],
7	1346-1353	CD	DATE	1346-1353	dep	2	SENT_181	[p10l448t2597r781b2643],
8	.	.	O	.	_	0	SENT_181	[p10l448t2597r781b2643],

1	Felson	NNP	PERSON	Felson	nn	2	SENT_182	[p10l148t2671r316b2718],
2	DT	NNP	O	DT	_	0	SENT_182	[p10l351t2673r442b2728],
3	,	,	O	,	_	0	SENT_182	[p10l351t2673r442b2728],
4	Anderson	NNP	PERSON	Anderson	nn	5	SENT_182	[p10l473t2671r736b2718],
5	JJ	NN	PERSON	jj	appos	2	SENT_182	[p10l767t2673r815b2729],
6	,	,	O	,	_	0	SENT_182	[p10l767t2673r815b2729],
7	Boers	NNP	ORGANIZATION	Boers	nn	8	SENT_182	[p10l851t2673r996b2718],
8	M	NNP	ORGANIZATION	M	appos	2	SENT_182	[p10l1030t2673r1097b2728],
9	,	,	O	,	_	0	SENT_182	[p10l1030t2673r1097b2728],
10	Bombardier	NNP	ORGANIZATION	Bombardier	nn	11	SENT_182	[p10l1133t2671r1459b2718],
11	C	NNP	ORGANIZATION	C	appos	2	SENT_182	[p10l1487t2672r1541b2729],
12	,	,	O	,	_	0	SENT_182	[p10l1487t2672r1541b2729],
13	Chernoff	NNP	PERSON	Chernoff	nn	14	SENT_182	[p10l1575t2671r1820b2718],
14	M	NNP	O	M	appos	2	SENT_182	[p10l1850t2673r1918b2728],
15	,	,	O	,	_	0	SENT_182	[p10l1850t2673r1918b2728],
16	Fried	NNP	O	Fried	nn	17	SENT_182	[p10l1954t2671r2083b2718],
17	B	NNP	O	B	appos	2	SENT_182	[p10l2119t2673r2148b2718],
18	et	FW	O	et	nn	19	SENT_182	[p10l147t2752r196b2795],
19	al.	FW	O	al.	dep	17	SENT_182	[p10l224t2746r282b2795],
20	.	.	O	.	_	0	SENT_182	[p10l224t2746r282b2795],

1	The	DT	O	the	det	3	SENT_183	[p10l314t2746r416b2795],
2	American	NNP	O	American	nn	3	SENT_183	[p10l445t2748r706b2795],
3	College	NNP	O	College	_	0	SENT_183	[p10l740t2746r949b2810],
4	of	IN	O	of	_	0	SENT_183	[p10l980t2746r1034b2795],
5	Rheumatology	NNP	O	Rheumatology	nn	8	SENT_183	[p10l1064t2746r1469b2810],
6	preliminary	JJ	O	preliminary	amod	8	SENT_183	[p10l1501t2746r1814b2810],
7	core	NN	O	core	nn	8	SENT_183	[p10l1844t2761r1961b2795],
8	set	NN	O	set	prep_of	3	SENT_183	[p10l1991t2752r2069b2795],
9	of	IN	O	of	_	0	SENT_183	[p10l2097t2746r2151b2795],
10	disease	NN	O	disease	nn	12	SENT_183	[p10l145t2823r340b2872],
11	activity	NN	O	activity	nn	12	SENT_183	[p10l381t2824r577b2887],
12	measures	NNS	O	measure	prep_of	3	SENT_183	[p10l617t2837r874b2872],
13	for	IN	O	for	_	0	SENT_183	[p10l910t2823r988b2872],
14	rheumatoid	JJ	O	rheumatoid	amod	15	SENT_183	[p10l1027t2823r1347b2872],
15	arthritis	NN	O	arthritis	prep_for	3	SENT_183	[p10l1389t2823r1597b2872],
16	clinical	JJ	O	clinical	amod	17	SENT_183	[p10l1636t2823r1821b2872],
17	trials	NNS	O	trial	dep	15	SENT_183	[p10l1862t2823r2005b2872],
18	.	.	O	.	_	0	SENT_183	[p10l1862t2823r2005b2872],

1	The	DT	O	the	det	2	SENT_184	[p10l2045t2823r2148b2872],
2	Committee	NNP	O	Committee	_	0	SENT_184	[p10l146t2900r460b2946],
3	on	IN	O	on	_	0	SENT_184	[p10l485t2913r552b2946],
4	outcome	NN	O	outcome	nn	5	SENT_184	[p10l580t2904r827b2946],
5	measures	NNS	O	measure	prep_on	2	SENT_184	[p10l855t2913r1110b2946],
6	in	IN	O	in	_	0	SENT_184	[p10l1136t2900r1181b2946],
7	rheumatoid	JJ	O	rheumatoid	amod	8	SENT_184	[p10l1210t2899r1530b2946],
8	arthritis	NN	O	arthritis	prep_in	2	SENT_184	[p10l1558t2899r1766b2946],
9	clinical	JJ	O	clinical	amod	10	SENT_184	[p10l1791t2899r1975b2946],
10	trials	NNS	O	trial	dep	8	SENT_184	[p10l2002t2899r2145b2946],
11	.	.	O	.	_	0	SENT_184	[p10l2002t2899r2145b2946],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_185	[p10l144t2974r355b3022],
2	Rheum	NNP	O	Rheum	_	0	SENT_185	[p10l380t2974r561b3022],
3	1993	CD	DATE	1993	num	2	SENT_185	[p10l588t2976r742b3032],
4	;	:	O	;	_	0	SENT_185	[p10l588t2976r742b3032],
5	36	CD	NUMBER	36	num	7	SENT_185	[p10l772t2976r856b3022],
6	:	:	O	:	_	0	SENT_185	[p10l772t2976r856b3022],
7	729-740	CD	NUMBER	729-740	dep	2	SENT_185	[p10l888t2976r1147b3022],
8	.	.	O	.	_	0	SENT_185	[p10l888t2976r1147b3022],

1	Felson	NNP	PERSON	Felson	nn	2	SENT_186	[p10l148t3049r316b3097],
2	DT	NNP	O	DT	_	0	SENT_186	[p10l348t3051r438b3107],
3	,	,	O	,	_	0	SENT_186	[p10l348t3051r438b3107],
4	Anderson	NNP	PERSON	Anderson	nn	5	SENT_186	[p10l466t3049r729b3097],
5	JJ	NN	PERSON	jj	appos	2	SENT_186	[p10l757t3051r804b3108],
6	,	,	O	,	_	0	SENT_186	[p10l757t3051r804b3108],
7	Boers	NNP	ORGANIZATION	Boers	nn	8	SENT_186	[p10l837t3051r982b3097],
8	M	NNP	ORGANIZATION	M	appos	2	SENT_186	[p10l1012t3051r1079b3107],
9	,	,	O	,	_	0	SENT_186	[p10l1012t3051r1079b3107],
10	Bombardier	NNP	ORGANIZATION	Bombardier	nn	11	SENT_186	[p10l1112t3049r1437b3097],
11	C	NNP	ORGANIZATION	C	appos	2	SENT_186	[p10l1462t3050r1516b3107],
12	,	,	O	,	_	0	SENT_186	[p10l1462t3050r1516b3107],
13	Furst	NNP	ORGANIZATION	Furst	nn	14	SENT_186	[p10l1549t3051r1680b3097],
14	D	NNP	ORGANIZATION	D	appos	2	SENT_186	[p10l1707t3051r1763b3107],
15	,	,	O	,	_	0	SENT_186	[p10l1707t3051r1763b3107],
16	Goldsmith	NNP	PERSON	Goldsmith	nn	17	SENT_186	[p10l1793t3049r2079b3097],
17	C	NNP	O	C	appos	2	SENT_186	[p10l2109t3050r2148b3097],
18	et	FW	O	et	nn	19	SENT_186	[p10l147t3131r196b3174],
19	al.	FW	O	al.	dep	17	SENT_186	[p10l247t3125r304b3174],
20	.	.	O	.	_	0	SENT_186	[p10l247t3125r304b3174],

1	American	NNP	ORGANIZATION	American	nn	2	SENT_187	[p10l358t3126r620b3174],
2	College	NNP	ORGANIZATION	College	_	0	SENT_187	[p10l676t3125r884b3189],
3	of	IN	ORGANIZATION	of	_	0	SENT_187	[p10l938t3125r992b3174],
4	Rheumatology	NNP	ORGANIZATION	Rheumatology	prep_of	2	SENT_187	[p10l1044t3125r1464b3189],
5	.	.	O	.	_	0	SENT_187	[p10l1044t3125r1464b3189],

1	Preliminary	JJ	O	preliminary	amod	2	SENT_188	[p10l1523t3125r1832b3189],
2	definition	NN	O	definition	_	0	SENT_188	[p10l1884t3125r2146b3174],
3	of	IN	O	of	_	0	SENT_188	[p10l145t3201r200b3249],
4	improvement	NN	O	improvement	prep_of	2	SENT_188	[p10l240t3202r618b3264],
5	in	IN	O	in	_	0	SENT_188	[p10l660t3202r704b3249],
6	rheumatoid	JJ	O	rheumatoid	amod	7	SENT_188	[p10l751t3201r1072b3249],
7	arthritis	NN	O	arthritis	prep_in	2	SENT_188	[p10l1116t3201r1339b3249],
8	.	.	O	.	_	0	SENT_188	[p10l1116t3201r1339b3249],

1	Arthritis	NNP	O	Arthritis	nn	2	SENT_189	[p10l1383t3201r1594b3249],
2	Rheum	NNP	O	Rheum	_	0	SENT_189	[p10l1636t3201r1817b3249],
3	1995	CD	DATE	1995	num	2	SENT_189	[p10l1861t3202r2015b3259],
4	;	:	O	;	_	0	SENT_189	[p10l1861t3202r2015b3259],
5	38	CD	NUMBER	38	num	7	SENT_189	[p10l2062t3202r2145b3249],
6	:	:	O	:	_	0	SENT_189	[p10l2062t3202r2145b3249],
7	727-735	CD	NUMBER	727-735	dep	2	SENT_189	[p10l148t3279r409b3325],
8	.	.	O	.	_	0	SENT_189	[p10l148t3279r409b3325],

